JPS6349511B2 - - Google Patents
Info
- Publication number
- JPS6349511B2 JPS6349511B2 JP58501976A JP50197683A JPS6349511B2 JP S6349511 B2 JPS6349511 B2 JP S6349511B2 JP 58501976 A JP58501976 A JP 58501976A JP 50197683 A JP50197683 A JP 50197683A JP S6349511 B2 JPS6349511 B2 JP S6349511B2
- Authority
- JP
- Japan
- Prior art keywords
- drug
- hydroxy
- patient
- bladder
- benzenediol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000003814 drug Substances 0.000 description 117
- 229940079593 drug Drugs 0.000 description 105
- 239000000443 aerosol Substances 0.000 description 51
- 210000004712 air sac Anatomy 0.000 description 33
- -1 t-butylamino Chemical group 0.000 description 29
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 26
- WVDDGKGOMKODPV-UHFFFAOYSA-N hydroxymethyl benzene Natural products OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 21
- 229940071648 metered dose inhaler Drugs 0.000 description 21
- 238000000034 method Methods 0.000 description 18
- 239000007921 spray Substances 0.000 description 18
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 17
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 16
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 16
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 15
- 239000000463 material Substances 0.000 description 14
- 238000002347 injection Methods 0.000 description 13
- 239000007924 injection Substances 0.000 description 13
- 238000012377 drug delivery Methods 0.000 description 12
- 238000011282 treatment Methods 0.000 description 12
- 235000019445 benzyl alcohol Nutrition 0.000 description 10
- 210000004072 lung Anatomy 0.000 description 10
- 239000002245 particle Substances 0.000 description 10
- 229940124630 bronchodilator Drugs 0.000 description 9
- 230000008901 benefit Effects 0.000 description 8
- 208000006673 asthma Diseases 0.000 description 7
- 206010006451 bronchitis Diseases 0.000 description 7
- 238000001647 drug administration Methods 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 7
- 230000000241 respiratory effect Effects 0.000 description 7
- 230000004044 response Effects 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 description 6
- 230000008021 deposition Effects 0.000 description 6
- 238000009826 distribution Methods 0.000 description 6
- 230000003434 inspiratory effect Effects 0.000 description 6
- 210000001331 nose Anatomy 0.000 description 6
- 235000014676 Phragmites communis Nutrition 0.000 description 5
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 5
- 239000000168 bronchodilator agent Substances 0.000 description 5
- 239000011521 glass Substances 0.000 description 5
- 230000011664 signaling Effects 0.000 description 5
- 239000004698 Polyethylene Substances 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 4
- 230000002457 bidirectional effect Effects 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 4
- LMOINURANNBYCM-UHFFFAOYSA-N metaproterenol Chemical compound CC(C)NCC(O)C1=CC(O)=CC(O)=C1 LMOINURANNBYCM-UHFFFAOYSA-N 0.000 description 4
- 210000004400 mucous membrane Anatomy 0.000 description 4
- 229920000573 polyethylene Polymers 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 210000002345 respiratory system Anatomy 0.000 description 4
- 238000013125 spirometry Methods 0.000 description 4
- OXKUBEGCUWJYFV-UHFFFAOYSA-N 3-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,2-diol Chemical compound CC(C)NCC(O)C1=CC=CC(O)=C1O OXKUBEGCUWJYFV-UHFFFAOYSA-N 0.000 description 3
- KUVIULQEHSCUHY-XYWKZLDCSA-N Beclometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COC(=O)CC)(OC(=O)CC)[C@@]1(C)C[C@@H]2O KUVIULQEHSCUHY-XYWKZLDCSA-N 0.000 description 3
- 206010006458 Bronchitis chronic Diseases 0.000 description 3
- 239000000150 Sympathomimetic Substances 0.000 description 3
- MKFFGUZYVNDHIH-UHFFFAOYSA-N [2-(3,5-dihydroxyphenyl)-2-hydroxyethyl]-propan-2-ylazanium;sulfate Chemical compound OS(O)(=O)=O.CC(C)NCC(O)C1=CC(O)=CC(O)=C1.CC(C)NCC(O)C1=CC(O)=CC(O)=C1 MKFFGUZYVNDHIH-UHFFFAOYSA-N 0.000 description 3
- 230000007883 bronchodilation Effects 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 208000007451 chronic bronchitis Diseases 0.000 description 3
- 238000009513 drug distribution Methods 0.000 description 3
- XSFJVAJPIHIPKU-XWCQMRHXSA-N flunisolide Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O XSFJVAJPIHIPKU-XWCQMRHXSA-N 0.000 description 3
- 229960000676 flunisolide Drugs 0.000 description 3
- 239000006199 nebulizer Substances 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 230000029058 respiratory gaseous exchange Effects 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 125000006850 spacer group Chemical group 0.000 description 3
- 201000001178 Bacterial Pneumonia Diseases 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 2
- 206010039085 Rhinitis allergic Diseases 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 201000010105 allergic rhinitis Diseases 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000763 evoking effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000003562 lightweight material Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000004199 lung function Effects 0.000 description 2
- 210000002850 nasal mucosa Anatomy 0.000 description 2
- WYWIFABBXFUGLM-UHFFFAOYSA-N oxymetazoline Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C)=C1CC1=NCCN1 WYWIFABBXFUGLM-UHFFFAOYSA-N 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000003380 propellant Substances 0.000 description 2
- 229940063566 proventil Drugs 0.000 description 2
- 230000001172 regenerating effect Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 229940127230 sympathomimetic drug Drugs 0.000 description 2
- YRCWQPVGYLYSOX-UHFFFAOYSA-N synephrine Chemical compound CNCC(O)C1=CC=C(O)C=C1 YRCWQPVGYLYSOX-UHFFFAOYSA-N 0.000 description 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
- 238000012549 training Methods 0.000 description 2
- CYRMSUTZVYGINF-UHFFFAOYSA-N trichlorofluoromethane Chemical compound FC(Cl)(Cl)Cl CYRMSUTZVYGINF-UHFFFAOYSA-N 0.000 description 2
- 229940029284 trichlorofluoromethane Drugs 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- JGQWKLHHTRIVSL-UHFFFAOYSA-N 10-octan-3-yloxy-10-oxodecanoic acid Chemical compound CCCCCC(CC)OC(=O)CCCCCCCCC(O)=O JGQWKLHHTRIVSL-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- TTZLPRMMCNBBMP-UHFFFAOYSA-N 4-amino-3-ethylbenzene-1,2-diol Chemical compound OC1=C(C(=C(C=C1)N)CC)O TTZLPRMMCNBBMP-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 229930000680 A04AD01 - Scopolamine Natural products 0.000 description 1
- 208000000884 Airway Obstruction Diseases 0.000 description 1
- 206010006322 Breath holding Diseases 0.000 description 1
- 208000009079 Bronchial Spasm Diseases 0.000 description 1
- 208000014181 Bronchial disease Diseases 0.000 description 1
- 206010006482 Bronchospasm Diseases 0.000 description 1
- 206010007559 Cardiac failure congestive Diseases 0.000 description 1
- 239000004338 Dichlorodifluoromethane Substances 0.000 description 1
- 208000010496 Heart Arrest Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010020850 Hyperthyroidism Diseases 0.000 description 1
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical class [H]C([H])([H])C(*)=O 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 1
- 229940060228 afrin Drugs 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 229950000210 beclometasone dipropionate Drugs 0.000 description 1
- NBMKJKDGKREAPL-DVTGEIKXSA-N beclomethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O NBMKJKDGKREAPL-DVTGEIKXSA-N 0.000 description 1
- 230000003182 bronchodilatating effect Effects 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 238000013400 design of experiment Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 description 1
- 235000019404 dichlorodifluoromethane Nutrition 0.000 description 1
- VJHINFRRDQUWOJ-UHFFFAOYSA-N dioctyl sebacate Chemical compound CCCCC(CC)COC(=O)CCCCCCCCC(=O)OCC(CC)CCCC VJHINFRRDQUWOJ-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 229920002457 flexible plastic Polymers 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- BWHLPLXXIDYSNW-UHFFFAOYSA-N ketorolac tromethamine Chemical compound OCC(N)(CO)CO.OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1 BWHLPLXXIDYSNW-UHFFFAOYSA-N 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 231100000516 lung damage Toxicity 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229940127554 medical product Drugs 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229940042006 metaproterenol sulfate Drugs 0.000 description 1
- 125000006178 methyl benzyl group Chemical group 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 201000003152 motion sickness Diseases 0.000 description 1
- 239000000133 nasal decongestant Substances 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 229940124624 oral corticosteroid Drugs 0.000 description 1
- 229960002657 orciprenaline Drugs 0.000 description 1
- 210000003300 oropharynx Anatomy 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 230000003534 oscillatory effect Effects 0.000 description 1
- 229960003684 oxedrine Drugs 0.000 description 1
- 229960005162 oxymetazoline hydrochloride Drugs 0.000 description 1
- BEEDODBODQVSIM-UHFFFAOYSA-N oxymetazoline hydrochloride Chemical compound Cl.CC1=CC(C(C)(C)C)=C(O)C(C)=C1CC1=NCCN1 BEEDODBODQVSIM-UHFFFAOYSA-N 0.000 description 1
- 238000007427 paired t-test Methods 0.000 description 1
- 230000000803 paradoxical effect Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 229960003733 phenylephrine hydrochloride Drugs 0.000 description 1
- OCYSGIYOVXAGKQ-FVGYRXGTSA-N phenylephrine hydrochloride Chemical compound [H+].[Cl-].CNC[C@H](O)C1=CC=CC(O)=C1 OCYSGIYOVXAGKQ-FVGYRXGTSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 230000009325 pulmonary function Effects 0.000 description 1
- 238000009613 pulmonary function test Methods 0.000 description 1
- 230000036387 respiratory rate Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 1
- 229960002646 scopolamine Drugs 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000001975 sympathomimetic effect Effects 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000013271 transdermal drug delivery Methods 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 238000011870 unpaired t-test Methods 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 229940070384 ventolin Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
è«æ±ã®ç¯å²
ïŒ (a) 空æ°è¢éå£ã®ã»ãã¯ç©ºæ°ãéããªããæ
å®ã®æ倧寞æ³ãæŒãã€ã¶ãããšã®ã§ãã空æ°
è¢ã (b) å£ããã³éŒ»éè·¯ã«éããäžç«¯ãæããããã
éã€ãŠãã®å察端ãŸã§éããäºæ¹åæµè·¯ã«ãã
該空æ°è¢éå£ãšé£çµãããéšåã§ãã€ãŠã該éš
åã¯æå®éã®è¬å€ãå«æãããšã¢ãŸã«åŽé§å°å ¥
çšã®è¬å€å°å ¥å£ãæãã該è¬å€å°å ¥å£ã¯ã該ãš
ã¢ãŸã«åŽé§ã該éšåããã³è©²ç©ºæ°è¢éå£ãéã€
ãŠè©²äžç«¯ããé¢ããæ¹åã§è©²ç©ºæ°è¢äžã«çŽæ¥å°
å ¥ãããããã«é 眮ãããéšåãããã³ (c) 該ãšã¢ãŸã«åŽé§ã®ééé床ãææã®éçãè¶
ããæã衚瀺ããããã«ãã€ãŠè¬å€ãåžå ¥ããŠ
ããæ£è ã«è©²ç©ºæ°è¢ã®æŒãã€ã¶ãé床ãæžãã
è¬å€å©çšãæ倧ã«ããããã«æ°ã¥ããã該äºæ¹
åæµè·¯å ã®ä¿¡å·æ段ãããªãã 該è¬å€éåºè£ 眮ã¯ã該æŒãã€ã¶ãããšã®ã§ãã空
æ°è¢ãå°ãªããšãéšåçã«ãµãããã§ããéã«è¬
å€å«æãšã¢ãŸã«ã該è¬å€å°å ¥å£ãéããŠå容ãã
該è¬å€ã¯è©²æŒãã€ã¶ãããšã®ã§ãã空æ°è¢ã®åçž®
ã«ãã該æ£è ã®åžå ¥ãéããŠè©²å£ããã³éŒ»éè·¯ã«
å°å ¥ãããããšãç¹åŸŽãšãããšã¢ãŸã«äžã«å«æã
ããè¬å€ãæ£è ã®ç²èçµèã§åžåããããã®æ£è
ã®å£ããã³éŒ»éè·¯ãžã®æäžçšè¬å€éåºè£ 眮ã ïŒ è©²è¬å€ããæ°ç®¡æ¯æ¡åŒµå€ã§ããåèšç¬¬ïŒé ã®
è¬å€éåºè£ 眮ã ïŒ ééããè¬å€ã®æµãã«å¯ŸããŠæµæãæäŸãã
ããã«è©²éšåå ã«é 眮ãããæµææ段ãå å«ãã
åèšç¬¬ïŒé ã®è¬å€éåºè£ 眮ã æçŽ°æž æ¬çºæã¯ã1981幎10æ29æ¥ã«å ¬éããããã€ã»
ãã¢ãŒãã·ãŠãŒãã€ã«ã«ãºã®å ¬éåºé¡ãPCTïŒ
US81ïŒ00532ã®æ¹è¯ãšããŠã®ãå£ããã³éŒ»çšè¬ã®
æäžã«é©ããåžå ¥è£ 眮ã«é¢ããã çºæã®æŠèŠ æ¬çºæã®ïŒæ æ§ã«ããã°ã (a) 空æ°è¢éå£ã®ã»ãã¯ç©ºæ°ãéããªããæå®ã®
æ倧寞æ³ãæŒãã€ã¶ãããšã®ã§ãã空æ°è¢ã (b) å£ããã³éŒ»éè·¯ã«éããäžç«¯ãæããããã
éã€ãŠãã®å察端ãŸã§éããäºæ¹åæµè·¯ã«ãã
該空æ°è¢éå£ãšé£çµãããéšåã§ãã€ãŠã該éš
åã¯æå®éã®è¬å€ãå«æãããšã¢ãŸã«åŽé§å°å ¥
çšã®è¬å€å°å ¥å£ãæãã該è¬å€å°å ¥å£ã¯ã該ãš
ã¢ãŸã«åŽé§ã該éšåããã³è©²ç©ºæ°è¢éå£ãéã€
ãŠè©²äžç«¯ããé¢ããæ¹åã§è©²ç©ºæ°è¢äžã«çŽæ¥å°
å ¥ãããããã«é 眮ãããéšåãããã³ (c) 該ãšã¢ãŸã«åŽé§ã®ééé床ãææã®éçãè¶
ããæã衚瀺ããããã«ãã€ãŠè¬å€ãåžå ¥ããŠ
ããæ£è ã«è©²ç©ºæ°è¢ã®æŒãã€ã¶ãé床ãæžãã
è¬å€å©çšãæ倧ã«ããããã«æ°ã¥ããã該äºæ¹
åæµè·¯å ã®ä¿¡å·æ段ãããªããšã¢ãŸã«äžã«å«æ
ãããè¬å€ãæ£è ã®ç²èçµèã§åžåããããã®
æ£è ã®å£ããã³éŒ»éè·¯ãžã®æäžçšè¬å€éåºè£ 眮
ãæäŸãããã®ã§ã該è¬å€éåºè£ 眮ã¯ã該æŒã
ã€ã¶ãããšã®ã§ãã空æ°è¢ãå°ãªããšãéšåç
ã«ãµãããã§ããéã«è¬å€å«æãšã¢ãŸã«ã該è¬
å€å°å ¥å£ãéããŠå容ãã該è¬å€ã¯æŒãã€ã¶ã
ããšã®ã§ãã空æ°è¢ã®åçž®ã«ãã該æ£è ã®åžå ¥
ãéããŠè©²å£ããã³éŒ»éè·¯ã«å°å ¥ãããã æäžéèšéåžå ¥åšã«ããæ²»çã¯æ°ééå¡ã®æ£è
ã«ãããŠæ°ç®¡æ¯æ¡åŒµå¹æãæããããåŸæ¥ã®æäž
éèšéåžå ¥åšã«ããéåºãããïŒâãïŒâããã
ãã·âïŒâãïŒïŒâã¡ãã«ãšãã«ïŒã¢ããããšã
ã«ããã³ãŒã³ãžãªãŒã«ãŸãã¯ïŒâããããã·âïŒ
âããããã·ã¡ãã«âαâãïŒïœâããã«ã¢ããïŒ
ã¡ãã«ããã³ãžã«ãšæ¯èŒããŠãæ¬çºæã«ããéåº
ãããïŒâãïŒâããããã·âïŒâãïŒïŒâã¡ãã«
ãšãã«ïŒã¢ããããšãã«ããã³ãŒã³ãžãªãŒã«ã¯ã
ã倧ããªæ°ç®¡æ¯æ¡åŒµãçãããæ¬çºæã«åŸãïŒâ
ãïŒâããããã·âïŒâãïŒïŒâã¡ãã«ãšãã«ïŒã¢
ããããšãã«ããã³ãŒã³ãžãªãŒã«ã«ããä»ã®æ²»ç
ãäžå»»ãSGawã®å¢å ã¯åžžæããªãã®ãã®ã§ãåŸ
æ¥ã®æäžéèšéåžå ¥åšãšã¯ç°ãªãããã®æäžåŸã
ïŒæéã§ãããç¶æããããæ¬çºæã«ããïŒâ
ãïŒâããããã·âïŒâãïŒïŒâã¡ãã«ãšãã«ïŒã¢
ããããšãã«ããã³ãŒã³ãžãªãŒã«ãŸãã¯ä»ã®æ°ç®¡
æ¯æ¡åŒµå€ã®ïŒæéããšã«ïŒåã®åŽå°ã¯ãåŸæ¥ã®æ
äžéèšéåžå ¥åšã«ããïŒãïŒæéããšã®æ¯æãã
ãéåžžã®æäžéã®ïŒåã®åŽå°ãããçåæ§æ°ç®¡æ¯
çæ£ã®éã®æ°ç®¡æ¯æ¡åŒµéæã®ããå¹æçãªæ段ã§
ããã 奜ãŸããã¯ã該äºæ¹åæµè·¯ã«ä¿¡å·æ段ãèšãã
該è¬å€ã®ééé床ãææã®éçãè¶ ãããšããè¡š
瀺ãããããã«ããã該è¬å€ãåžå ¥ããŠããæ£è
ã«è©²ç©ºæ°è¢ã®æŒãã€ã¶ãé床ãæžããè¬å€å©çšã
æ倧ã«ããããæ°ã¥ãããã該è¬å€éåºè£ 眮ã¯ã
æŒãã€ã¶ãããšã®ã§ãã空æ°è¢ãå°ãªããšãéšå
çã«ãµãããã§ããéãè¬å€å°å ¥å£ãéããŠè¬å€
å«æãšã¢ãŸã«ãå容ã§ããè¬å€ã¯è©²æŒãã€ã¶ãã
ãšã®ã§ãã空æ°è¢ã®åçž®ã«ãã該å£ããã³éŒ»éè·¯
ã«å°å ¥ããããèšããä¿¡å·æ段ã¯ç©ºæ°ã該空æ°è¢
ãã該äºæ¹åæµè·¯ãžææã®éçãè¶ ããé床ã§é
éããããšã«ããäœåããç¬ãããšã«ããªãŒãç¬
è£ çœ®ãšããããšãã§ãããåèšéšåã¯å£ãšéãã
管ã§ãããã«ãã該è¬å€ã¯æ°ç®¡æ°ç®¡æ¯æš¹ã«éãã
ããæŒãã€ã¶ãããšã®ã§ããè¢ã¯æå©ã«ã該空æ°
è¢éå£ãæãã第ïŒã®éå£ä»ç«¯éšãã€ããããã³
該第ïŒã®éå£ä»ç«¯éšãã€ãããšå¯Ÿé¢ãã第ïŒã®ç«¯
éšãã€ãããæããïŒã€ã®ç«¯éšãã€ããã¯æŒãã€
ã¶ãããšã®ã§ããææã§é£çµãããŠãããæŒãã€
ã¶ãããšã®ã§ããææã¯æå©ã«ãã空æ°è¢ãæŒã
ã€ã¶ããã«ã€ãã察é¢ãã端éšãã€ãããçžäºã«
é¢é£ããŠå転ããããã«ïŒã€ã®ç«¯éšãã€ããã«å
ãä»ããããŠããã å¥ã®å ·äœäŸã«ãããŠã¯ã該éšåã¯éŒ»ã«éãã圢
ããããã¹ã¯ã§ãããããã«ãã該è¬å€ã錻ç²è
ã«éããããä¿¡å·æ段ã¯å¥œãŸããå ·äœäŸã§ããã
ããããŠãæ¬çºæã¯ããã«åºãã¯ãå£ããã³éŒ»é
è·¯ã«éãäžç«¯ãæããéšåã§ãã€ãŠã該éšåã®å
察端ãéãäºæ¹åæµè·¯ã«ãã€ãŠç©ºæ°è¢éå£ãšé£çµ
ããéšåã該éšåãè¬å€å«æåŽé§å°å ¥çšã®è¬å€å°
å ¥å£ãæãã該è¬å€å°å ¥å£ã該éšåããã³è©²ç©ºæ°
è¢éå£ãéãã該äžç«¯ããé¢ããæ¹åã§è¬å€ãçŽ
æ¥è©²ç©ºæ°è¢ã«å°å ¥ãããããã«é 眮ããããã
ãšãæå®ã®æ倧寞æ³ã®ã該空æ°è¢éå£ãé€ããŠç©º
æ°ãéããªãæŒãã€ã¶ãããšã®ã§ãã空æ°è¢ãã
ãªãè¬å€éåºè£ 眮ã§ã該éåºè£ 眮ã¯è©²ç©ºæ°è¢ãå°
ãªããšãéšåçã«ãµãããã§ããéã該è¬å€å°å ¥
å£ãéããŠè¬å€å«æãšã¢ãŸã«ãå容ã§ãã該è¬å€
ã¯è©²æŒãã€ã¶ãããšã®ã§ãã空æ°è¢ã®åçž®ã«ãã
å£ããã³éŒ»éè·¯ã«å°å ¥ããããšã¢ãŸã«ã«å«æãã
ãè¬å€æäžçšã®è¬å€éåºè£ 眮ã«åããããŠããã 空æ°è¢ïŒä»¥äžãæã ãèšåŒµåŒæ°å¢ãšãããïŒã¯
èšç®ãããéã®ãšã¢ãŸã«åè¬å€ïŒä»¥äžãæã ãå»
è¬ãšãããïŒãåããããã«èšããããŠããã空
æ°è¢ãããã¯æ°å¢ã¯åãå ¥ããè¬å€ãããã¯å»è¬
ãå°ã³èŸŒããå é¢ãšãè¬å€ãããã¯å»è¬ãæ£è ã«
éãéå£ãæããŠããã該空æ°è¢äžã®ãæå®éã®
空æ°ãšæ··åããè¬å€ãæ£è ã®å£ãŸãã¯éŒ»ã«å°ãã
ãã«ã該éå£ã«é£çµããŠéšåãèšããããŠããã
æ£è ã¯è©²ããŠã¹ããŒã¹ïŒéšåïŒã«è² å§ããããã
ãšã«ããã空æ°è¢ã空ã«ãããæ°å¢ã®å é¢ã«ã¯ã
ãããé¢ããŠããããã®æ段ãèšããããŠããã
ããã«ãããæ°å¢ã®æŒãã€ã¶ãã劚ãããããæ¬
çºæã«ããè£ çœ®ã®å¥œãŸããæ æ§ã«ãããŠã¯ãå»è¬
ã¯å å§åžå ¥åšç¶ã«æ¥ç¶ããå°ããªåŽé§åšãéããŠ
æ°å¢äžã«åŽå°ããããç¶ããæå®éã®ãšã¢ãŸã«ã
ãã³å»è¬ãåŽå°ããããšãåŽå°æµã¯æ°å¢äžã«å°ã
ãããæ°å¢ã¯åŽé§åšãšé£ç¶çã«æ¥ç¶ããããŠã¹ã
ãŒã¹ãšæ¥ç¶ããŠãããåŸãããæ§é ã¯ãå»è¬ã第
ïŒã®æ¹åã§æ°å¢äžã«å ¥ããæ£è ã«ããããŠã¹ããŒ
ã¹ã«è² å§ãããããããšãæ°å¢äžã®å 容ç©ãèšåŒµ
ããæ¹åãšå察ã®ç¬¬ïŒã®æ¹åãããªãã¡ãæ£è ã®
èºçµç¹ãžéãããããšãå¯èœã«ããããŸãããšã¢
ãŸã«åããå»è¬ãæ°å¢ã«æºãããã€ãã§ãæ°å¢äž
ã®å 容ç©ãæ£è ã®åŒåžåšç³»ãžåŒãåºãããšã«ã
ããå¶åŸ¡ãããå»è¬ã®åžå ¥ãçããåŒåžéãžã®å»
è¬æäžã®é床ããã³ååžãæ¹åãããã å³é¢ã®èª¬æ 第ïŒå³ã¯å£è åžå ¥çšã®æ¬çºæã®ããïŒã€å¥ã®æ
æ§ã®åæ¬ ããéšåæé¢å³ã§ããã 第ïŒå³ã¯ç¬¬ïŒå³ã«ç€ºããæ¬çºæã®æ æ§ã®ããã
ããè¬å€ã®éŒ»æäžçšã«æ¹é ããåæ¬ ããéšåæé¢
å³ã§ããã 第ïŒå³ã¯ç¬¬ïŒå³ã®åŽé§åšéšåããã³ããŠã¹ããŒ
ã¹ã®ããïŒã€å¥ã®æ æ§ã®éšååæ¬ å³ã§ããã 第ïŒå³ã¯ç¬¬ïŒå³ã®çºæã§çšãããã€ã¹ã¯ã瀺
ãã 第ïŒå³ã¯ç¬¬ïŒå³ã®çºæã§çšããã¹ã¯ãªãŒã³ã瀺
ãã
å®ã®æ倧寞æ³ãæŒãã€ã¶ãããšã®ã§ãã空æ°
è¢ã (b) å£ããã³éŒ»éè·¯ã«éããäžç«¯ãæããããã
éã€ãŠãã®å察端ãŸã§éããäºæ¹åæµè·¯ã«ãã
該空æ°è¢éå£ãšé£çµãããéšåã§ãã€ãŠã該éš
åã¯æå®éã®è¬å€ãå«æãããšã¢ãŸã«åŽé§å°å ¥
çšã®è¬å€å°å ¥å£ãæãã該è¬å€å°å ¥å£ã¯ã該ãš
ã¢ãŸã«åŽé§ã該éšåããã³è©²ç©ºæ°è¢éå£ãéã€
ãŠè©²äžç«¯ããé¢ããæ¹åã§è©²ç©ºæ°è¢äžã«çŽæ¥å°
å ¥ãããããã«é 眮ãããéšåãããã³ (c) 該ãšã¢ãŸã«åŽé§ã®ééé床ãææã®éçãè¶
ããæã衚瀺ããããã«ãã€ãŠè¬å€ãåžå ¥ããŠ
ããæ£è ã«è©²ç©ºæ°è¢ã®æŒãã€ã¶ãé床ãæžãã
è¬å€å©çšãæ倧ã«ããããã«æ°ã¥ããã該äºæ¹
åæµè·¯å ã®ä¿¡å·æ段ãããªãã 該è¬å€éåºè£ 眮ã¯ã該æŒãã€ã¶ãããšã®ã§ãã空
æ°è¢ãå°ãªããšãéšåçã«ãµãããã§ããéã«è¬
å€å«æãšã¢ãŸã«ã該è¬å€å°å ¥å£ãéããŠå容ãã
該è¬å€ã¯è©²æŒãã€ã¶ãããšã®ã§ãã空æ°è¢ã®åçž®
ã«ãã該æ£è ã®åžå ¥ãéããŠè©²å£ããã³éŒ»éè·¯ã«
å°å ¥ãããããšãç¹åŸŽãšãããšã¢ãŸã«äžã«å«æã
ããè¬å€ãæ£è ã®ç²èçµèã§åžåããããã®æ£è
ã®å£ããã³éŒ»éè·¯ãžã®æäžçšè¬å€éåºè£ 眮ã ïŒ è©²è¬å€ããæ°ç®¡æ¯æ¡åŒµå€ã§ããåèšç¬¬ïŒé ã®
è¬å€éåºè£ 眮ã ïŒ ééããè¬å€ã®æµãã«å¯ŸããŠæµæãæäŸãã
ããã«è©²éšåå ã«é 眮ãããæµææ段ãå å«ãã
åèšç¬¬ïŒé ã®è¬å€éåºè£ 眮ã æçŽ°æž æ¬çºæã¯ã1981幎10æ29æ¥ã«å ¬éããããã€ã»
ãã¢ãŒãã·ãŠãŒãã€ã«ã«ãºã®å ¬éåºé¡ãPCTïŒ
US81ïŒ00532ã®æ¹è¯ãšããŠã®ãå£ããã³éŒ»çšè¬ã®
æäžã«é©ããåžå ¥è£ 眮ã«é¢ããã çºæã®æŠèŠ æ¬çºæã®ïŒæ æ§ã«ããã°ã (a) 空æ°è¢éå£ã®ã»ãã¯ç©ºæ°ãéããªããæå®ã®
æ倧寞æ³ãæŒãã€ã¶ãããšã®ã§ãã空æ°è¢ã (b) å£ããã³éŒ»éè·¯ã«éããäžç«¯ãæããããã
éã€ãŠãã®å察端ãŸã§éããäºæ¹åæµè·¯ã«ãã
該空æ°è¢éå£ãšé£çµãããéšåã§ãã€ãŠã該éš
åã¯æå®éã®è¬å€ãå«æãããšã¢ãŸã«åŽé§å°å ¥
çšã®è¬å€å°å ¥å£ãæãã該è¬å€å°å ¥å£ã¯ã該ãš
ã¢ãŸã«åŽé§ã該éšåããã³è©²ç©ºæ°è¢éå£ãéã€
ãŠè©²äžç«¯ããé¢ããæ¹åã§è©²ç©ºæ°è¢äžã«çŽæ¥å°
å ¥ãããããã«é 眮ãããéšåãããã³ (c) 該ãšã¢ãŸã«åŽé§ã®ééé床ãææã®éçãè¶
ããæã衚瀺ããããã«ãã€ãŠè¬å€ãåžå ¥ããŠ
ããæ£è ã«è©²ç©ºæ°è¢ã®æŒãã€ã¶ãé床ãæžãã
è¬å€å©çšãæ倧ã«ããããã«æ°ã¥ããã該äºæ¹
åæµè·¯å ã®ä¿¡å·æ段ãããªããšã¢ãŸã«äžã«å«æ
ãããè¬å€ãæ£è ã®ç²èçµèã§åžåããããã®
æ£è ã®å£ããã³éŒ»éè·¯ãžã®æäžçšè¬å€éåºè£ 眮
ãæäŸãããã®ã§ã該è¬å€éåºè£ 眮ã¯ã該æŒã
ã€ã¶ãããšã®ã§ãã空æ°è¢ãå°ãªããšãéšåç
ã«ãµãããã§ããéã«è¬å€å«æãšã¢ãŸã«ã該è¬
å€å°å ¥å£ãéããŠå容ãã該è¬å€ã¯æŒãã€ã¶ã
ããšã®ã§ãã空æ°è¢ã®åçž®ã«ãã該æ£è ã®åžå ¥
ãéããŠè©²å£ããã³éŒ»éè·¯ã«å°å ¥ãããã æäžéèšéåžå ¥åšã«ããæ²»çã¯æ°ééå¡ã®æ£è
ã«ãããŠæ°ç®¡æ¯æ¡åŒµå¹æãæããããåŸæ¥ã®æäž
éèšéåžå ¥åšã«ããéåºãããïŒâãïŒâããã
ãã·âïŒâãïŒïŒâã¡ãã«ãšãã«ïŒã¢ããããšã
ã«ããã³ãŒã³ãžãªãŒã«ãŸãã¯ïŒâããããã·âïŒ
âããããã·ã¡ãã«âαâãïŒïœâããã«ã¢ããïŒ
ã¡ãã«ããã³ãžã«ãšæ¯èŒããŠãæ¬çºæã«ããéåº
ãããïŒâãïŒâããããã·âïŒâãïŒïŒâã¡ãã«
ãšãã«ïŒã¢ããããšãã«ããã³ãŒã³ãžãªãŒã«ã¯ã
ã倧ããªæ°ç®¡æ¯æ¡åŒµãçãããæ¬çºæã«åŸãïŒâ
ãïŒâããããã·âïŒâãïŒïŒâã¡ãã«ãšãã«ïŒã¢
ããããšãã«ããã³ãŒã³ãžãªãŒã«ã«ããä»ã®æ²»ç
ãäžå»»ãSGawã®å¢å ã¯åžžæããªãã®ãã®ã§ãåŸ
æ¥ã®æäžéèšéåžå ¥åšãšã¯ç°ãªãããã®æäžåŸã
ïŒæéã§ãããç¶æããããæ¬çºæã«ããïŒâ
ãïŒâããããã·âïŒâãïŒïŒâã¡ãã«ãšãã«ïŒã¢
ããããšãã«ããã³ãŒã³ãžãªãŒã«ãŸãã¯ä»ã®æ°ç®¡
æ¯æ¡åŒµå€ã®ïŒæéããšã«ïŒåã®åŽå°ã¯ãåŸæ¥ã®æ
äžéèšéåžå ¥åšã«ããïŒãïŒæéããšã®æ¯æãã
ãéåžžã®æäžéã®ïŒåã®åŽå°ãããçåæ§æ°ç®¡æ¯
çæ£ã®éã®æ°ç®¡æ¯æ¡åŒµéæã®ããå¹æçãªæ段ã§
ããã 奜ãŸããã¯ã該äºæ¹åæµè·¯ã«ä¿¡å·æ段ãèšãã
該è¬å€ã®ééé床ãææã®éçãè¶ ãããšããè¡š
瀺ãããããã«ããã該è¬å€ãåžå ¥ããŠããæ£è
ã«è©²ç©ºæ°è¢ã®æŒãã€ã¶ãé床ãæžããè¬å€å©çšã
æ倧ã«ããããæ°ã¥ãããã該è¬å€éåºè£ 眮ã¯ã
æŒãã€ã¶ãããšã®ã§ãã空æ°è¢ãå°ãªããšãéšå
çã«ãµãããã§ããéãè¬å€å°å ¥å£ãéããŠè¬å€
å«æãšã¢ãŸã«ãå容ã§ããè¬å€ã¯è©²æŒãã€ã¶ãã
ãšã®ã§ãã空æ°è¢ã®åçž®ã«ãã該å£ããã³éŒ»éè·¯
ã«å°å ¥ããããèšããä¿¡å·æ段ã¯ç©ºæ°ã該空æ°è¢
ãã該äºæ¹åæµè·¯ãžææã®éçãè¶ ããé床ã§é
éããããšã«ããäœåããç¬ãããšã«ããªãŒãç¬
è£ çœ®ãšããããšãã§ãããåèšéšåã¯å£ãšéãã
管ã§ãããã«ãã該è¬å€ã¯æ°ç®¡æ°ç®¡æ¯æš¹ã«éãã
ããæŒãã€ã¶ãããšã®ã§ããè¢ã¯æå©ã«ã該空æ°
è¢éå£ãæãã第ïŒã®éå£ä»ç«¯éšãã€ããããã³
該第ïŒã®éå£ä»ç«¯éšãã€ãããšå¯Ÿé¢ãã第ïŒã®ç«¯
éšãã€ãããæããïŒã€ã®ç«¯éšãã€ããã¯æŒãã€
ã¶ãããšã®ã§ããææã§é£çµãããŠãããæŒãã€
ã¶ãããšã®ã§ããææã¯æå©ã«ãã空æ°è¢ãæŒã
ã€ã¶ããã«ã€ãã察é¢ãã端éšãã€ãããçžäºã«
é¢é£ããŠå転ããããã«ïŒã€ã®ç«¯éšãã€ããã«å
ãä»ããããŠããã å¥ã®å ·äœäŸã«ãããŠã¯ã該éšåã¯éŒ»ã«éãã圢
ããããã¹ã¯ã§ãããããã«ãã該è¬å€ã錻ç²è
ã«éããããä¿¡å·æ段ã¯å¥œãŸããå ·äœäŸã§ããã
ããããŠãæ¬çºæã¯ããã«åºãã¯ãå£ããã³éŒ»é
è·¯ã«éãäžç«¯ãæããéšåã§ãã€ãŠã該éšåã®å
察端ãéãäºæ¹åæµè·¯ã«ãã€ãŠç©ºæ°è¢éå£ãšé£çµ
ããéšåã該éšåãè¬å€å«æåŽé§å°å ¥çšã®è¬å€å°
å ¥å£ãæãã該è¬å€å°å ¥å£ã該éšåããã³è©²ç©ºæ°
è¢éå£ãéãã該äžç«¯ããé¢ããæ¹åã§è¬å€ãçŽ
æ¥è©²ç©ºæ°è¢ã«å°å ¥ãããããã«é 眮ããããã
ãšãæå®ã®æ倧寞æ³ã®ã該空æ°è¢éå£ãé€ããŠç©º
æ°ãéããªãæŒãã€ã¶ãããšã®ã§ãã空æ°è¢ãã
ãªãè¬å€éåºè£ 眮ã§ã該éåºè£ 眮ã¯è©²ç©ºæ°è¢ãå°
ãªããšãéšåçã«ãµãããã§ããéã該è¬å€å°å ¥
å£ãéããŠè¬å€å«æãšã¢ãŸã«ãå容ã§ãã該è¬å€
ã¯è©²æŒãã€ã¶ãããšã®ã§ãã空æ°è¢ã®åçž®ã«ãã
å£ããã³éŒ»éè·¯ã«å°å ¥ããããšã¢ãŸã«ã«å«æãã
ãè¬å€æäžçšã®è¬å€éåºè£ 眮ã«åããããŠããã 空æ°è¢ïŒä»¥äžãæã ãèšåŒµåŒæ°å¢ãšãããïŒã¯
èšç®ãããéã®ãšã¢ãŸã«åè¬å€ïŒä»¥äžãæã ãå»
è¬ãšãããïŒãåããããã«èšããããŠããã空
æ°è¢ãããã¯æ°å¢ã¯åãå ¥ããè¬å€ãããã¯å»è¬
ãå°ã³èŸŒããå é¢ãšãè¬å€ãããã¯å»è¬ãæ£è ã«
éãéå£ãæããŠããã該空æ°è¢äžã®ãæå®éã®
空æ°ãšæ··åããè¬å€ãæ£è ã®å£ãŸãã¯éŒ»ã«å°ãã
ãã«ã該éå£ã«é£çµããŠéšåãèšããããŠããã
æ£è ã¯è©²ããŠã¹ããŒã¹ïŒéšåïŒã«è² å§ããããã
ãšã«ããã空æ°è¢ã空ã«ãããæ°å¢ã®å é¢ã«ã¯ã
ãããé¢ããŠããããã®æ段ãèšããããŠããã
ããã«ãããæ°å¢ã®æŒãã€ã¶ãã劚ãããããæ¬
çºæã«ããè£ çœ®ã®å¥œãŸããæ æ§ã«ãããŠã¯ãå»è¬
ã¯å å§åžå ¥åšç¶ã«æ¥ç¶ããå°ããªåŽé§åšãéããŠ
æ°å¢äžã«åŽå°ããããç¶ããæå®éã®ãšã¢ãŸã«ã
ãã³å»è¬ãåŽå°ããããšãåŽå°æµã¯æ°å¢äžã«å°ã
ãããæ°å¢ã¯åŽé§åšãšé£ç¶çã«æ¥ç¶ããããŠã¹ã
ãŒã¹ãšæ¥ç¶ããŠãããåŸãããæ§é ã¯ãå»è¬ã第
ïŒã®æ¹åã§æ°å¢äžã«å ¥ããæ£è ã«ããããŠã¹ããŒ
ã¹ã«è² å§ãããããããšãæ°å¢äžã®å 容ç©ãèšåŒµ
ããæ¹åãšå察ã®ç¬¬ïŒã®æ¹åãããªãã¡ãæ£è ã®
èºçµç¹ãžéãããããšãå¯èœã«ããããŸãããšã¢
ãŸã«åããå»è¬ãæ°å¢ã«æºãããã€ãã§ãæ°å¢äž
ã®å 容ç©ãæ£è ã®åŒåžåšç³»ãžåŒãåºãããšã«ã
ããå¶åŸ¡ãããå»è¬ã®åžå ¥ãçããåŒåžéãžã®å»
è¬æäžã®é床ããã³ååžãæ¹åãããã å³é¢ã®èª¬æ 第ïŒå³ã¯å£è åžå ¥çšã®æ¬çºæã®ããïŒã€å¥ã®æ
æ§ã®åæ¬ ããéšåæé¢å³ã§ããã 第ïŒå³ã¯ç¬¬ïŒå³ã«ç€ºããæ¬çºæã®æ æ§ã®ããã
ããè¬å€ã®éŒ»æäžçšã«æ¹é ããåæ¬ ããéšåæé¢
å³ã§ããã 第ïŒå³ã¯ç¬¬ïŒå³ã®åŽé§åšéšåããã³ããŠã¹ããŒ
ã¹ã®ããïŒã€å¥ã®æ æ§ã®éšååæ¬ å³ã§ããã 第ïŒå³ã¯ç¬¬ïŒå³ã®çºæã§çšãããã€ã¹ã¯ã瀺
ãã 第ïŒå³ã¯ç¬¬ïŒå³ã®çºæã§çšããã¹ã¯ãªãŒã³ã瀺
ãã
ç¡«é
žå¡©ã®åã®ïŒâãïŒâããããã·âïŒâãïŒïŒ
âã¡ãã«ãšãã«ïŒã¢ããããšãã«ãâïŒïŒïŒâã
ã³ãŒã³ãžãªãŒã«ã¯åºãçšããããŠããæ°ç®¡æ¯æ¡åŒµ
å€ã§ããïŒã¡ã¿ãããã¬ããŒã«ãAlupentã
MetaprelãAlotecãNovasmasolïŒããããšåã
äžè¬çã«ããŽãªãŒã®ä»ã®è¬å€ã¯ïŒâããããã·â
ïŒâããããã·ã¡ãã«âαâãïŒïœâããã«ã¢ã
ãïŒã¡ãã«ããã³ãžã«ã¢ã«ã³ãŒã«ïŒAerolinã
BroncovaleasãSultanolãVentlinãVentolinã
ProventilïŒã§ãããåŸæ¥ã®é©çšæ¹æ³ã«ããã°ã
ïŒâãïŒâããããã·âïŒâãïŒïŒâã¡ãã«ãšãã«ïŒ
ã¢ããããšãã«ããã³ãŒã³ãžãªãŒã«ã®è£œé è ã¯äž
掻æ§åŽå°å€äžã225mgã®è¶ 埮ç²ç ãããç²æ«ãæ
ããæäžéèšéåžå ¥åšãæšå¥šããŠãããããã¯çŽ
300æäžéãæããŠããã該è¬å€ã¯è¬å€æäžçšã®
ããŠã¹ããŒã¹ã«åµãã15mlåžå ¥åšäžã«å容ãããŠ
ãããåžå ¥è¬å€ã®ïŒãïŒåã®åŽå°ãéåžžã®ïŒåã®
æäžã§ãããè¿ãæäžã¯çŽïŒãïŒæéããšä»¥äžãš
ã¯ãªãããïŒæ¥ã®ç·æäžã¯æ倧ããããåžå ¥è¬å€
ã®çŽ12ååŽå°ã§ãããFacts and Comparisonsã
p586ïŒ1980ïŒã«ããã°ãåžå ¥èª¿è£œç©ã®éå°ãªäœ¿çš
åŸã®æ»äº¡ãå ±åãããŠãããæ£ç¢ºãªåå ã¯äžæã§
ããããæ°äŸã«ãããŠå¿åæ¢ãèªãããããšè¿°ã¹
ãããŠããããŸããåæ¯æç¶ç¶æ ããã³ç°åžžè¡æ¶²
ã¬ã¹å§ã®æ£è ã«ãããŠãèºæŽ»éããã³è¡æ¶²ã¬ã¹å§
ã®æ¹åã¯æ°ç®¡çæ£ã®æçœãªè»œæžã䜵ãªããªããã
ãããªããšãè¿°ã¹ãŠããããŸããïŒâãïŒâãã
ããã·âïŒâãïŒïŒâã¡ãã«ãšãã«ïŒã¢ããããšã
ã«ããã³ãŒã³ãžãªãŒã«ã«ã€ããŠå ±åãããŠããã
ãšã¯ãå¶ç¶ã®æ£è ã«ãããŠãåžå ¥èª¿è£œç©ã®å埩é
å°äœ¿çšã§æ¿ããé説æ°éæµæãèµ·ãããšã®èŠ³å¯ã§
ãããïŒâããããã·âïŒâããããã·ã¡ãã«â
αâãïŒïœâããã«ã¢ããïŒã¡ãã«ããã³ãžã«ã¢ã«
ã³ãŒã«ã«ã€ããŠãã¢ãã¬ããªã³æ§ãšã¢ãŸã«ã®éå°
䜿çšã¯å±éºãªå¯èœæ§ããããšå ±åãããŠãã
ãPhysicianâ²s Desk Referenceãp662ïŒ1981ïŒãã
AlupentïŒã¡ã¿ãããã¬ããŒã«ç¡«é žå¡©ã®åæšåïŒ
ã®æäžéèšéåžå ¥åšã®éå°äœ¿çšåŸã®èŽæ»çãä»ã®
亀æç¥çµäœçšåžå ¥èª¿è£œç©ã«ãããšåæ§ã«å ±åãã
ãŠããããã®PDRæç®ã«ãããŠãç¹ã«ããä»å ç
亀æç¥çµäœçšè¬å€ã®æäžã«é¢ããŠéåžžãªæ³šæãæ
ãããªããã°ãªããªããããïŒã€å¥ã®äº€æç¥çµäœ
çšå€ãæäžããåã«å åãªæéééãçµéããã
ã¹ãã§ãããâŠâŠâŠé«è¡å§ãå åèçŸæ£ããã€è¡
æ§å¿äžå šãç²ç¶ç·äº¢é²çããã³ç³å°¿ç ã®æ£è ã«ã
ããŠããããã¯äº€æç¥çµäœçšã¢ãã³ã«éææ§ãã
ãå Žåã«ã¯å å泚æããŠäœ¿çšãã¹ãã§ãããããš
èšãããŠãããå ããŠãïŒâãïŒâããããã·â
ïŒâãïŒïŒâã¡ãã«ãšãã«ïŒã¢ããããšãã«ããã³
ãŒã³ãžãªãŒã«ãŸãã¯ïŒâããããã·âïŒâããã
ãã·ã¡ãã«âαâãïŒïœâããã«ã¢ããïŒã¡ãã«ã
ãã³ãžã«ã¢ã«ã³ãŒã«ã®ãããªè¬å€ã«éåžžçšããã
ããããªåŸæ¥ã®ãšã¢ãŸã«ã®åŽå°ã§ã¯ãè¬å€ã®å£äž
ãžã®æ¥éæäžã¯ããšã¢ãŸã«ã®äœçšãå©çšããŠå®è³ª
çã«è¬å€ãæ£è ã®æ°ç®¡æ°ç®¡æ¯æš¹ãžéãããã®ãæ£
è ã®èºãžã®çªçºçãªç©ºæ°ã®ãšã蟌ã¿ã䌎ãªããã
è¬å€ã®å€ãã¯ãã®ææã®éšäœãžè¡ã代ãã«ãèè ž
管ãžéã蟌ãŸããïŒâãïŒâããããã·âïŒâ
ãïŒïŒâã¡ãã«ãšãã«ïŒã¢ããããšãã«ããã³ãŒã³
ãžãªãŒã«ã®ãããªãšã¢ãŸã«è¬å€ãããªãã¡ãæ°ç®¡
æ°ç®¡æ¯æš¹ãžéã蟌ãããã«èšèšãããè¬å€ã®æäž
ã®ãŸãããå察ã«ãªããšç¹ã«èªèãã¹ãã§ããã
ãã®åé¡ããšã¢ãŸã«ïŒâããããã·âïŒâããã
ãã·ã¡ãã«âαâãïŒïœâããã«ã¢ããïŒã¡ãã«ã
ãã³ãžã«ã¢ã«ã³ãŒã«èª¿è£œç©çšã®Proventil
ïŒScheringïŒâPatientâ²s Instructions for Useâ
ã«ãããŠæã«èªããããŠãããããã¯ä»¥äžã®æ瀺
ãå å«ããŠããã ïŒ å åã«æ¯ãã¯ããããªãã®èºããã§ããã ã
空æ°ãã¯ãåºããâŠâŠâŠ ïŒ æ·±ãæ¯ããããªãããéå±å®¹åšã®é éšãå å
ã«æŒãäžãããâŠâŠâŠ ïŒ ã§ããã ãé·ãæ¯ããšãããâŠâŠâŠ æèšããã°ããšã¢ãŸã«è¬å€æäžã®åŸæ¥ã®åŽå°
ã¯ãæ£è ããšã¢ãŸã«ã®åŽå°ãæäžãããšãã«æ£è
ã«éåžžã«æ·±ãæ¯ãããããã€ãã§ãæ£è ã«ã§ãã
ã ãé·ãæ¯ããšããããããšã«ãããè¬å€ãã§ã
ãã ãå€ãæ°ç®¡æ°ç®¡æ¯æš¹ãžå°éãããããšè©Šã¿ãŠ
ãããå°é家èªèº«ã«ãã€ãŠãå®å šã«æºè¶³ãããŠã¯
ããªãããã«èªãããããããã¯åŸãã®ã«å°é£ãª
æäœã§ãããåèšGayrardãã®å ¬è¡šãããç¥èŠã«
ããã°ã圌ã®ç 究ã«ãããŠèŠ³å¯ããæ£è ã®1/4ã
ã»ãã®ãããã«è¶ ããæ£è ããã®åã®æ瀺ã«åŸã€
ãŠããã®ã¿ã§ããããšã¯æå€ã§ã¯ãªãã åžå ¥ã«ãã€ãŠæäžãããŠããããïŒã€å¥ã®è¬å€
ã¯ïŒâã¯ããâ11βïŒ17ïŒ21âããªããããã·â
16βâã¡ãã«âãã¬ã°ãâïŒïŒïŒâãžãšã³âïŒïŒ
20âãžãªã³17ïŒ21âãžããããªããŒãããã¯ãã¡
ã¿ãŸã³ã»ãžããããªããŒããBecloventïŒGlaxoïŒã
ã§ãæäžéèšéåŽå°ãšåæ§ãªåžå ¥åšããæäžã
ããïŒâã¯ããâ11βïŒ17ïŒ21âããªããããã·
â16βâã¡ãã«ãã¬ã°ãâïŒïŒïŒâãžãšã³âïŒïŒ
20âãžãªã³17ïŒ21âãžããããªããŒãã»ããªã¯ã
ãã¢ããã«ãªãã¡ã¿ã³å æ¥ååç©ã®ãããªã¯ãã
ã¢ããã«ãªãã¡ã¿ã³ããã³ãžã¯ãããžãã«ãªãã¡
ã¿ã³åŽå°å€ã®ãªã¬ã€ã³é žäžæ··å液äžã®åŸ®çµæ¶æžæ¿
液ãå«æãããåäœåã«ãã42ÎŒïœã®ïŒâã¯ãã
â11βïŒ17ïŒ21âããªããããã·â16βâã¡ãã«
ãã¬ã°ãâïŒïŒïŒâãžãšã³âïŒïŒ20âãžãªã³17ïŒ
21âãžããããªããŒãã®åŽå°ãéãåºãããçŽ
200åã®çµå£åŽå°ãæäŸããã æ¬çºæã®ããïŒã€ã®æ æ§ã«ããã°ãæäžçµè·¯ãš
ããŠè¬å€ã®éŒ»æäžã®éžæãæäŸããããã®æäžçµ
è·¯ã¯ã錻çµè·¯ã«æ¥è§Šãããããã®è¬å€ã®å±ææäž
ããã®éšäœã®ããšãã«ãšããšãªã³å¡©é žå¡©ïŒNeoâ
SynephrineãWinthropïŒãŸãã¯ãªãã·ã¡ã¿ãŸãª
ã³å¡©é žå¡©ïŒAfrinãScheringïŒã®ãããªè¬å€ã«ã
ã軜æžãå¿ èŠãªå Žåãªãã³ã«è¬å€ã®çµå£æäžã«ã
ã°ãã°äŒŽãªãåé¡ããããããã«éŒ»ç²èçµç¹ãé
ããŠè¬å€ãå šèº«äœã«ãšã蟌ãå¿ èŠãããç¶æ ã«å¿
èŠãšããããäŸãã°ãã¹ã³ãã©ãã³ã¯å¹æçãªå
æºç è¬ã§ã¯ããããèèãééããããšããã®æ
äžæ³ãäžæºè¶³ã«ãã錻ç²èãéããããšã該è¬å€
ã®çµå£æäžã«äŒŽãªãæåã®èèééãããããŸ
ããæ¯èŒçæ¥éãªè¬å€ã®åé ãäžãããã®ç¹ã§ã
錻æäžã«å¯ŸããŠäœçšã®é ããªãçµç®æäžãããã
ãããŠãããæ¬çºæã«ãã錻å è¡æå¶è¬ã®æäž
ã¯ãåŸæ¥ã®åžå ¥è¬ããç¹ã«ïŒã€ã®ç¹ã§æå©ã§ãã
ããšã瀺ããããåŸæ¥ã®åžå ¥è¬ã«ãããŠã¯ãè¬å€
ã¯éŒ»ã«æ¥éã«åŽå°ããããšã«ããæäžããããã®
çµæãè¬å€ã®å€§éšåã錻ã®åéšã§éŒ»éè·¯ã«åœãã
ã»ãã®å°éã®è¬å€ã錻éè·¯ã®åŸéšã«åœãã ãã§ã
ããæ¬çºæã«åŸã€ãŠè¬å€ãæ®éã«ãã蟌ãããšã«
ããã錻ç²èåå šäœã«ããã€ãŠããåäžãªè¬å€ã®
ééãçããããšãèŠããããå ããŠãåŸæ¥ã®éŒ»
å ãžãæã¡èŸŒãŸãããè¬å€ã¯ãæ¥éåŽå°æäžåŸã
æ£è ãããã«åŒåžããã®ã§äœå ãžééããããšã
ãããæ¬çºæã«ããã°ãè¬å€ã®æäžåŸããã€ãæ£
è ãããã«åŒåžããåãæ¬çºæã®è£ 眮ã¯æäžãã
ãšåãéã®ç©ºæ°ãé€å»ããããã«äœåããããªã
ã¡ãæäžããããšåãéã®ç©ºæ°ã錻éè·¯ããé€
ããããã«ãããè¬å€ãåŒåºãããã«åŸã€ãŠéŒ»é
è·¯ãéãè¬å€ã®ç¬¬ïŒã®ééãäžããæªåžåè¬å€ã®
å šãŠãé€å»ãã錻ç²èçµç¹ãéã€ãŠå ¥ã€ããã®ã
é€ããäœå ãžå ¥ãè¬å€ã¯å®è³ªçã«ãªãã 第ïŒå³ã¯ãããŠã¹ããŒã¹ïŒïŒããã³å å§åžå ¥åš
ç¶ïŒïŒãæããåºæ¬çãªåŽé§è£ 眮ïŒïŒã瀺ããåŽ
é§è£ 眮ïŒïŒã¯ã空æ°è¢è£ 眮ïŒïŒã®ããŠã³ãéšïŒïŒ
ã«åä»ããããã空æ°è¢è£ 眮ïŒïŒã¯ãæå端éšã
ã€ããïŒïŒããã³ç«¯éšãã€ããïŒïŒãšããããçµ
åããåŽå£ïŒïŒãããªããæå端éšãã€ããïŒ
ïŒã端éšãã€ããïŒïŒããã³åŽå£ïŒïŒã¯ã空éïŒ
ïŒã圢æãããæå端éšãã€ããïŒïŒããã³ç«¯éš
ãã€ããïŒïŒã¯ãåžè²©ã®ãã©ã¹ããã¯ææããäœ
ãããŠããŠãããå£ïŒïŒã¯ãé©åœãªæè»æ§ãæ
ãããã€è»œéãªãã®ã§ããã°ã©ã®ãããªææã§ã§
ããŠããŠãããããïŒ 1/4ãã«ããªãšãã¬ã³ã§äœ
補ãããã®ã奜ãŸãããåŽå£ïŒïŒã¯ããã®å€åšïŒ
ïŒã®åšå²ã«ããŒãã·ãŒã«ãè¡ãªãããšã«ãããæ
å端éšãã€ããïŒïŒããã³ç«¯éšãã€ããïŒïŒã«çµ
åãããã空æ°è¢è£ 眮ïŒïŒã¯ãã¬ã¹äžééæ§ã§ã
åŽé§è£ 眮ïŒïŒã«åä»ããããšã®ã§ããå¯éããã
è¢ãäžããé©åœãªææã§ããã°ããããªãææã§
äœè£œããããšãã§ãããæå端éšãã€ããããã³
端éšãã€ããã¯ã容æã«æºåž¯ã§ããããããããª
ã䜿çšè ã®ãã±ããã«ãå ¥ãããã«äœè£œãããã®
ãæãŸãããæå端éšãã€ããïŒïŒãããã€ãŠåŽ
é§è£ 眮ïŒïŒããåãã¯ãããšãæå端éšãã€ãã
ïŒïŒã¯ç«¯éšãã€ããïŒïŒãšé¢é£ããŠå転ããã
ããæå端éšãã€ããïŒïŒã該ãã€ãããåãä»
ãããã端éšãã€ããïŒïŒããã³ãããã®éã«èª
ç¶ã«æããããŸããåŽå£ïŒïŒãæããå¹³ããªè£ 眮
ã圢æãããããããã®éšåã¯ãå ±åããŠåã
ãã容æã«çµç«ãŠãããšãã§ãã容æã«äœ¿çšã
ããéåžžã«æå¹ãªè£ 眮ãæäŸããã第ïŒå³ã«ç€ºã
ããè£ çœ®ã¯ããšã¢ãŸã«ãåŽå°ããã700mlã®æŒã
ã€ã¶ãããšã®ã§ããè¢ãæãããããŠã¹ããŒã¹äž
ã®å£éŒ»éè·¯ãé£çµ¡ããäºæ¹åæ§ã®æ段ã¯ããªãŒã
ã§éããã該ãªãŒãã¯ã0.3ïŒç§ä»¥äžã®åžæ¯
æµã«ãŠæ¯åããã€ãºãçºãããæ£è ã¯ãåŒåžäžã
éãã«åžå ¥ããããšãæ瀺ãããã第ïŒå³ã®è£ 眮
ã«ããæäžãããïŒåã®ïŒâãïŒâããããã·â
ïŒâãïŒïŒâã¡ãã«ãšãã«ïŒã¢ããããšãã«ããã³
ãŒã³ãžãªãŒã«ïŒ650ÎŒïœïŒã¯ã身äœãã¬ãã¹ã¢ã°
ã©ãããã³ã¹ããã¡ãŒã¿ã«ããé£ç¶æž¬å®ãçšãã
éåžžã®æäžéèšéåžå ¥åšã«ããåïŒåã®ïŒâãïŒ
âããããã·âïŒâãïŒïŒâã¡ãã«ãšãã«ïŒã¢ã
ãããšãã«ããã³ãŒã³ãžãªãŒã«ïŒ650ÎŒïœïŒãã
ã³ïŒâããããã·âïŒâããããã·ã¡ãã«âαâ
ãïŒïœâããã«ã¢ããïŒã¡ãã«ãã³ãžã«ïŒ100ÎŒïœïŒ
ã«çžåœãããåŒåžèªåŒãã¬ãã¹ã¢ã°ã©ãã€ãŒã¯ã
æäžéèšéåžå ¥åšã®åäœã®ç¹åŸŽãåžå ¥å®¹éãåžæ¯
æµããã³æ¯ã®äŒæ¢ã®ééã枬å®ãããåæ¯ãŸãã¯
æ ¢æ§æ°ç®¡æ¯çã«ããæ ¢æ§çãªç©ºæ°æµã®å¶éãæã
ãæ£è 10人ã«ãè©Šéšåã«ãæäžéèšéåžå ¥åšã®äœ¿
çšæ³ã«ã€ããŠã®æ瀺ãäžããçæéèšç·Žããã第
ïŒå³ã®è£ 眮ããåŽé§ãããïŒâãïŒâããããã·
âïŒâãïŒïŒâã¡ãã«ãšãã«ïŒã¢ããããšãã«ãã
ã³ãŒã³ãžãªãŒã«ã¯ãSGawã«ãããŠ195±52ïŒ
ïŒSEïŒã瀺ããåŸæ¥ã®æäžéèšéåžå ¥åšã«ããåŽ
é§ãããïŒâãïŒâããããã·âïŒâãïŒïŒâã¡ã
ã«ãšãã«ïŒã¢ããããšãã«ããã³ãŒã³ãžãªãŒã«ãŸ
ãã¯ïŒâããããã·âïŒâããããã·ã¡ãã«âα
âãïœâããã«ã¢ããïŒã¡ãã«ããã³ãžã«ã®å101
±24ïŒ ããã³86±26ïŒ ã«æ¯ã¹ãããªã倧ããªæ倧
å¢å éã瀺ãïŒïœïŒ0.003ïŒãæäžéèšéåžå ¥åšã®
äœåãåžæ°äœçšãšãšãã«ã§ããªãïŒäººã®æ£è ã®æ°
管æ¯æ¡åŒµåå¿ã¯ãããŸãæäžéèšéåžå ¥åšãåæ±
ãïŒäººã®æ£è ããããªãå°ããïŒïœïŒ0.005ïŒãå¹³
åæµéã¯ãSPTããã³ïŒâãïŒâããããã·âïŒ
âãïŒïŒâã¡ãã«ãšãã«ïŒã¢ããããšãã«ããã³ãŒ
ã³ãžãªãŒã«ã®åžå ¥æã1.02±0.29ïŒç§ããã³
0.54±0.16ïŒç§ã§ãããåã ã第ïŒå³ã®è£ 眮ã
çšããååããã³ïŒåç®ã®åžå ¥æã®0.19±0.02
ïŒç§ããã³0.24±0.03ïŒç§ã«çžåœããããã®
è£ çœ®ã¯ãæ£è ã«å åã«èš±å®¹ãããåŸæ¥ã®æäžéèš
éåžå ¥åšãããå¹æçã«æ°ç®¡æ¯æ¡åŒµãä¿é²ããã
第ïŒå³ã®è£ 眮ã®å¹æã¯ãïŒååã®ïŒâãïŒâãã
ããã·âïŒâãïŒïŒâã¡ãã«ãšãã«ïŒã¢ããããšã
ã«ããã³ãŒã³ãžãªãŒã«ã®äœ¿çšãè¡ãªãããšã«ã
ããæ ¢æ§ã®æ°éééçãæãã10人ã®æ£è ã«åŸæ¥
ã®æäžéèšéåžå ¥åšã«ãã€ãŠäžããããïŒååã®
ïŒâãïŒâããããã·âïŒâãïŒïŒâã¡ãã«ãšãã«ïŒ
ã¢ããããšãã«ããã³ãŒã³ãžãªãŒã«ããã³ïŒâã
ãããã·âïŒâããããã·ã¡ãã«âαâãïŒïœâã
ãã«ã¢ããïŒã¡ãã«ããã³ãžã«ã«çžåœããããšã
ããããæ£è ã¯å šãŠè©Šéšåã«ïŒãïŒæ¥éæäžéèš
éåžå ¥åšã®äœ¿çšã®èšç·Žãåãã圌ãã®æè¡ã¯ãç®
ç«ããªãããã«ããŠè©ŠéšäžãåŒåžèªåŒãã¬ãã¹ã¢
ã°ã©ãã€ãŒãçšããŠè©äŸ¡ãããæ ¢æ§çãªç©ºæ°æµé
ã«å¶éãæããç·æ§ïŒåããã³å¥³æ§ïŒåããã¡ïŒ
åã¯åæ¯ã§ãããïŒåã¯æ°ç®¡æ¯çã§ãããã®ãè©Š
éšã«çšããçµæã以äžã®ç¬¬ïŒè¡šã«ç€ºãã
âã¡ãã«ãšãã«ïŒã¢ããããšãã«ãâïŒïŒïŒâã
ã³ãŒã³ãžãªãŒã«ã¯åºãçšããããŠããæ°ç®¡æ¯æ¡åŒµ
å€ã§ããïŒã¡ã¿ãããã¬ããŒã«ãAlupentã
MetaprelãAlotecãNovasmasolïŒããããšåã
äžè¬çã«ããŽãªãŒã®ä»ã®è¬å€ã¯ïŒâããããã·â
ïŒâããããã·ã¡ãã«âαâãïŒïœâããã«ã¢ã
ãïŒã¡ãã«ããã³ãžã«ã¢ã«ã³ãŒã«ïŒAerolinã
BroncovaleasãSultanolãVentlinãVentolinã
ProventilïŒã§ãããåŸæ¥ã®é©çšæ¹æ³ã«ããã°ã
ïŒâãïŒâããããã·âïŒâãïŒïŒâã¡ãã«ãšãã«ïŒ
ã¢ããããšãã«ããã³ãŒã³ãžãªãŒã«ã®è£œé è ã¯äž
掻æ§åŽå°å€äžã225mgã®è¶ 埮ç²ç ãããç²æ«ãæ
ããæäžéèšéåžå ¥åšãæšå¥šããŠãããããã¯çŽ
300æäžéãæããŠããã該è¬å€ã¯è¬å€æäžçšã®
ããŠã¹ããŒã¹ã«åµãã15mlåžå ¥åšäžã«å容ãããŠ
ãããåžå ¥è¬å€ã®ïŒãïŒåã®åŽå°ãéåžžã®ïŒåã®
æäžã§ãããè¿ãæäžã¯çŽïŒãïŒæéããšä»¥äžãš
ã¯ãªãããïŒæ¥ã®ç·æäžã¯æ倧ããããåžå ¥è¬å€
ã®çŽ12ååŽå°ã§ãããFacts and Comparisonsã
p586ïŒ1980ïŒã«ããã°ãåžå ¥èª¿è£œç©ã®éå°ãªäœ¿çš
åŸã®æ»äº¡ãå ±åãããŠãããæ£ç¢ºãªåå ã¯äžæã§
ããããæ°äŸã«ãããŠå¿åæ¢ãèªãããããšè¿°ã¹
ãããŠããããŸããåæ¯æç¶ç¶æ ããã³ç°åžžè¡æ¶²
ã¬ã¹å§ã®æ£è ã«ãããŠãèºæŽ»éããã³è¡æ¶²ã¬ã¹å§
ã®æ¹åã¯æ°ç®¡çæ£ã®æçœãªè»œæžã䜵ãªããªããã
ãããªããšãè¿°ã¹ãŠããããŸããïŒâãïŒâãã
ããã·âïŒâãïŒïŒâã¡ãã«ãšãã«ïŒã¢ããããšã
ã«ããã³ãŒã³ãžãªãŒã«ã«ã€ããŠå ±åãããŠããã
ãšã¯ãå¶ç¶ã®æ£è ã«ãããŠãåžå ¥èª¿è£œç©ã®å埩é
å°äœ¿çšã§æ¿ããé説æ°éæµæãèµ·ãããšã®èŠ³å¯ã§
ãããïŒâããããã·âïŒâããããã·ã¡ãã«â
αâãïŒïœâããã«ã¢ããïŒã¡ãã«ããã³ãžã«ã¢ã«
ã³ãŒã«ã«ã€ããŠãã¢ãã¬ããªã³æ§ãšã¢ãŸã«ã®éå°
䜿çšã¯å±éºãªå¯èœæ§ããããšå ±åãããŠãã
ãPhysicianâ²s Desk Referenceãp662ïŒ1981ïŒãã
AlupentïŒã¡ã¿ãããã¬ããŒã«ç¡«é žå¡©ã®åæšåïŒ
ã®æäžéèšéåžå ¥åšã®éå°äœ¿çšåŸã®èŽæ»çãä»ã®
亀æç¥çµäœçšåžå ¥èª¿è£œç©ã«ãããšåæ§ã«å ±åãã
ãŠããããã®PDRæç®ã«ãããŠãç¹ã«ããä»å ç
亀æç¥çµäœçšè¬å€ã®æäžã«é¢ããŠéåžžãªæ³šæãæ
ãããªããã°ãªããªããããïŒã€å¥ã®äº€æç¥çµäœ
çšå€ãæäžããåã«å åãªæéééãçµéããã
ã¹ãã§ãããâŠâŠâŠé«è¡å§ãå åèçŸæ£ããã€è¡
æ§å¿äžå šãç²ç¶ç·äº¢é²çããã³ç³å°¿ç ã®æ£è ã«ã
ããŠããããã¯äº€æç¥çµäœçšã¢ãã³ã«éææ§ãã
ãå Žåã«ã¯å å泚æããŠäœ¿çšãã¹ãã§ãããããš
èšãããŠãããå ããŠãïŒâãïŒâããããã·â
ïŒâãïŒïŒâã¡ãã«ãšãã«ïŒã¢ããããšãã«ããã³
ãŒã³ãžãªãŒã«ãŸãã¯ïŒâããããã·âïŒâããã
ãã·ã¡ãã«âαâãïŒïœâããã«ã¢ããïŒã¡ãã«ã
ãã³ãžã«ã¢ã«ã³ãŒã«ã®ãããªè¬å€ã«éåžžçšããã
ããããªåŸæ¥ã®ãšã¢ãŸã«ã®åŽå°ã§ã¯ãè¬å€ã®å£äž
ãžã®æ¥éæäžã¯ããšã¢ãŸã«ã®äœçšãå©çšããŠå®è³ª
çã«è¬å€ãæ£è ã®æ°ç®¡æ°ç®¡æ¯æš¹ãžéãããã®ãæ£
è ã®èºãžã®çªçºçãªç©ºæ°ã®ãšã蟌ã¿ã䌎ãªããã
è¬å€ã®å€ãã¯ãã®ææã®éšäœãžè¡ã代ãã«ãèè ž
管ãžéã蟌ãŸããïŒâãïŒâããããã·âïŒâ
ãïŒïŒâã¡ãã«ãšãã«ïŒã¢ããããšãã«ããã³ãŒã³
ãžãªãŒã«ã®ãããªãšã¢ãŸã«è¬å€ãããªãã¡ãæ°ç®¡
æ°ç®¡æ¯æš¹ãžéã蟌ãããã«èšèšãããè¬å€ã®æäž
ã®ãŸãããå察ã«ãªããšç¹ã«èªèãã¹ãã§ããã
ãã®åé¡ããšã¢ãŸã«ïŒâããããã·âïŒâããã
ãã·ã¡ãã«âαâãïŒïœâããã«ã¢ããïŒã¡ãã«ã
ãã³ãžã«ã¢ã«ã³ãŒã«èª¿è£œç©çšã®Proventil
ïŒScheringïŒâPatientâ²s Instructions for Useâ
ã«ãããŠæã«èªããããŠãããããã¯ä»¥äžã®æ瀺
ãå å«ããŠããã ïŒ å åã«æ¯ãã¯ããããªãã®èºããã§ããã ã
空æ°ãã¯ãåºããâŠâŠâŠ ïŒ æ·±ãæ¯ããããªãããéå±å®¹åšã®é éšãå å
ã«æŒãäžãããâŠâŠâŠ ïŒ ã§ããã ãé·ãæ¯ããšãããâŠâŠâŠ æèšããã°ããšã¢ãŸã«è¬å€æäžã®åŸæ¥ã®åŽå°
ã¯ãæ£è ããšã¢ãŸã«ã®åŽå°ãæäžãããšãã«æ£è
ã«éåžžã«æ·±ãæ¯ãããããã€ãã§ãæ£è ã«ã§ãã
ã ãé·ãæ¯ããšããããããšã«ãããè¬å€ãã§ã
ãã ãå€ãæ°ç®¡æ°ç®¡æ¯æš¹ãžå°éãããããšè©Šã¿ãŠ
ãããå°é家èªèº«ã«ãã€ãŠãå®å šã«æºè¶³ãããŠã¯
ããªãããã«èªãããããããã¯åŸãã®ã«å°é£ãª
æäœã§ãããåèšGayrardãã®å ¬è¡šãããç¥èŠã«
ããã°ã圌ã®ç 究ã«ãããŠèŠ³å¯ããæ£è ã®1/4ã
ã»ãã®ãããã«è¶ ããæ£è ããã®åã®æ瀺ã«åŸã€
ãŠããã®ã¿ã§ããããšã¯æå€ã§ã¯ãªãã åžå ¥ã«ãã€ãŠæäžãããŠããããïŒã€å¥ã®è¬å€
ã¯ïŒâã¯ããâ11βïŒ17ïŒ21âããªããããã·â
16βâã¡ãã«âãã¬ã°ãâïŒïŒïŒâãžãšã³âïŒïŒ
20âãžãªã³17ïŒ21âãžããããªããŒãããã¯ãã¡
ã¿ãŸã³ã»ãžããããªããŒããBecloventïŒGlaxoïŒã
ã§ãæäžéèšéåŽå°ãšåæ§ãªåžå ¥åšããæäžã
ããïŒâã¯ããâ11βïŒ17ïŒ21âããªããããã·
â16βâã¡ãã«ãã¬ã°ãâïŒïŒïŒâãžãšã³âïŒïŒ
20âãžãªã³17ïŒ21âãžããããªããŒãã»ããªã¯ã
ãã¢ããã«ãªãã¡ã¿ã³å æ¥ååç©ã®ãããªã¯ãã
ã¢ããã«ãªãã¡ã¿ã³ããã³ãžã¯ãããžãã«ãªãã¡
ã¿ã³åŽå°å€ã®ãªã¬ã€ã³é žäžæ··å液äžã®åŸ®çµæ¶æžæ¿
液ãå«æãããåäœåã«ãã42ÎŒïœã®ïŒâã¯ãã
â11βïŒ17ïŒ21âããªããããã·â16βâã¡ãã«
ãã¬ã°ãâïŒïŒïŒâãžãšã³âïŒïŒ20âãžãªã³17ïŒ
21âãžããããªããŒãã®åŽå°ãéãåºãããçŽ
200åã®çµå£åŽå°ãæäŸããã æ¬çºæã®ããïŒã€ã®æ æ§ã«ããã°ãæäžçµè·¯ãš
ããŠè¬å€ã®éŒ»æäžã®éžæãæäŸããããã®æäžçµ
è·¯ã¯ã錻çµè·¯ã«æ¥è§Šãããããã®è¬å€ã®å±ææäž
ããã®éšäœã®ããšãã«ãšããšãªã³å¡©é žå¡©ïŒNeoâ
SynephrineãWinthropïŒãŸãã¯ãªãã·ã¡ã¿ãŸãª
ã³å¡©é žå¡©ïŒAfrinãScheringïŒã®ãããªè¬å€ã«ã
ã軜æžãå¿ èŠãªå Žåãªãã³ã«è¬å€ã®çµå£æäžã«ã
ã°ãã°äŒŽãªãåé¡ããããããã«éŒ»ç²èçµç¹ãé
ããŠè¬å€ãå šèº«äœã«ãšã蟌ãå¿ èŠãããç¶æ ã«å¿
èŠãšããããäŸãã°ãã¹ã³ãã©ãã³ã¯å¹æçãªå
æºç è¬ã§ã¯ããããèèãééããããšããã®æ
äžæ³ãäžæºè¶³ã«ãã錻ç²èãéããããšã該è¬å€
ã®çµå£æäžã«äŒŽãªãæåã®èèééãããããŸ
ããæ¯èŒçæ¥éãªè¬å€ã®åé ãäžãããã®ç¹ã§ã
錻æäžã«å¯ŸããŠäœçšã®é ããªãçµç®æäžãããã
ãããŠãããæ¬çºæã«ãã錻å è¡æå¶è¬ã®æäž
ã¯ãåŸæ¥ã®åžå ¥è¬ããç¹ã«ïŒã€ã®ç¹ã§æå©ã§ãã
ããšã瀺ããããåŸæ¥ã®åžå ¥è¬ã«ãããŠã¯ãè¬å€
ã¯éŒ»ã«æ¥éã«åŽå°ããããšã«ããæäžããããã®
çµæãè¬å€ã®å€§éšåã錻ã®åéšã§éŒ»éè·¯ã«åœãã
ã»ãã®å°éã®è¬å€ã錻éè·¯ã®åŸéšã«åœãã ãã§ã
ããæ¬çºæã«åŸã€ãŠè¬å€ãæ®éã«ãã蟌ãããšã«
ããã錻ç²èåå šäœã«ããã€ãŠããåäžãªè¬å€ã®
ééãçããããšãèŠããããå ããŠãåŸæ¥ã®éŒ»
å ãžãæã¡èŸŒãŸãããè¬å€ã¯ãæ¥éåŽå°æäžåŸã
æ£è ãããã«åŒåžããã®ã§äœå ãžééããããšã
ãããæ¬çºæã«ããã°ãè¬å€ã®æäžåŸããã€ãæ£
è ãããã«åŒåžããåãæ¬çºæã®è£ 眮ã¯æäžãã
ãšåãéã®ç©ºæ°ãé€å»ããããã«äœåããããªã
ã¡ãæäžããããšåãéã®ç©ºæ°ã錻éè·¯ããé€
ããããã«ãããè¬å€ãåŒåºãããã«åŸã€ãŠéŒ»é
è·¯ãéãè¬å€ã®ç¬¬ïŒã®ééãäžããæªåžåè¬å€ã®
å šãŠãé€å»ãã錻ç²èçµç¹ãéã€ãŠå ¥ã€ããã®ã
é€ããäœå ãžå ¥ãè¬å€ã¯å®è³ªçã«ãªãã 第ïŒå³ã¯ãããŠã¹ããŒã¹ïŒïŒããã³å å§åžå ¥åš
ç¶ïŒïŒãæããåºæ¬çãªåŽé§è£ 眮ïŒïŒã瀺ããåŽ
é§è£ 眮ïŒïŒã¯ã空æ°è¢è£ 眮ïŒïŒã®ããŠã³ãéšïŒïŒ
ã«åä»ããããã空æ°è¢è£ 眮ïŒïŒã¯ãæå端éšã
ã€ããïŒïŒããã³ç«¯éšãã€ããïŒïŒãšããããçµ
åããåŽå£ïŒïŒãããªããæå端éšãã€ããïŒ
ïŒã端éšãã€ããïŒïŒããã³åŽå£ïŒïŒã¯ã空éïŒ
ïŒã圢æãããæå端éšãã€ããïŒïŒããã³ç«¯éš
ãã€ããïŒïŒã¯ãåžè²©ã®ãã©ã¹ããã¯ææããäœ
ãããŠããŠãããå£ïŒïŒã¯ãé©åœãªæè»æ§ãæ
ãããã€è»œéãªãã®ã§ããã°ã©ã®ãããªææã§ã§
ããŠããŠãããããïŒ 1/4ãã«ããªãšãã¬ã³ã§äœ
補ãããã®ã奜ãŸãããåŽå£ïŒïŒã¯ããã®å€åšïŒ
ïŒã®åšå²ã«ããŒãã·ãŒã«ãè¡ãªãããšã«ãããæ
å端éšãã€ããïŒïŒããã³ç«¯éšãã€ããïŒïŒã«çµ
åãããã空æ°è¢è£ 眮ïŒïŒã¯ãã¬ã¹äžééæ§ã§ã
åŽé§è£ 眮ïŒïŒã«åä»ããããšã®ã§ããå¯éããã
è¢ãäžããé©åœãªææã§ããã°ããããªãææã§
äœè£œããããšãã§ãããæå端éšãã€ããããã³
端éšãã€ããã¯ã容æã«æºåž¯ã§ããããããããª
ã䜿çšè ã®ãã±ããã«ãå ¥ãããã«äœè£œãããã®
ãæãŸãããæå端éšãã€ããïŒïŒãããã€ãŠåŽ
é§è£ 眮ïŒïŒããåãã¯ãããšãæå端éšãã€ãã
ïŒïŒã¯ç«¯éšãã€ããïŒïŒãšé¢é£ããŠå転ããã
ããæå端éšãã€ããïŒïŒã該ãã€ãããåãä»
ãããã端éšãã€ããïŒïŒããã³ãããã®éã«èª
ç¶ã«æããããŸããåŽå£ïŒïŒãæããå¹³ããªè£ 眮
ã圢æãããããããã®éšåã¯ãå ±åããŠåã
ãã容æã«çµç«ãŠãããšãã§ãã容æã«äœ¿çšã
ããéåžžã«æå¹ãªè£ 眮ãæäŸããã第ïŒå³ã«ç€ºã
ããè£ çœ®ã¯ããšã¢ãŸã«ãåŽå°ããã700mlã®æŒã
ã€ã¶ãããšã®ã§ããè¢ãæãããããŠã¹ããŒã¹äž
ã®å£éŒ»éè·¯ãé£çµ¡ããäºæ¹åæ§ã®æ段ã¯ããªãŒã
ã§éããã該ãªãŒãã¯ã0.3ïŒç§ä»¥äžã®åžæ¯
æµã«ãŠæ¯åããã€ãºãçºãããæ£è ã¯ãåŒåžäžã
éãã«åžå ¥ããããšãæ瀺ãããã第ïŒå³ã®è£ 眮
ã«ããæäžãããïŒåã®ïŒâãïŒâããããã·â
ïŒâãïŒïŒâã¡ãã«ãšãã«ïŒã¢ããããšãã«ããã³
ãŒã³ãžãªãŒã«ïŒ650ÎŒïœïŒã¯ã身äœãã¬ãã¹ã¢ã°
ã©ãããã³ã¹ããã¡ãŒã¿ã«ããé£ç¶æž¬å®ãçšãã
éåžžã®æäžéèšéåžå ¥åšã«ããåïŒåã®ïŒâãïŒ
âããããã·âïŒâãïŒïŒâã¡ãã«ãšãã«ïŒã¢ã
ãããšãã«ããã³ãŒã³ãžãªãŒã«ïŒ650ÎŒïœïŒãã
ã³ïŒâããããã·âïŒâããããã·ã¡ãã«âαâ
ãïŒïœâããã«ã¢ããïŒã¡ãã«ãã³ãžã«ïŒ100ÎŒïœïŒ
ã«çžåœãããåŒåžèªåŒãã¬ãã¹ã¢ã°ã©ãã€ãŒã¯ã
æäžéèšéåžå ¥åšã®åäœã®ç¹åŸŽãåžå ¥å®¹éãåžæ¯
æµããã³æ¯ã®äŒæ¢ã®ééã枬å®ãããåæ¯ãŸãã¯
æ ¢æ§æ°ç®¡æ¯çã«ããæ ¢æ§çãªç©ºæ°æµã®å¶éãæã
ãæ£è 10人ã«ãè©Šéšåã«ãæäžéèšéåžå ¥åšã®äœ¿
çšæ³ã«ã€ããŠã®æ瀺ãäžããçæéèšç·Žããã第
ïŒå³ã®è£ 眮ããåŽé§ãããïŒâãïŒâããããã·
âïŒâãïŒïŒâã¡ãã«ãšãã«ïŒã¢ããããšãã«ãã
ã³ãŒã³ãžãªãŒã«ã¯ãSGawã«ãããŠ195±52ïŒ
ïŒSEïŒã瀺ããåŸæ¥ã®æäžéèšéåžå ¥åšã«ããåŽ
é§ãããïŒâãïŒâããããã·âïŒâãïŒïŒâã¡ã
ã«ãšãã«ïŒã¢ããããšãã«ããã³ãŒã³ãžãªãŒã«ãŸ
ãã¯ïŒâããããã·âïŒâããããã·ã¡ãã«âα
âãïœâããã«ã¢ããïŒã¡ãã«ããã³ãžã«ã®å101
±24ïŒ ããã³86±26ïŒ ã«æ¯ã¹ãããªã倧ããªæ倧
å¢å éã瀺ãïŒïœïŒ0.003ïŒãæäžéèšéåžå ¥åšã®
äœåãåžæ°äœçšãšãšãã«ã§ããªãïŒäººã®æ£è ã®æ°
管æ¯æ¡åŒµåå¿ã¯ãããŸãæäžéèšéåžå ¥åšãåæ±
ãïŒäººã®æ£è ããããªãå°ããïŒïœïŒ0.005ïŒãå¹³
åæµéã¯ãSPTããã³ïŒâãïŒâããããã·âïŒ
âãïŒïŒâã¡ãã«ãšãã«ïŒã¢ããããšãã«ããã³ãŒ
ã³ãžãªãŒã«ã®åžå ¥æã1.02±0.29ïŒç§ããã³
0.54±0.16ïŒç§ã§ãããåã ã第ïŒå³ã®è£ 眮ã
çšããååããã³ïŒåç®ã®åžå ¥æã®0.19±0.02
ïŒç§ããã³0.24±0.03ïŒç§ã«çžåœããããã®
è£ çœ®ã¯ãæ£è ã«å åã«èš±å®¹ãããåŸæ¥ã®æäžéèš
éåžå ¥åšãããå¹æçã«æ°ç®¡æ¯æ¡åŒµãä¿é²ããã
第ïŒå³ã®è£ 眮ã®å¹æã¯ãïŒååã®ïŒâãïŒâãã
ããã·âïŒâãïŒïŒâã¡ãã«ãšãã«ïŒã¢ããããšã
ã«ããã³ãŒã³ãžãªãŒã«ã®äœ¿çšãè¡ãªãããšã«ã
ããæ ¢æ§ã®æ°éééçãæãã10人ã®æ£è ã«åŸæ¥
ã®æäžéèšéåžå ¥åšã«ãã€ãŠäžããããïŒååã®
ïŒâãïŒâããããã·âïŒâãïŒïŒâã¡ãã«ãšãã«ïŒ
ã¢ããããšãã«ããã³ãŒã³ãžãªãŒã«ããã³ïŒâã
ãããã·âïŒâããããã·ã¡ãã«âαâãïŒïœâã
ãã«ã¢ããïŒã¡ãã«ããã³ãžã«ã«çžåœããããšã
ããããæ£è ã¯å šãŠè©Šéšåã«ïŒãïŒæ¥éæäžéèš
éåžå ¥åšã®äœ¿çšã®èšç·Žãåãã圌ãã®æè¡ã¯ãç®
ç«ããªãããã«ããŠè©ŠéšäžãåŒåžèªåŒãã¬ãã¹ã¢
ã°ã©ãã€ãŒãçšããŠè©äŸ¡ãããæ ¢æ§çãªç©ºæ°æµé
ã«å¶éãæããç·æ§ïŒåããã³å¥³æ§ïŒåããã¡ïŒ
åã¯åæ¯ã§ãããïŒåã¯æ°ç®¡æ¯çã§ãããã®ãè©Š
éšã«çšããçµæã以äžã®ç¬¬ïŒè¡šã«ç€ºãã
ãè¡šã
幎什ã®å¹
ã¯ã41ã77æïŒå¹³å64æïŒã§ãããè©Š
éšäžãæ£è ã¯ããããç æ°ã®æªåãçµéšããªãã€
ããè©Šéšåãå šãŠã®æ£è ã¯ãïŒç§éã®åŒ·å¶åŒæ°å®¹
ç©ã«ãããå¢å å°ãªããšã15ïŒ ã瀺ãããã€D30
çºçåšã«ããäžãããããšã¢ãŸã«åããã©ã»ãäœ
ã®ãšãããã€ãªã³ãŸãã¯ã€ãœãšã¿ãªã³ãïŒåæ·±åŒ
åžããåŸãå°ãªããšã45ïŒ ã®æ¯æ°éã³ã³ãã¯ã¿ã³
ã¹ïŒSpecific airway conductance.S GawïŒã®å¢
å ã瀺ããæ£è ã«ã¯ãåè©Šéšæ¥ã®åãå°ãªããšã
ïŒæé圌ããéåžžçšããŠããæäžéèšéåžå ¥åšã®
䜿çšãäžæ¢ãããå°ãªããšã16æéããªãã€ãªã³
ã®äœ¿çšãäžæ¢ããããšãèŠæ±ãããããããã®çµ
å£ã³ã«ãã³ã¹ããã€ãã®æäžã¯ãç¶ç¶ããŠè¡ãªã
ããã å šãŠã®æ£è ã¯ã座ã€ãç¶æ ã§èºæ©èœãã¹ããå
ãããïŒç§éã®åŒ·å¶åŒæ°å®¹ç©ïŒFEV1ïŒããã³åŒ·
å¶çäœå®¹ç©ïŒvital capacityïŒã®æž¬å®ããã©ã€ã
ãŒãªã³ã°ã·ãŒã«ã¹ããã¡ãŒã¿ïŒdry rolling seal
Spirometerããªãã€ãª800ããªãã€ãªã¡ãã€ã«ã«
ãããã¯ã瀟補ããããµã¹å·ããŠãŒã¹ãã³ïŒã«ã
ã€ãŠè¡ãªããæ°éæµæïŒRawïŒããã³æ©èœæ®ç容
ç©ïŒfunctional residual capacityãFRCïŒã¯ã
身äœãã¬ãã¹ã¢ã°ã©ãã€ãŒã«ãã€ãŠæž¬å®ãããã
æ¯æ°éã³ã³ãã¯ã¿ã³ã¹ã¯ãRawã®éæ°ãRawã枬
å®ããèžéšã¬ã¹å®¹éã§å²ã€ãŠèšç®ããããããŒã¹
ã©ã€ã³ã®å€ã¯ãæ°ç®¡æ¯æ¡åŒµå€ã®æäžåŸã15ã30ã
60ããã³120ååŸã«ããè¿ãèšé²ãããã身äœã
ã¬ãã¹ã¢ã°ã©ãã€ãŒããã³ã¹ããã¡ããªãŒã®ïŒå
ã®æž¬å®ã®å¹³åããã³æ倧ã¯ãçµ±èšçåææ³ã«ãã
åŠçãããã è©Šéšã¯ã第ïŒå³ã®è£ 眮ãçšããè©²è£ çœ®ã¯ãæ¡åŒµ
ãã圢æ ã§çŽåŸïŒcmãé·ã11.5cmã®ç©ºæ°è¢ãæã
ãããšã¢ãŸãŒã«åããïŒâãïŒâããããã·âïŒ
âãïŒïŒâã¡ãã«ãšãã«ïŒã¢ããããšãã«ããã³ãŒ
ã³ãžãªãŒã«ãå«ã猶ã®ããºã«ãããŠã¹ããŒã¹ã«æ¿
å ¥ããããšã¢ãŸãŒã«åããïŒâãïŒâããããã·
âïŒâãïŒïŒâã¡ãã«ãšãã«ïŒã¢ããããšãã«ãã
ã³ãŒã³ãžãªãŒã«ãæ³šå ¥ãããæ£è ã¯ãè¢ããµãã
ãŸãããšã¢ãŸãŒã«çŒ¶ãäœåããã空ã«ãªããŸã§è¢
ããåžå ¥ãè¡ãªãããã€ããïŒã€æ°ããéæ¯ãæ¢
ããè¢ãžæ¯ãå¹ãåºããã€ãã§åã³åžå ¥ããŠãã
ã€ããïŒã€æ°ããéæ¯ãæ¢ããããã«æ瀺ãã
ããæ£è ã¯ããªãŒããé³ãçºçããªããããã€ã
ããšåžå ¥ããããã«èŠè«ãããã æäžéèšéåžå ¥åšã«ããäžãããããšã¢ãŸãŒã«
ã®ç²åŸååžã¯ãïŒæ®µã«ã¹ã±ãŒãã€ã³ãã¯ã¿ãŒïŒã¢
ã³ããŒãœã³ã»ãµã³ãã«ãºã»ã€ã³ã³ãŒãã¬ãŒããã
補ãã¢ãã©ã³ã¿ãGAïŒãçšããŠæž¬å®ããããé
åžžã®æäžæ¹åŒã®æ¡ä»¶äžã«ãããŠå£è åœé ã®è¡šé¢ã«
ãããæäžéèšéåžå ¥åšã®è¡æãã¹ã¯ãåžè²©ã®ã¢
ãã«ïŒã©ãšã«ãã«ã»ã¡ãã€ã«ã«ã»ã³ãŒãã¬ã€ã·ãš
ã³ãã¿ãã«ããŒãNY10707ïŒãšåæ§ã®ç¹åŸŽãæ
ããæ人ã®å£è åœé ã®ã¬ã©ã¹ã¢ãã«ãçšããŠæž¬å®
ãããæäžéèšéåžå ¥åšãã¬ã©ã¹ã¢ãã«ã®å£ã«å
ä»ãã0.5ïŒç§ã®ä¹Ÿç¥ç©ºæ°ã該ã¢ãã«ã«é£ç¶ç
ã«éããªããããšã¢ãŸã«ã該ã¢ãã«äžã«çŽæ¥äžã
ãã該ã¢ãã«ã®åœé ã®ç«¯ããéãããšã¢ãŸãŒã«ç²
åããã€ã«ã¿ãŒã«éãééãã¯ããã æ°éå ã®ãšã¢ãŸãŒã«ã®ä»çã確å®ãšããå埩åŒ
åžæ°ã®åœ±é¿ãè©äŸ¡ããããã質éäžå€®å€4.0ÎŒïœã®
空æ°ååŠççŽåŸãæããååæ£ãšã¢ãŸãŒã«ã第ïŒ
å³ã®è£ 眮ã«äžããã€ãã§ãæ£è ã30åïŒåã®é床
ã§ãšã¢ãŸã«ãããè¿ãåŒåžããéããšã¢ãŸã«æ¿åºŠ
ã®æžå°ãã©ã€ãã»ã¹ãã€ã¿ãªã³ã°ã»ãšã¢ãŸãŒã«ã»
ããªãã¡ãŒã¿ã«ããé£ç¶çã«ã¢ãã¿ãŒããããšã¢
ãŸã«ã¯ããžâïŒïŒãšãã«ããã·ã«ïŒã»ãã±ãŒãæ²¹
ããã¡ããã·ã³ã¯ã«ãšã¢ãŒâã©ã¡ã«ïŒSinclairâ
LaMerïŒåãšã¢ãŸã«çºçåšã«ããçºçãããã
ãšã¢ãŸãŒã«ã®ç²åŸååžã¯ããã«ãåæåšãæãã
ã©ã€ã³ïŒRaycoïŒ220å åŠã«ãŠã³ã¿ãŒã«ãã枬å®
ãããã è¬å€æäžèšç»æ¡ã¯ãå€åœ¢ã©ã³ãã åäžéç²æ€äº€
åæ³ã«ããšã¥ããŠè©Šéšãè¡ãªããããæ£è ã¯ãæ
äžéèšéåžå ¥åšããïŒâãïŒâããããã·âïŒâ
ãïŒïŒâã¡ãã«ãšãã«ïŒã¢ããããšãã«ããã³ãŒã³
ãžãªãŒã«ãŸãã¯ãïŒâããããã·âïŒâãããã
ã·ã¡ãã«âαâãïŒïœâããã«ã¢ããïŒã¡ãã«ãã
ã³ãžã«ã®ãããããæäžãããã®ããèºæ©èœãã¹
ããè¡ãªãæåž«ããããã®æ¹æ³ãŸãã¯è¬å€ãè©Šéš
ããã®ãç¥ããªããæ¬çºæè£ çœ®ã«ããïŒååã®ïŒ
âãïŒâããããã·âïŒâãïŒïŒâã¡ãã«ãšãã«ïŒ
ã¢ããããšãã«ããã³ãŒã³ãžãªãŒã«ïŒ650ÎŒïœïŒ
ã®å¹æãåŸæ¥ã®æäžéèšéåžå ¥åšã«ããæäžãã
ãïŒååã®ïŒâãïŒâããããã·âïŒâãïŒïŒâã¡
ãã«ãšãã«ïŒã¢ããããšãã«ããã³ãŒã³ãžãªãŒã«
ããã³ïŒååã®ïŒâããããã·âïŒâããããã·
ã¡ãã«âαâãïŒïœâããã«ã¢ããïŒã¡ãã«ããã³
ãžã«ïŒ100ÎŒïœïŒãšæ¯èŒãããæ£è ã¯å šãŠæäžé
èšéåžå ¥åšãå®æçã«çšããŠãããå°ãªããšãæ°
ã±æåã«ãããã®æäžãæ瀺ããããè©Šéšã®çŽ
åãå šãŠã®æ£è ã¯ãç 究è ã®ïŒäººã«ãã€ãŠããã«
èšç·ŽãåããããŠãŒãã³ãïŒNewman et al
ãSimple Instructions for Using Pressurized
Aerosol BrochodilatorsããJ.Royal Soc.Med.
Vol.73ãpp776ã779ïŒ1980ïŒïŒã«ããéçºããã
æ瀺ãäžããããã該æ瀺ã¯ã猶ãæ¯ããFRC
ãŸã§æ¯ãåãåºãéã«åã®éã«æäžéèšéåžå ¥åš
ã®ããŠã¹ããŒã¹ãåä»ããèºã®å®¹éäžæ¯ã«ãã€ã
ããšæ·±ãæ¯ãåžã蟌ãéãæäžéèšéåžå ¥åšã®é
æŸãè¡ãªãããã®èºå®¹éã§10æ°ããéæ¯ãæ¢ãã
ããšãããªãã åŒåžèªåŒãã¬ãã¹ã¢ã°ã©ãã€ãŒã¯ãã€ãã®æ¹æ³
ã«ãŠæž¬å®ããããDCâé£çµåŒåžèªåŒãã¬ãã¹ã¢
ã°ã©ãããã³ãã®æž¬å®ïŒRespitraceãNonâ
Invasive Monitoring SystemsãInc.ãArdsleyã
NYïŒã«ã€ããŠã®è©³çŽ°ãªèšèŒã¯ããã€ãŒãã
ïŒChahda et alããValidation of Respiratory
Inductive Plethysmography Utilizing
Different Calibration ProceduresããAmer.
Rev.Respir.Dis.ïŒå°å·äžïŒïŒã«ããå ¬éãããŠã
ããããã¯ãè骚ã®éªšçµã¿ãšåŸ©éšãå ã匟æ§åž¯ã«
çž«ãã€ããããïŒæ¬ã®ãããã³çµ¶çžã¯ã€ã€ãããª
ãããããã¯çºæ¯åšéšã«é£çµãããŠãããè骚ã®
骚çµã¿ããã³è ¹éšã®æé¢ç©ã®å€åã¯ãã³ã€ã«ã®èª
å·±ã€ã³ãã¯ã¿ã³ã¹ããã³ãã®æ¯ååšæãå€ããé©
åœãªæž¬å®ãè¡ãªãããšã«ããèºæŽ»é枬å®æ³ã«ãã
枬å®ãããæ¯å容ç©ãåæ ãããåŒåžç³»ãïŒã€ã®
èªç±åºŠããã€ãŠåããšä»®å®ãããšãè©²è£ çœ®ã¯ãè
骚ã®éªšçµãè ¹éšããã³ã¹ããã¡ãŒã¿å®¹ç©ãçšã
ãŠãè骚骚çµïŒã¹ããã¡ãŒã¿ïŒè ¹éšïŒã¹ããã¡ãŒ
ã¿ïŒïŒã®åŒã«ãã枬å®ããããæ£è ã¯ãäºã€ã®å§¿
å¢ã§ã¹ããã¡ãŒã¿ã«æ¯ãåããåšæçã«å€åãã
容ç©ã«å¯Ÿããè骚ã®éªšçµãšè ¹éšãšã®å¯äžã®å·®ãç
ããããæçã«åŒã解ããããåŒåžèªåŒãã¬ãã¹
ã¢ã°ã©ãã®æž¬å®ã®ç¢ºèªã¯ããŸã€ããç«ã€ãäœçœ®ã
ãã³ããåãã®äœçœ®ã§ãåæã«è¡ãªãèºæŽ»é枬å®
æ³ã«å¯ŸããŠè¡ãªãããæ£è ã®èºæŽ»é枬å®ããã®å¹³
åããŒã»ã³ãåå·®ïŒÂ±SDïŒã¯ãåã 4.1±2.4ïŒ ã
4.6±2.8ïŒ ã§ããã åŒåžèªåŒãã¬ãã¹ã¢ã°ã©ãããåŸãããä¿¡å·
ã¯ããã€ã¯ãããã»ããµãŒã·ã¹ãã ãåºæ¬ãšãã
â80AïŒRespicompRespitrace Corp.ã
ArdsleyãNYïŒã«èšé²ãããããã¯ã20ç¹ïŒç§
ã«ãŠä¿¡å·ãæ¡åãããæäžéèšéåžå ¥åšãäœåã
ãããšãã芳å¯è ã¯ãã³ã³ããŠãŒã¿ãŒã«ã¢ããã°
ã¹ãããé»å§ã«ãã€ãŠä¿¡å·ãéããã€ãã§ãèšé²
ãã«ãŒãœã«ããã°ã©ã ã«ããåæããã³ã³ããŠãŒ
ã¿ã¯ãã€ãã®ãã©ã¡ãŒã¿ãèšç®ããã (1) FRCããæäžéèšéåžå ¥åšã®æäœãžã®èºå®¹
ç©ã®å€åã (2) æäžéèšéåžå ¥åšã®æäœããåžå ¥ã®ããŒã¯ãž
ã®èºå®¹ç©ã®å€åã (3) (1)ããã³(2)ã®æç¶æéãããã³ã€ãã«æ¯ãå
ããŸã§ã®æ¯ãæ¢ããŠããæéã (4) FRCããæäœãŸã§ãããã³æäœããåžå ¥ã®
ããŒã¯ã«ãããå¹³ååžæ°æµé èºæ©èœæ¹åã®ããã®ïŒã€ã®åŠçœ®ã®éã®çµ±èšçãª
å·®ãããã¯ã¹ïŒHicksïŒãã®ãã¹ãããã»ãã¢ã¯
ããªã¢ã«ã»ãã¶ã€ã³ïŒãNested and Nested
Factorial ExperimentsããFundamental
Concepts in the Design of Experiments ïŒ
EditionïŒ1973ïŒHoltãRenehart and Winston
Inc.ãNew Yorkãpp188ã203ïŒã«ããåæã
ãããããè©Šéšæ¥éã®ããŒã¹ã©ã€ã³æž¬å®ã«ããã
è©äŸ¡ã®åå·®ãšããŠçšãããææå·®ãããã°ãããŒ
ã¿ãããã«ïŒ±çµ±èšè¡šã«ããåæãããã倧ããªå
å¿ãçããåŠçœ®ã決å®ããããŸããã¢ãïœâãã¹
ããè¡ãªãããæ°ç®¡æ¯æ¡åŒµå€ãçšããåŸã®åæé
ã«ãããïŒã€ã®åŠçœ®ã®å¹æãæ¯èŒãããæ°ç®¡æ¯æ¡
匵å€ã¯ãæäžéèšéåžå ¥åšã®åæ±ããããŸãæ£è
ã¯ããžããªæ£è ãšã»ãŒåãã§ããããšãã¢ã³ãã¢
ãïœâãã¹ãã«ãã瀺ãããçµæãå¹³å±æšæºèª€
å·®ïŒïŒžÂ±SEïŒãšããŠè¡šããã ïŒæ®µã«ã¹ã±ãŒãã€ã³ãã¯ã¿ãŒã«ãã枬å®ããã
ç²åŸååžã¯ãã»ãŒå¯Ÿæ°âæ£èŠæ°ã®é¢ä¿ã«ãããïŒ
âãïŒâããããã·âïŒâãïŒïŒâã¡ãã«ãšãã«ïŒ
ã¢ããããšãã«ããã³ãŒã³ãžãªãŒã«ã¯ã質éå¹³å
空æ°ååŠåŸ4.9ïŒSD±0.8ïŒÎŒïœã幟äœæšæºåå·®2.1
ãæããïŒâããããã·âïŒâã¡ããã·ã¡ãã«â
αâãïŒïœâããã«ã¢ããïŒã¡ãã«ããã³ãžã«ã¯ã
質éå¹³å空æ°ååŠåŸ2.4ïŒSD±0.28ïŒÎŒïœã幟äœæš
æºåå·®1.7ãæããã å£è åœé ã¢ãã«ã®è¡šé¢ã«ãããæäžéèšéåžå ¥
åšããã®è¡æãã¹ã¯ãïŒâãïŒâããããã·âïŒ
âãïŒïŒâã¡ãã«ãšãã«ïŒã¢ããããšãã«ããã³ãŒ
ã³ãžãªãŒã«ã«ã€ããŠã¯43ïŒ ãïŒâããããã·âïŒ
âããããã·ã¡ãã«âαâãïŒïœâããã«ã¢ããïŒ
ã¡ãã«ããã³ãžã«ã«ã€ããŠã¯31ïŒ ã§ãããïŒâ
ãïŒâããããã·âïŒâãïŒïŒâã¡ãã«ãšãã«ïŒã¢
ããããšãã«ããã³ãŒã³ãžãªãŒã«ã第ïŒå³ã«ç€ºã
ãšã¢ãŸãŒã«éåºã·ã¹ãã ã®ç©ºæ°è¢ã«äŸçµŠãããšã
æ°é®®ãªç©ºæ°ã§ïŒåæŽãããšã«ããããšã¢ãŸãŒã«ã®
50ïŒ ã¯ååããããšã¢ãŸãŒã«ã®41ïŒ ã¯ç¬¬ïŒå³ã®è£
眮äžã«å€±ãªããããã¬ã©ã¹ã¢ãã«ã«åä»ããå Ž
åã第ïŒå³ã®è£ 眮ã«ããäŸçµŠãããïŒâãïŒâã
ãããã·âïŒâãïŒïŒâã¡ãã«ãšãã«ïŒã¢ããããš
ãã«ããã³ãŒã³ãžãªãŒã«ã®ãšã¢ãŸãŒã«ïŒïŒ ã該ã¢
ãã«ã«ä»çããããããã€ãŠãïŒâãïŒâããã
ãã·âïŒâãïŒïŒâã¡ãã«ãšãã«ïŒã¢ããããšã
ã«ããã³ãŒã³ãžãªãŒã«ã«ã€ããŠã¯ããšã¢ãŸãŒã«ã®
47ïŒ ã倱ãªããããšãšãã«ã53ïŒ ãæœåšçã«ã¬ã©
ã¹ã¢ãã«ããé¢ããŠæ°éã«å ¥ãã ãšã¢ãŸãŒã«ã®æ°éãžã®ä»çãè¡ãªãããã®åŒåž
æ°ã®æ±ºå®ã¯ãïŒäººã®æ£åžžãªæ€äœããã³ïŒäººã®æ ¢æ§
æ°ç®¡æ¯çæ£è ã«ãã€ãŠåŸããããæ£åžžãªæ€äœã«ã
ããŠã¯ã第ïŒå³ã®è£ 眮äžã«åãã®ãšã¢ãŸã«ã®90ïŒ
ãèºã«ä¿æãããåŒåžåæ°ã¯ã4.8ïŒSD±0.8ïŒå
ã§ãããäžæ¹ãæ ¢æ§æ°ç®¡æ¯çãæããæ£è ã«ãã
ãŠã¯ã1.8ïŒSD±0.8ïŒåã§ããããããã€ãŠãæ£
è ã«ãããŠã¯ã第ïŒå³ã®è£ 眮ããã®ïŒåã®åŒåžãš
ããã«ç¶ãã該è¢ããã®å埩åŒåžã®ïŒåç®ã®åŒåž
ããã³ãããã®åŒåžã®éã®æ¯ãæ¢ããæéã«ã
ããèºèå ã®äºé žåççŽ ã®ç®ç«ã€ãå¢å ã䌎ãªã
ãã«ãšã¢ãŸã«ã®æé©ä»çãè¡ãªãããã æ°ç®¡æ¯æ¡åŒµå€ã«å¯Ÿããåå¿ã¯ãïŒçš®ã®æ²»çã«ã
ããèºæ©èœææšã®å¹³åå€åéã«ãã€ãŠåæãã
ããïŒçš®ã®æ²»çå šãŠã«ãããŠã Gawã¯70ïŒ ä»¥
äžå¢å ãããã第ïŒå³ã®è£ 眮ã«ããïŒâãïŒâã
ãããã·âïŒâãïŒïŒâã¡ãã«ãšãã«ïŒã¢ããããš
ãã«ããã³ãŒã³ãžãªãŒã«ã«å¯Ÿããåå¿ã¯ãå šãŠã®
å Žåã«ãããŠãæäžéèšéåžå ¥åšã«ããæäžãã
ãïŒâãïŒâããããã·âïŒâãïŒïŒâã¡ãã«ãšã
ã«ïŒã¢ããããšãã«ããã³ãŒã³ãžãªãŒã«ãŸãã¯ïŒ
âããããã·âïŒâããããã·ã¡ãã«âαâãïŒïœ
âããã«ã¢ããïŒã¡ãã«ããã³ãžã«ã®å Žåããã
ããªãé¡èã§ããïŒïœïŒ0.003ïŒãæäžéèšéåžå ¥
åšã«ããæäžãããïŒâããããã·âïŒâããã
ãã·ã¡ãã«âαâãïŒïœâããã«ã¢ããïŒã¡ãã«ã
ãã³ãžã«ããã³ïŒâãïŒâããããã·âïŒâãïŒïŒ
âã¡ãã«ãšãã«ïŒã¢ããããšãã«ããã³ãŒã³ãžãª
ãŒã«ã¯ãåã  Gawã®æ倧å¢å é86±26ïŒ ãã
ã³101±24ïŒ ã§ãã€ãŠé¡èãªå·®ã¯ãªããããã«å¯Ÿ
ããŠãæ¬çºæã«ããäžããããïŒâãïŒâããã
ãã·âïŒâãïŒïŒâã¡ãã«ãšãã«ïŒã¢ããããšã
ã«ããã³ãŒã³ãžãªãŒã«ã¯ãæ倧å¢å é195±52ïŒ
ã瀺ããæ°ç®¡æ¯æ¡åŒµå€ã®æäžïŒæéåŸãïŒâãã
ããã·âïŒâããããã·ã¡ãã«âαâãïŒïœâãã
ã«ã¢ããïŒã¡ãã«ããã³ãžã«ããã³ïŒâãïŒâã
ãããã·âïŒâãïŒïŒâã¡ãã«ãšãã«ïŒã¢ããããš
ãã«ããã³ãŒã³ãžãªãŒã«ã«ã€ããŠïŒ³ Gawã®æ倧
å€ããã®äœäžãèªãããããã第ïŒå³ã®è£ 眮ã«ã
ãïŒâãïŒâããããã·âïŒâãïŒïŒâã¡ãã«ãšã
ã«ïŒã¢ããããšãã«ããã³ãŒã³ãžãªãŒã«ã«å¯Ÿãã
åå¿ã¯ãè¯å¥œã«ä¿æãããã FEV1ã®å¢å ã¯ã第ïŒå³ã®è£ 眮ã«ããïŒâãïŒ
âããããã·âïŒâãïŒïŒâã¡ãã«ãšãã«ïŒã¢ã
ãããšãã«ããã³ãŒã³ãžãªãŒã«ã®å Žåã¯ãïŒâã
ãããã·âïŒâããããã·ã¡ãã«âαâãïŒïœâã
ãã«ã¢ããïŒã¡ãã«ããã³ãžã«ãŸãã¯ïŒâãïŒâ
ããããã·âïŒâãïŒïŒâã¡ãã«ãšãã«ïŒã¢ããã
ãšãã«ããã³ãŒã³ãžãªãŒã«ã«æ¯ããŠãã倧ããªã
ãšãå€ããå¹³åæ倧å¢å éã¯ãåã 47±13ïŒ ã24
±ïŒïŒ ããã³22±ïŒïŒ ã§ãããããããã®å·®ã¯ã
çµ±èšçææãªçŸ€ã«ã¯è³ããªãã€ããåæ§ã«ã
FVCã®å¢å ã¯ã第ïŒå³ã®è£ 眮ã«ããïŒâãïŒâã
ãããã·âïŒâãïŒïŒâã¡ãã«ãšãã«ïŒã¢ããããš
ãã«ããã³ãŒã³ãžãªãŒã«ã®å ŽåãïŒâããããã·
âïŒâããããã·ã¡ãã«âαâãïŒïœâããã«ã¢ã
ãïŒã¡ãã«ããã³ãžã«ãŸãã¯ïŒâãïŒâãããã
ã·âïŒâãïŒïŒâã¡ãã«ãšãã«ïŒã¢ããããšãã«ã
ãã³ãŒã³ãžãªãŒã«ã®å Žåããã倧ããããšãå€ã
èªããããåæ倧å¢å éã¯ã36±11ïŒ ã13±ïŒïŒ
ããã³ïŒÂ±ïŒïŒ ã§ãã€ããæ¬çºæã«ããå ŽåãåŸ
æ¥ã®æäžéèšéåžå ¥åšã«æ¯ããŠïŒâãïŒâããã
ãã·âïŒâãïŒïŒâã¡ãã«ãšãã«ïŒã¢ããããšã
ã«ããã³ãŒã³ãžãªãŒã«æäž30ååŸãé¡èãªå·®ç°ã
36±11ïŒ ããã³13±ïŒïŒ ãåã èªããããïŒïœïŒ
0.05ïŒãFRCã®æžå°ã¯ãå šãŠã®æ²»çã§èªãããã
æ¬çºæã®ãã®ãçšããïŒâãïŒâããããã·âïŒ
âãïŒïŒâã¡ãã«ãšãã«ïŒã¢ããããšãã«ããã³ãŒ
ã³ãžãªãŒã«ã®å Žåã¯ãä»ã®æ²»çã«æ¯ã¹ãŠãããã
ã§ãã倧ãããšèªããããïŒïœïŒ0.054ïŒã æäžéèšéåžå ¥åšã®åæ±ãæè¡ã¯ãã€ãã®æ¹æ³
ã«ãŠæ€èšãããå šãŠã®æ£è ã¯ãéåžžãæäžéèšé
åžå ¥åšãçšããŠããïŒå¹³å12.6幎䜿çšïŒãè©Šéšã®
ïŒãïŒç®åã«åèšç·Žãåãããã圌ãã®åããæ
瀺ã«åŸã€ãŠãåŸæ¥ã®æäžéèšéåžå ¥åšãæäœã§ã
ããã®ã¯ãããã§ãã€ããïŒäººã®æ£è ã¯ãåžå ¥æ
éäžãæäžéèšéåžå ¥åšã®æäœãè¡ãªããªãã€
ããã²ãšãã®æ£è ã¯ãã»ãŒïŒãåžå ¥ããïŒç§é
æ¯ãæ¢ããåŸãæäžéèšéåžå ¥åšãæäœããã€ã
ã§çŽã¡ã«æ¯ãåããã第ïŒã®æ£è ã¯ãæ·±åŒåžãã
åŸã®æ¯ãåãæéã«åžå ¥åšãæäœãã第ïŒã®æ£è
ã¯ãå¢æžããåŒåžã®åžæ°ã®ããŒã¯ã§ãã®æäœãè¡
ãªããæ¯ãåããã€ãã«æ·±åŒåžã延é·ããã第ïŒ
ã®æ£è ã¯ãæ¯ãåãéã«åžå ¥åšãæäœããã€ãã§
æ·±ãåžæ°ã«ç§»ã€ãããããã®æ£è ã¯å šãŠã第ïŒå³
ã®è£ 眮ãå°é£ãªã䜿çšã§ããã åžæ°äžã«åžå ¥åšãããŸãäœåãããïŒäººã®æ£è
ã®ãã¡ã倧éšåã¯ãã»ãŒ0.5ã®ç©ºæ°ãåžå ¥ãã
åŸã«ããããäœåããããäœåã«ã€ã¥ããå¹³ååž
å ¥å®¹éã¯ïŒã§ãããæ¯ããšããæéã¯14ç§ã§ã
ããåžå ¥é床ã§ã¯ããªãã®å·®ããããè¯å¥œãªæäž
éèšéåžå ¥åšæè¡ãæã€ïŒäººã®æ£è ã«ãããŠãã
ã®å¹³åæµéã¯ïŒâããããã·âïŒâããããã·ã¡
ãã«âαâãïŒïœâããã«ã¢ããïŒã¡ãã«ããã³ãž
ã«ããã³ïŒâãïŒâããããã·âïŒâãïŒïŒâã¡ã
ã«ãšãã«ïŒã¢ããããšãã«ããã³ãŒã³ãžãªãŒã«ã®
åžå ¥äžãåã ã1.02±0.29ïŒç§ããã³0.54±
0.16ïŒç§ã§ããã®ã«å¯ŸããŠã第ïŒå³ã®è£ 眮ãçš
ãã10人ã®æ£è å šãŠã«ãããŠã¯ã第ïŒçªç®ãšç¬¬ïŒ
çªç®ã®åžå ¥äžãåã ã0.19±0.02ïŒç§ããã³
0.24±0.03ïŒç§ã§ããã第ïŒå³ã®è£ 眮ã«ããæ
é«åžå ¥æµé床ã¯ãåŸæ¥ã®æäžéèšéåžå ¥åšã§ã®
1.90ïŒç§ã«å¯ŸããŠ0.50ïŒç§ã§ããã åŸæ¥ã®æäžéèšéåžå ¥åšæäžã«ããæ°ç®¡æ¯æ¡åŒµ
åå¿ã«ãããŠãæµéã«é¢ä¿ãªãåžæ°äžã«æäžéèš
éåžå ¥åšã®æäœãè¡ãªãè¯å¥œãªæè¡ãæã€æ£è
ãšãããã«å¯ŸããŠãæ¯ãæ¢ããéãŸãã¯æ¯ãåã
éã«æäžéèšéåžå ¥åšã®æäœãè¡ãªãäžååãªæ
è¡ãæã€æ£è ã®éã«æ確ãªå·®ç°ãèªãããããæ
äžéèšéåžå ¥åšã«ããïŒâãïŒâããããã·âïŒ
âãïŒïŒâã¡ãã«ãšãã«ïŒã¢ããããšãã«ããã³ãŒ
ã³ãžãªãŒã«ã®æäžåŸã®SGawã®æ倧å¢å ã¯ãè¯å¥œ
ãªæè¡ãæã€ïŒäººã®æ£è ã150±23ïŒ ã§ããã®ã«
察ããäžååãªæè¡ãæã€ïŒäººã®æ£è ã¯27±9.3
ïŒ ã§ããïŒïœïŒ0.005ïŒãåŸè ãæ¬çºæã䜿çšãã
å ŽåãïŒäººã¯163±90ïŒ ã®SGawã®æ倧平åå¢å é
ã瀺ããïŒäººã¯åŸæ¥ã®æäžéèšéåžå ¥åšã«ããå¢
å ãšåçã§ãããè¯å¥œãªæäžéèšéåžå ¥æè¡ãæ
ã€ïŒäººã®æ£è ã«ãããŠã¯ã第ïŒå³ã®è£ 眮ã«ãã
SGawã®æ倧åå¿ã¯ã236±78ïŒ ã§ãããïŒâãïŒ
âããããã·âïŒâãïŒïŒâã¡ãã«ãšãã«ïŒã¢ã
ãããšãã«ããã³ãŒã³ãžãªãŒã«ãéåºããæäžé
èšéåžå ¥åšã«ããæ倧åå¿150±23ïŒ ããããªã
倧ããã 第ïŒå³ã¯ãæ¬çºæã®ä»ã®æ æ§ã瀺ãããã®æ æ§
ã¯éŒ»ãä»ããåžå ¥ã«äœ¿çšã§ããæ§é ãæãã錻é
è·¯ã«ææã®è¬å€ãå¡åžããããšãã§ããã第ïŒå³
ã®æ æ§ã§ã¯ã第ïŒå³ã§ç€ºãããããªããŒã¹ïŒéš
åïŒïŒïŒããã³å å§åžå ¥ç¶ïŒïŒãåããåºæ¬çåŽ
é§è£ 眮ïŒïŒã䜿çšããããã¹ã¯ïŒïŒã¯ããœããã¬
ã¹ã±ããïŒïŒãšãšãã«æ£è ã«åä»ãããã該ãã¹
ã¯ã®å€æ°ããã®å¯éãæ¹åããããã¹ã¯ïŒïŒã¯ã
å³ç€ºããããã«ãæ£è ã®éŒ»ããã³å£ã«ãã¶ããŠäœ¿
çšããããã該ãã¹ã¯ã¯æ£è ã®éŒ»ã ãã«ãã¶ããŠ
ã䜿çšã§ããããã«ãããŠããããã¹ã¯ïŒïŒã¯ã
è¬å€ããã¹ã¯äžã«éãããããã®åºéšã«éå£ïŒïŒ
ãæãããããŠãŒãïŒïŒã¯ããã¹ã¯ïŒïŒã®éå£éš
ïŒïŒãåŽé§è£ 眮ïŒïŒã®ããŒã¹ïŒïŒã«é£çµãããã
ãŠãŒãïŒïŒã¯ãããŒã¹ïŒïŒã®åšå²ã«åºå®ãããã
ãæè»ãªãã©ã¹ãã€ã¯ã¹ãŸãã¯é©åœãªææã§è£œé
ãããŠãããåœæ¥è ã«åšç¥ã®ããŠãŒãïŒïŒãšããŠ
ã¹ããŒã¹ïŒïŒéã®ä»ã®ãããã®åœ¢åŒã®é£çµããã®
èšèŒããèããããããåŽé§è£ 眮ïŒïŒã¯ç©ºæ°è¢è£
眮ïŒïŒã®åä»éšïŒïŒã«åä»ããããã空æ°è¢è£ 眮
ïŒïŒã¯ãæå端éšãã€ããïŒïŒããã³ç«¯éšãã€ã
ãïŒïŒãããªããåŽå£ïŒïŒã«ããå ±ã«é£çµãããŠ
ãããæå端éšãã€ããïŒïŒã端éšïŒïŒããã³åŽ
å£ïŒïŒã¯ã空éïŒïŒã圢æãããæå端éšãã€ã
ãïŒïŒããã³ç«¯éšãã€ããïŒïŒã¯ãåžè²©ã®å ¥æå¯
èœãªãã©ã¹ããã¯ææãã補é ããŠãããå£ïŒïŒ
ã¯ãé©å®ã®æè»ã§è»œéãªãããã®ææã§ã§ããŠã
ãŠããããã2.25ãã«ããªãšãã¬ã³ãã補é ãã
ãã®ããããåŽå£ïŒïŒã¯ããã®å€åšïŒïŒã®åšå²ã«
ããŒãã·ãŒã«ãè¡ãªãããšã«ããæå端éšãã€ã
ãïŒïŒããã³ç«¯éšãã€ããïŒïŒã«é£çµãããã空
æ°è¢è£ 眮ïŒïŒã¯ãåŽé§è£ 眮ïŒïŒã«åä»ãããã¬ã¹
äžééæ§å¯éè¢ãæäŸãããããªé©åœãªææã§ã
ãã°ããããªãææã§èšèšãããŠããããæå端
éšãã€ããããã³ç«¯éšãã€ããã¯ã容æã«æã¡é
ã³ã§ããããã«è£œé ããããããã®äœ¿çšè ã®ãã±
ããã«ãé©åãããããšãããšãã«ã奜ãŸããã
æå端éšãã€ããïŒïŒããããã«ããåŽé§è£ 眮ïŒ
ïŒããåé¢ããããšãæå端éšãã€ããïŒïŒã¯ã
端éšãã€ããïŒïŒã«å¯ŸããŠå転ããããåŽå£ïŒïŒ
ããã®éã«èªåçã«æŒãã€ã¶ãããŠå¹³ããªè£ 眮ã
圢æãããããã«ãåŽé§åšïŒïŒã¯ããã¹ã¯ïŒïŒã
ãã³ããŠãŒãïŒïŒãããšãé¢ãããšãã§ãããã
ãã®éšåã¯ããŸããæ£è ã®ãã±ããã«ãã¡ããšçŽ
ãŸãã®ãããããããã®éšåã¯ãååããŠã容æ
ã«çµã¿ããŠããã容æã«äœ¿çšã§ããéåžžã«æå¹ãª
è£ çœ®ãæäŸããã æ¬çºæã®è¬å€éåºè£ 眮ã¯ãåŸæ¥ã®åžå ¥åšãäŸã
ã°ãå ¬ç¥ã®ïŒâãïŒâããããã·âïŒâãïŒïŒâã¡
ãã«ãšãã«ïŒã¢ããããšãã«ããã³ãŒã³ãžãªãŒã«
ããã³ïŒâããããã·âïŒâããããã·ã¡ãã«â
αâãïŒïœâããã«ã¢ããïŒã¡ãã«ããã³ãžã«ã¢ã«
ã³ãŒã«ïŒåã ãBoehringer Ingelheimããã³
SheringïŒãŸãã¯ãGlaxoïŒïŒã«çšããããå å§æ
äžåžå ¥åšããè¬å€ããåŽå°ãããããåŸæ¥ã®è¬å€
éåºã·ã¹ãã ã«å¯Ÿãæããã«å©ç¹ãæããããã
ãŸã§ã«ææ¡ãããŠããã¹ããŒãµãŒã·ã¹ãã ãšæ¯èŒ
ãããšãæ¬çºæã«ãããŠå ·äœåããã空æ°è¢ã·ã¹
ãã ã¯æ確ãªå©ç¹ãæããã空æ°è¢ã·ã¹ãã ã¯ã
è¬å€æäžäžã«å¿ èŠãªãæ£è ã«ãã調æŽãæå°ã§ã
ããšããç¹ãã奜ãŸãããæ¬çºæã®ä¿¡å·æ段ã¯ã
è¬å€æäžäžã空æ°ã®æµéããã³æµéãæ£è ã«ç¥ã
ããåŸæ¥ææ¡ãããŠããã¹ããŒãµãŒã·ã¹ãã ãã
ããã«ããããŠããããŸãã空æ°è¢ãžã®è¬å€ã®èš
éåŽå°ã«ããåçè¬å€æäžã¯ãå è¡æè¡ã«ãã
ãŠãïŒâãïŒâããããã·âïŒâãïŒïŒâã¡ãã«ãš
ãã«ïŒã¢ããããšãã«ããã³ãŒã³ãžãªãŒã«ããã³
ïŒâããããã·âïŒâããããã·ã¡ãã«âαâ
ãïŒïœâããã«ã¢ããïŒã¡ãã«ããã³ãžã«ã¢ã«ã³ãŒ
ã«ã®ããã«ææ¡ãããŠããå ¬ç¥ã®åžå ¥åšãããã
ãšãã«æå©ã§ãããåŸæ¥ææ¡ãããŠããïŒâãïŒ
âããããã·âïŒâãïŒïŒâã¡ãã«ãšãã«ïŒã¢ã
ãããšãã«ããã³ãŒã³ãžãªãŒã«ããã³ïŒâããã
ãã·âïŒâããããã·ã¡ãã«âαâãïŒïœâããã«
ã¢ããïŒã¡ãã«ããã³ãžã«ã¢ã«ã³ãŒã«çšã®ïŒã€ã®
åžå ¥åšããã³ã¹ããŒãµãŒãããããã«æå©ãªç¹
ã¯ãæ£è ã«ããåžå ¥åŠçœ®äžãããåäžãªè¬å€ååž
ãåŸãããããšã§ãããããå¹æçãªè¬å€ååžã«
ããæè¬ã®ç®¡çã¯ãæ¬çºæã®ç©ºæ°è¢ã·ã¹ãã ã®ã
ãã«æå©ãªç¹ã§ããã æ£è ã«ãšã€ãŠäœ¿çšã容æã§ããããšã¯ãæ¬çºæ
ã®ç©ºæ°è¢ã·ã¹ãã ã®éåžžã®äœ¿çšã®ããã«æ£è ã«ãš
ã€ãŠç¹ã«éèŠãªæå°ã®èŠæ±ã§ãã€ãŠããã®ç¹ã¯ã
å€ãã®æ£è ãåŸæ¥ã®ãïŒâãïŒâããããã·âïŒ
âãïŒïŒâã¡ãã«ãšãã«ïŒã¢ããããšãã«ããã³ãŒ
ã³ãžãªãŒã«ããã³ïŒâããããã·âïŒâãããã
ã·ã¡ãã«âαâãïŒïœâããã«ã¢ããïŒã¡ãã«ãã
ã³ãžã«ã¢ã«ã³ãŒã«åžå ¥åšã«å¯ŸããŠãããã®ã·ã¹ã
ã ãé©åã«äœ¿çšã§ããªãããšã瀺ããæ¬çºæã®è
æ¯ã®æ€èšã«ãããŠèšèŒã®ç 究ã«ãã匷調ãããŠã
ããä¿¡å·æ段ã奜ãŸããã¯ãæ¬çºæã®å¥œãŸããæ
æ§ã«ãŠå ·äœçã«ç€ºãããªãŒãç¬ã¯ãè¬å€æäžã®ã
ãã®é©æ£ãªåŒåžæè¡ãæ£è ã«å¯ŸããŠãèšç·Žããã
åœç¶ã空æ°æµéã®ææã®æ倧éãè¶ããå Žåã«ã¯
æ£è ã«åå³ãããããªä»å±ã®è£å©åšå ·ãšãªããã
ã®æ¹æ³ã«ãããæ£è ã¯ãèºè¬å€ã®æäžã«æå©ãªã
ã€ãããšããåžæ°æµéåããã³å€§ããªãæ·±åŒåžã
ãè¡ãªãæ¹æ³ãç¿åŸãããäžåºŠã«å€éã®è¬å€ãæ
äŸããïŒâãïŒâããããã·âïŒâãïŒïŒâã¡ãã«
ãšãã«ïŒã¢ããããšãã«ããã³ãŒã³ãžãªãŒã«ãŸã
ã¯ïŒâããããã·âïŒâããããã·ã¡ãã«âαâ
ãïŒïœâããã«ã¢ããïŒã¡ãã«ããã³ãžã«ã¢ã«ã³ãŒ
ã«çšåžå ¥åšã§ã®è¬å€ã®ãåŽå°ãã«å¯Ÿãã空æ°è¢ã
ãã®ç©ºæ°æµã«ãã調æŽãããè¬å€ã®éåºã«ããã
æ¬çºæ䜿çšã®ä»ã®å¹æã§ããå£è åœé ã«ããããš
ã¢ãŸã«ä»çã®æå°åãéæããããæ°ç®¡æ°ç®¡æ¯æš¹
ãžã®åçæäžã¯ãåæ§ã«ããŠæ倧ãšãªããæ°ç®¡æ°
管æ¯æš¹ã«åäžãªååžãäžããã«ã¯ãåžæ°åŠçœ®ã®
éãåäžãªæè¬ååžãšããã®ããããæ¬çºæè£ çœ®
ã®çµã¿ç«ãŠããã³æºåž¯ã®å®¹ææ§ã䞊ã³ã«åèšã®ä»
ã®å©ç¹ãšã¯ãŸãå¥ã«ãæ¬çºæã®è¬å€éåºè£ 眮ãçš
ãææã®æ°ç®¡æ°ç®¡æ¯æš¹ä»¥å€ããæ£è ã®åšå®äžã«å°
å ¥ãããè¬å€ãæå°åããããšã«ãã€ãŠãçŸåšã
åžè²©ã®ïŒâãïŒâããããã·âïŒâãïŒïŒâã¡ãã«
ãšãã«ïŒã¢ããããšãã«ããã³ãŒã³ãžãªãŒã«ãŸã
ã¯ïŒâããããã·âïŒâããããã·ã¡ãã«âαâ
ãïŒïœâããã«ã¢ããïŒã¡ãã«ããã³ãžã«ã¢ã«ã³ãŒ
ã«åžå ¥åšãçšãããããå¹æçãªæäžãè¡ãªãã
ãããšããšãã«èªããããã å£ãéããŠæ°ç®¡æ°ç®¡æ¯æš¹ã«è¬å€ãéåºãããã
ã®ç©ºæ°è¢ã®å®¹éã¯ã空æ°è¢ãååã«åºãã€ãç¶æ
ã§ã¯ã代衚çã«ã¯700c.c.ã§ããããçŽ500ãçŽ1500
c.c.ã®å¹ ããæ¬çºæã®å¥œãŸããæ æ§ã«ãããŠæ¡çšã
ãããã錻ç²èéè·¯ãžã®éåºã«ã¯æ¯èŒçå°å®¹éã
çšããããã¹ãã§ãã€ãŠã100c.c.ããã®äœ¿çšã«é©
ãã空æ°è¢ã®å¥œãŸããæ倧æ¡åŒµå®¹éã§ãããå°å®¹
éã§ããè¬å€ã錻ã®ç²èåå šäœãéãã®ã«ã¯åå
ãªç©ºæ°éã§ãããããã«æ£è ã«ç©ºæ°è¢ã®å 容ç©ã
浞éãããããã«æ£è ã«å®è³ªçã«ããå€ãã®ç©ºæ°
ãäžããããšã¯ãæ¬çºæã®ïŒã€ã®æ æ§ïŒéŒ»éè·¯ãž
ã ãã®æäžãæãå ŽåïŒã«ãããŠã¯é¿ããã¹ãã§
ãããè¬å€ã錻éè·¯ãè¶ããŠéåºãããå Žåã«
ã¯ãæ倧空æ°å®¹éã®ãã倧ããªç©ºæ°è¢ãçšããã
ãšãã§ãããããããå Žåã«ãããŠã¯ãäžè¬ã«å£
ãéããŠéåºãè¡ãªãããããšããããã ä¿¡å·æ段ãäœåãããã®ã«çšãããã空æ°é床
ã«é¢ããŠãåœæ¥è ã¯ãä¿¡å·ãçããé床ã¯ãææ
ã®é床ã«å¿ããŠå€åããããããšãåšç¥ããŠã
ããïŒâãïŒâããããã·âïŒâãïŒïŒâã¡ãã«ãš
ãã«ïŒã¢ããããã³ãŒã³ãžãªãŒã«ã®æäžãè¡ãªã
æ¬çºæã«ãããŠã¯ããã®ïŒã€ã®æ æ§ãšããŠã20
ïŒåãè¶ããåžåŒæµéã«ãŠä¿¡å·ãçããããšã
æãŸããããªãŒãç¬ã¯ã代衚çã«ã¯ã20ïŒå以
äžã®é床ã§ç©ºæ°ãåžã蟌ãŸããå Žåã«èããšãã
ãç¬ã®é³ãçºããããã«äºæ¹åæµè·¯ã«çœ®ãããã
ãã«ãã€ãŠç©ºæ°åžå ¥é床ãäœäžãããããã«æ£è
ã«åå³ããéå°ãªåžå ¥é床ããã³ããã«äŒŽãªãå
èšã®äžå©ãªç¹ãåé¿ããã æ¬çºæã«ããè¬å€éåºè£ 眮ãå°ãå®éšã«ãã
ãŠãå®éäžãè¡çªã«ããå šãŠã®ãšã¢ãŸã«ã®æ倱
ã¯ãã¬ã©ã¹è£œå£è åœé ã¢ãã«ã«ãããŠå šãçããª
ãã§ã空æ°è¢äžã§çããããšã芳å¯ãããæ°ç®¡æ°
管æ¯æš¹ä»¥å€ãéã€ãŠã®æ£è ã®åšå®ãžã®è¬å€äŸµå ¥ã
é¿ãããããšããç¹ã«ãããŠæ¬çºæãåªããŠãã
ããšã瀺ãããã該è¢ã§ã®ãšã¢ãŸã«æ倱ã®çšåºŠ
ã¯ãèšéãšã¢ãŸã«ã該ã¢ãã«ã«äœ¿çšãããå Žåã®
該ã¢ãã«äžã§ã®æ倱ãšåæ§ã§ããã質éå¹³åæµäœ
ååŠåŸ2.5ÎŒïœã®ãžâïŒâãšãã«ããã·ã«ã»ãã±ãŒ
ãã®ãšã¢ãŸã«ã0.5貯èµè¢ãã10åïŒåã§åžå ¥
ããæ£åžžãªè¢«éšè ããã³æ°ç®¡æ¯çæ£è ã«ããããš
ã¢ãŸã«ä»çã«ã€ããŠèª¿æ»ãããæ¬çºæã«çšããã
ã®ååŒã®æž¬å®æ³ã«ã€ããŠã®èå¯ã¯ããã©ãŠã³ã
ïŒBrown et alããMesurement of Aerosol
Retention Using ïœ Rebreathing Technique
in Normal and Chronic BronchiticsãAm.
Rev.Resp.Dis.ã«çºè¡šïŒå°å·äžïŒïŒã«ãã€ãŠãªãã
ãŠãããæ£åžžãªè¢«éšè ã«ãããŠã90ïŒ ä»çã¯ã
4.6ãSD0.7åŒåžãæ°ç®¡æ¯çæ£è ã«ãããŠã¯ã3.2ã
SD0.7åŒåžã§çããïŒïœïŒ0.01ïŒãæ°ç®¡æ¯çæ£è ã«
ãããåèšããŒã¿ã¯ã質éå¹³åæµäœååŠåŸ4ÎŒïœ
ã®ãšã¢ãŸã«ïŒèšéãšã¢ãŸã«ç²åã®å€§ããïŒã®90ïŒ
ä»çãïŒåŒåžä»¥å ã«çããã¯ãã§ããããšã瀺
ãã空æ°è¢ã§ã®è¬å€æ倱ã®ä»ã«ãæ¬çºæã®è¬å€é
åºè£ 眮ã¯ãåŸæ¥ããã®ïŒâãïŒâããããã·âïŒ
ãïŒïŒâã¡ãã«ãšãã«ïŒã¢ããããã³ãŒã³ãžãªãŒã«
ããã³ïŒâããããã·âïŒâããããã·ã¡ãã«â
αâãïŒïœâããã«ã¢ããïŒã¡ãã«ããã³ãžã«ã¢ã«
ã³ãŒã«çšåžå ¥åšã®ãããªå ¬ç¥ã®è£ 眮ãšæ¯èŒããŠå£
ããã³éŒ»çµè·¯ã«ããæäžãããè¬å€ã®éåºã«åªã
ãŠããããããåŸæ¥ã®åžå ¥åšãšåæ§ã«çµã¿ç«ãŠã®
容ææ§ãšè£œé ã®çµæžæ§ãæããæ£è ã®éåžžã®äœ¿çš
ã容æã«ãã該æ£è ã¯ã€ã¶ãã空æ°è¢ãå°ããªã
ã±ããã«å ¥ããŠéã³ã空æ°è¢ããã³éšåãç°¡åã«
çµç«ãŠãããšãã§ããæžå€ã«ãããŠãå¿ èŠãªãšã
ã«äœ¿çšã§ããã æ¬çºæã®ä»ã®æ æ§ã«ããã°ãååç©6αâãã«
ãªãâ11βïŒ16αïŒ17ïŒ21âããã©ããããã·ã
ã¬ã°ãâïŒïŒïŒâãžãšã³âïŒïŒ20âãžãªã³ç°åŒ
16ïŒ17âã¢ã»ã¿ãŒã«ã¯ã第ïŒå³ã«ç€ºãããããªã
ãŠã¹ããŒã¹ã«ããæ°ç®¡æ°ç®¡æ¯æš¹ãéããŠæäžãã
å Žåãæ°ç®¡æ¯åæ¯ã®æ²»ççšè¬å€ãšããŠäœ¿çšã§ã
ãã該è¬å€ã¯ç¬¬ïŒå³ãšåæ§ãªæ¹æ³ã§æ£è ã«æäžã
ããæ°ç®¡æ¯åæ¯ã®è»œæžãè¡ãªãã該è¬å€6αâã
ã«ãªãâ11βïŒ16αïŒ17ïŒ21âããã©ããããã·
ãã¬ã°ãâïŒïŒïŒâãžãšã³âïŒïŒ20âãžãªã³ç°åŒ
16ïŒ17âã¢ã»ã¿ãŒã«ã¯ãçŸåšãåæšããµã©ã€ã
ïŒNasalidïŒïŒSyntex LaboratoriesãInc.ãPolo
AltoãCaliforniaïŒã«ãŠã錻ããã®æäžã«ããä»
ã®çšéãç¥ãããŠãããæ¬çºæã«ãã6αâãã«
ãªãâ11βïŒ16αïŒ17ïŒ21âããã©ããããã¬ã°
ãâïŒïŒïŒâãžãšã³âïŒïŒ20âãžãªã³ç°åŒ16ïŒ17
âã¢ã»ã¿ãŒã«ãæ°ç®¡æ¯åæ¯è»œæžã®ããã«å£ãä»ã
ãŠæ°ç®¡æ°ç®¡æ¯æš¹ã«æäžããå Žåãããµã©ã€ãã®åŽ
é§ã第ïŒå³ã®ç©ºæ°è¢äžãžè¡ãªã€ãŠããããæ°ç®¡æ¯
åæ¯ãæ²»çããå Žåãæ¬çºæã®ïŒã€ã®æ æ§ãšããŠ
ããµã©ã€ãïŒåã®åŽå°30mcgãïŒæ¥åœããïŒåæ
äžããçšéãæšå¥šãããã æ¬çºæã®ããã«å¥ã®æ æ§ã«ããã°ãååç©6α
âãã«ãªãâ11βïŒ16αïŒ17ïŒ21âããã©ããã
ãã·ãã¬ã°ãâïŒïŒïŒâãžãšã³âïŒïŒ20âãžãªã³
ç°åŒ16ïŒ17âã¢ã»ã¿ãŒã«ã¯ã第ïŒå³ã®æ æ§ã«åŸã€
ãŠéŒ»ã«æäžããå Žåãã¢ã¬ã«ã®ãŒæ§éŒ»çã«äœ¿çšã§
ãããšèãããããã¢ã¬ã«ã®ãŒæ§éŒ»çã®æ²»ççšã®
6αâãã«ãªãâ11βïŒ16αïŒ17ïŒ21âããã©ãã
ããã·ãã¬ã°ãâïŒïŒïŒâãžãšã³âïŒïŒ20âãžãª
ã³ç°åŒ16ïŒ17âã¢ã»ã¿ãŒã«ã®äœ¿çšã¯ã錻ã«æäžã
ãåžè²©ã®ããµã©ã€ãã®äœ¿çšã«ããå ¬ç¥ã§ããã第
ïŒå³ã®å ·äœäŸã瀺ããããšã錻ããã®æäžã¯ãè¬
å€ã®éŒ»ç²èéè·¯ãžã®ããåäžãªååžãæäŸãããš
ãšãã«ãä»ã®æ段ã«ããçããè¬å€ã®æ£è ã®åšå®
ãžã®äŸµå ¥ãæå°ã«ãããã®ã§ã6αâãã«ãªãâ
11βïŒ16αïŒ17ïŒ21âããã©ããããã¬ã°ãâïŒïŒ
ïŒâãžãšã³âïŒïŒ20âãžãªã³ç°åŒ16ïŒ17âã¢ã»ã¿
ãŒã«ã®æäžã«ãããŠåŸãããå©ç¹ã¯éåžžã«å€ãã
ããµã©ã€ãã®åŽå¯ã«ãã€ãŠã¯ãïŒæ¥ã«ã€ãïŒåæ
äžã§ïŒåã®åŽå°30mcïœãæ¬çºæã®ãã®æ æ§ã®äž
å ·äœäŸã«åŸãè¡ãªãã¹ãã§ãããšèããããã æ¬çºæã®ç©ºæ°è¢ã¯ãè¬å€ã®ééã«å¯ŸããŠãäžé
éãã§ãããšèšèŒãããŠããããšã«æ³šç®ãã¹ãã§
ãããæ¬çºæã®ç©ºæ°è¢ã®ææãšããŠèããããã
ãªãšãã¬ã³ã®ãããªææã¯ãäŸãã°ãçµç®è¬å€æ
äžæ¹æ³ã®æº¶è§£æ§èã«ãŠçšããããæ¯èŒçäœéã®è¬
å€ååã®ééã蚱容ãããšç解ãã¹ãã§ãããã
ããã€ãŠããäžééããªãèªãããè¬å€ãçæé
ã ã空æ°è¢ãšæ¥è§Šããæ¬çºæã§ã®äœ¿çšã«ã¯ãè¬å€
ååã®ééã«å¯ŸããŠå®è³ªçã«äžééã§ããææã
æ¡çšãããããªãšãã¬ã³ããã³æ¬çºæã®ç©ºæ°è¢ã®
æ§é ã«é©ããæ¬çºæã®ç¯å²å ã«ããä»ã®ææãæ¡
çšããããšç解ãã¹ãã§ããããŸããæ¬çºæã®äž
ã€ã®æ æ§ã«ãããŠã¯ãè¬å€ã«å¯ŸããŠã¯å®è³ªçã«äž
ééã§ããããããããã®ç©ºæ°ã®ééã¯èš±å®¹ãã
ã空æ°è¢ææãæ¬çºæã«ãããŠæå©ã«äœ¿çšã§ãã
ããšãèªãããããããããçŸåšãæ¬çºæã®ãã®
ç¹å¥ã®æ æ§ãæºè¶³ããææã¯å®éã«ã¯ååšããª
ãã ãŸããããæ£è ã«å¯ŸããŠããšãã«å°å ããã³è
人ã®æ£è ã®å Žåã«ã¯ããªãŒãç¬ã®ãããªä¿¡å·æ段
ã¯æºè¶³ãªçµæã瀺ããªãããšãããããããšã«æ³š
æãã¹ãã§ãããåäŸã¯ãç解ã®æ¬ åŠããŸãã¯å€§
人ã®å Žåã«æ±ããããå»è ã®æ瀺ã«åŸãèšç·Žãäž
è¬çã«æ¬ åŠããŠãããç¬ã®ãåœä»€ãã«åŸãããšã
å°ãªãããã§ãããè人ã®æ£è ã«ãã€ãŠã¯ããã°
ãã°ãèŽåã®åé¡ã«ééããããããã€ãŠã第ïŒ
å³ã®ç©ºæ°è¢ã¯ãåèšäºæ¹åæµè·¯å ã«ç©ºæ°æµææ段
ãæããããã«å€åœ¢ããŠããããããã«ãããæ£
è åŽã倧ããªåªåãã¯ãã€ããšããŠãã該äºæ¹å
æµè·¯ãéãäžå®ã®æ倧空æ°æµéééãè¶ããããš
ã¯å®¹æã§ãªããªããããªãã¡ãä»ã®å Žåã«ã¯ä¿¡å·
æ段ã«ãã€ãŠå¶åŸ¡ãããäžå®ã®æ倧空æ°æµéã¯ã
äºæ¹åæµè·¯ã«æµææ段ãå å«ããããšã«ãã€ãŠã
該äºæ¹åæµè·¯ã«åºæã®æ倧空æ°æµéãšããããšã
ã§ããã第ïŒå³ã«ç€ºããæµææ段ïŒç¬¬ïŒå³ã®æ æ§
ã®ããŠã¹ããŒã¹ã®äžéšã ãã瀺ãïŒã®ããšããã¯
ãã·ã€ãŒåœ¢ãã€ã¹ã¯ïŒïŒãåãããã該äºæ¹åæµ
è·¯ãéã€ãŠééã§ãã空æ°éã¯ããªãªãã€ã¹ïŒïŒ
ãæããã¯ãã·ã€ãŒåœ¢ãã€ã¹ã¯ïŒïŒã«ãã€ãŠå¶é
ãããŠãããã¯ãã·ã€ãŒåœ¢ãã€ã¹ã¯ïŒïŒã¯ã第ïŒ
å³ã«ã瀺ããã¯ãã·ã€ãŒåœ¢ãã€ã¹ã¯ïŒïŒã«å ã
ãŠãä»ã®æµææ段ãšããŠã¯ã第ïŒå³ã«ç€ºããã¬ãŒ
ã ïŒïŒã«åŒµãããã¹ã¯ãªãŒã³ïŒïŒãåãããã¬ãŒ
ã ïŒïŒãæããã¹ã¯ãªãŒã³éšæïŒïŒãæãããã
ããã¯ã第ïŒå³ã«ãããä»ã®åœ¢æ ã®ã¯ãã·ã€ãŒåœ¢
ãã€ã¹ã¯ïŒïŒã眮ãæãããã®ã§ããã第ïŒå³ã
ãã³ç¬¬ïŒå³ã«ç€ºããæµææ段ã®ä»£ããšããŠãäºæ¹
åæµè·¯ãéãåäœæéåœããã®ç©ºæ°éãæžå°ãã
ã該äºæ¹åæµè·¯å ã®ä»ã®é害ç©ã䜿çšããããŸ
ããè¬å€ã空æ°è¢ã«å ¥ãå°ç¹ããå£ãšã€ãªããå°
ç¹ãŸã§ã®éã®äºæ¹åæµè·¯ã®äžéšãŸãã¯å šéšããåŽ
é§ãããè¬å€ã®äŸµå ¥å°ç¹ãšç©ºæ°è¢ã®éã®äºæ¹åæµ
è·¯ã®æé¢ç©ãããçãæé¢ç©ãæããŠãããã éåžžã«åŸ®å°ãªç²åãæ°ç®¡æ°ç®¡æ¯æš¹ã«æäžããã
ãšãå¿ èŠãªæ¬çºæã®ä»ã®æ æ§ã«ãããŠã¯ã第ïŒå³
ã«ç€ºãããããªéåžžã«å°ããªç²åã ãã蚱容ãã
ã¹ã¯ãªãŒã³ãçšããŠããããäŸãã°ãã°ã©ã é°æ§
èºçã®å Žåã«ã¯ã掻æ§è¬å€ãäŸãã°ãã²ã³ããã·
ã³ãµã«ããšãŒãïŒgentimicin sulfateïŒã§èºã®æ
ãæ·±ãåºåãæ²»çããããšãæãŸãããè¬å€ã®é§
ã倧ããªç²åãæããå Žåã倧ããªç²åã¯ãèºã®
æ·±ãåºåã«å°éããåã«æ°ç®¡æ°ç®¡æ¯æš¹ããææã
ãããäŸãã°ãç²åŸçŽ0.1ãã¯ãã³ä»¥äžã®å°ããªç²
åã ããééããããã¹ã¯ãªãŒã³ãåããããšã«
ãããæ£è ã¯ãã®è¬å€ã®å®è³ªéšåãèºã®ææã®æ
ãæ·±ãåºåã«éããããã«è¬å€ã®åŽé§ãåããã
ã²ã³ããã·ã³ãµã«ããšãŒããã°ã©ã é°æ§èºçã®æ²»
çã«çšããæ¬çºæã®æ æ§ã®äžå ·äœäŸã«ãããŠã第
ïŒå³ã«åŸã€ãŠæ¹è¯ãã0.1ãã¯ãã³ä»¥äžã®çŽåŸã
æããç²åã ããééãããã¹ã¯ãªãŒã³ã«ãŠå€åœ¢
ãã第ïŒå³ã®è£ 眮ã«ããäžåã®åŽé§è¬å€éã¯ä»£è¡š
çã«ã¯60mgã§ããã
éšäžãæ£è ã¯ããããç æ°ã®æªåãçµéšããªãã€
ããè©Šéšåãå šãŠã®æ£è ã¯ãïŒç§éã®åŒ·å¶åŒæ°å®¹
ç©ã«ãããå¢å å°ãªããšã15ïŒ ã瀺ãããã€D30
çºçåšã«ããäžãããããšã¢ãŸã«åããã©ã»ãäœ
ã®ãšãããã€ãªã³ãŸãã¯ã€ãœãšã¿ãªã³ãïŒåæ·±åŒ
åžããåŸãå°ãªããšã45ïŒ ã®æ¯æ°éã³ã³ãã¯ã¿ã³
ã¹ïŒSpecific airway conductance.S GawïŒã®å¢
å ã瀺ããæ£è ã«ã¯ãåè©Šéšæ¥ã®åãå°ãªããšã
ïŒæé圌ããéåžžçšããŠããæäžéèšéåžå ¥åšã®
䜿çšãäžæ¢ãããå°ãªããšã16æéããªãã€ãªã³
ã®äœ¿çšãäžæ¢ããããšãèŠæ±ãããããããã®çµ
å£ã³ã«ãã³ã¹ããã€ãã®æäžã¯ãç¶ç¶ããŠè¡ãªã
ããã å šãŠã®æ£è ã¯ã座ã€ãç¶æ ã§èºæ©èœãã¹ããå
ãããïŒç§éã®åŒ·å¶åŒæ°å®¹ç©ïŒFEV1ïŒããã³åŒ·
å¶çäœå®¹ç©ïŒvital capacityïŒã®æž¬å®ããã©ã€ã
ãŒãªã³ã°ã·ãŒã«ã¹ããã¡ãŒã¿ïŒdry rolling seal
Spirometerããªãã€ãª800ããªãã€ãªã¡ãã€ã«ã«
ãããã¯ã瀟補ããããµã¹å·ããŠãŒã¹ãã³ïŒã«ã
ã€ãŠè¡ãªããæ°éæµæïŒRawïŒããã³æ©èœæ®ç容
ç©ïŒfunctional residual capacityãFRCïŒã¯ã
身äœãã¬ãã¹ã¢ã°ã©ãã€ãŒã«ãã€ãŠæž¬å®ãããã
æ¯æ°éã³ã³ãã¯ã¿ã³ã¹ã¯ãRawã®éæ°ãRawã枬
å®ããèžéšã¬ã¹å®¹éã§å²ã€ãŠèšç®ããããããŒã¹
ã©ã€ã³ã®å€ã¯ãæ°ç®¡æ¯æ¡åŒµå€ã®æäžåŸã15ã30ã
60ããã³120ååŸã«ããè¿ãèšé²ãããã身äœã
ã¬ãã¹ã¢ã°ã©ãã€ãŒããã³ã¹ããã¡ããªãŒã®ïŒå
ã®æž¬å®ã®å¹³åããã³æ倧ã¯ãçµ±èšçåææ³ã«ãã
åŠçãããã è©Šéšã¯ã第ïŒå³ã®è£ 眮ãçšããè©²è£ çœ®ã¯ãæ¡åŒµ
ãã圢æ ã§çŽåŸïŒcmãé·ã11.5cmã®ç©ºæ°è¢ãæã
ãããšã¢ãŸãŒã«åããïŒâãïŒâããããã·âïŒ
âãïŒïŒâã¡ãã«ãšãã«ïŒã¢ããããšãã«ããã³ãŒ
ã³ãžãªãŒã«ãå«ã猶ã®ããºã«ãããŠã¹ããŒã¹ã«æ¿
å ¥ããããšã¢ãŸãŒã«åããïŒâãïŒâããããã·
âïŒâãïŒïŒâã¡ãã«ãšãã«ïŒã¢ããããšãã«ãã
ã³ãŒã³ãžãªãŒã«ãæ³šå ¥ãããæ£è ã¯ãè¢ããµãã
ãŸãããšã¢ãŸãŒã«çŒ¶ãäœåããã空ã«ãªããŸã§è¢
ããåžå ¥ãè¡ãªãããã€ããïŒã€æ°ããéæ¯ãæ¢
ããè¢ãžæ¯ãå¹ãåºããã€ãã§åã³åžå ¥ããŠãã
ã€ããïŒã€æ°ããéæ¯ãæ¢ããããã«æ瀺ãã
ããæ£è ã¯ããªãŒããé³ãçºçããªããããã€ã
ããšåžå ¥ããããã«èŠè«ãããã æäžéèšéåžå ¥åšã«ããäžãããããšã¢ãŸãŒã«
ã®ç²åŸååžã¯ãïŒæ®µã«ã¹ã±ãŒãã€ã³ãã¯ã¿ãŒïŒã¢
ã³ããŒãœã³ã»ãµã³ãã«ãºã»ã€ã³ã³ãŒãã¬ãŒããã
補ãã¢ãã©ã³ã¿ãGAïŒãçšããŠæž¬å®ããããé
åžžã®æäžæ¹åŒã®æ¡ä»¶äžã«ãããŠå£è åœé ã®è¡šé¢ã«
ãããæäžéèšéåžå ¥åšã®è¡æãã¹ã¯ãåžè²©ã®ã¢
ãã«ïŒã©ãšã«ãã«ã»ã¡ãã€ã«ã«ã»ã³ãŒãã¬ã€ã·ãš
ã³ãã¿ãã«ããŒãNY10707ïŒãšåæ§ã®ç¹åŸŽãæ
ããæ人ã®å£è åœé ã®ã¬ã©ã¹ã¢ãã«ãçšããŠæž¬å®
ãããæäžéèšéåžå ¥åšãã¬ã©ã¹ã¢ãã«ã®å£ã«å
ä»ãã0.5ïŒç§ã®ä¹Ÿç¥ç©ºæ°ã該ã¢ãã«ã«é£ç¶ç
ã«éããªããããšã¢ãŸã«ã該ã¢ãã«äžã«çŽæ¥äžã
ãã該ã¢ãã«ã®åœé ã®ç«¯ããéãããšã¢ãŸãŒã«ç²
åããã€ã«ã¿ãŒã«éãééãã¯ããã æ°éå ã®ãšã¢ãŸãŒã«ã®ä»çã確å®ãšããå埩åŒ
åžæ°ã®åœ±é¿ãè©äŸ¡ããããã質éäžå€®å€4.0ÎŒïœã®
空æ°ååŠççŽåŸãæããååæ£ãšã¢ãŸãŒã«ã第ïŒ
å³ã®è£ 眮ã«äžããã€ãã§ãæ£è ã30åïŒåã®é床
ã§ãšã¢ãŸã«ãããè¿ãåŒåžããéããšã¢ãŸã«æ¿åºŠ
ã®æžå°ãã©ã€ãã»ã¹ãã€ã¿ãªã³ã°ã»ãšã¢ãŸãŒã«ã»
ããªãã¡ãŒã¿ã«ããé£ç¶çã«ã¢ãã¿ãŒããããšã¢
ãŸã«ã¯ããžâïŒïŒãšãã«ããã·ã«ïŒã»ãã±ãŒãæ²¹
ããã¡ããã·ã³ã¯ã«ãšã¢ãŒâã©ã¡ã«ïŒSinclairâ
LaMerïŒåãšã¢ãŸã«çºçåšã«ããçºçãããã
ãšã¢ãŸãŒã«ã®ç²åŸååžã¯ããã«ãåæåšãæãã
ã©ã€ã³ïŒRaycoïŒ220å åŠã«ãŠã³ã¿ãŒã«ãã枬å®
ãããã è¬å€æäžèšç»æ¡ã¯ãå€åœ¢ã©ã³ãã åäžéç²æ€äº€
åæ³ã«ããšã¥ããŠè©Šéšãè¡ãªããããæ£è ã¯ãæ
äžéèšéåžå ¥åšããïŒâãïŒâããããã·âïŒâ
ãïŒïŒâã¡ãã«ãšãã«ïŒã¢ããããšãã«ããã³ãŒã³
ãžãªãŒã«ãŸãã¯ãïŒâããããã·âïŒâãããã
ã·ã¡ãã«âαâãïŒïœâããã«ã¢ããïŒã¡ãã«ãã
ã³ãžã«ã®ãããããæäžãããã®ããèºæ©èœãã¹
ããè¡ãªãæåž«ããããã®æ¹æ³ãŸãã¯è¬å€ãè©Šéš
ããã®ãç¥ããªããæ¬çºæè£ çœ®ã«ããïŒååã®ïŒ
âãïŒâããããã·âïŒâãïŒïŒâã¡ãã«ãšãã«ïŒ
ã¢ããããšãã«ããã³ãŒã³ãžãªãŒã«ïŒ650ÎŒïœïŒ
ã®å¹æãåŸæ¥ã®æäžéèšéåžå ¥åšã«ããæäžãã
ãïŒååã®ïŒâãïŒâããããã·âïŒâãïŒïŒâã¡
ãã«ãšãã«ïŒã¢ããããšãã«ããã³ãŒã³ãžãªãŒã«
ããã³ïŒååã®ïŒâããããã·âïŒâããããã·
ã¡ãã«âαâãïŒïœâããã«ã¢ããïŒã¡ãã«ããã³
ãžã«ïŒ100ÎŒïœïŒãšæ¯èŒãããæ£è ã¯å šãŠæäžé
èšéåžå ¥åšãå®æçã«çšããŠãããå°ãªããšãæ°
ã±æåã«ãããã®æäžãæ瀺ããããè©Šéšã®çŽ
åãå šãŠã®æ£è ã¯ãç 究è ã®ïŒäººã«ãã€ãŠããã«
èšç·ŽãåããããŠãŒãã³ãïŒNewman et al
ãSimple Instructions for Using Pressurized
Aerosol BrochodilatorsããJ.Royal Soc.Med.
Vol.73ãpp776ã779ïŒ1980ïŒïŒã«ããéçºããã
æ瀺ãäžããããã該æ瀺ã¯ã猶ãæ¯ããFRC
ãŸã§æ¯ãåãåºãéã«åã®éã«æäžéèšéåžå ¥åš
ã®ããŠã¹ããŒã¹ãåä»ããèºã®å®¹éäžæ¯ã«ãã€ã
ããšæ·±ãæ¯ãåžã蟌ãéãæäžéèšéåžå ¥åšã®é
æŸãè¡ãªãããã®èºå®¹éã§10æ°ããéæ¯ãæ¢ãã
ããšãããªãã åŒåžèªåŒãã¬ãã¹ã¢ã°ã©ãã€ãŒã¯ãã€ãã®æ¹æ³
ã«ãŠæž¬å®ããããDCâé£çµåŒåžèªåŒãã¬ãã¹ã¢
ã°ã©ãããã³ãã®æž¬å®ïŒRespitraceãNonâ
Invasive Monitoring SystemsãInc.ãArdsleyã
NYïŒã«ã€ããŠã®è©³çŽ°ãªèšèŒã¯ããã€ãŒãã
ïŒChahda et alããValidation of Respiratory
Inductive Plethysmography Utilizing
Different Calibration ProceduresããAmer.
Rev.Respir.Dis.ïŒå°å·äžïŒïŒã«ããå ¬éãããŠã
ããããã¯ãè骚ã®éªšçµã¿ãšåŸ©éšãå ã匟æ§åž¯ã«
çž«ãã€ããããïŒæ¬ã®ãããã³çµ¶çžã¯ã€ã€ãããª
ãããããã¯çºæ¯åšéšã«é£çµãããŠãããè骚ã®
骚çµã¿ããã³è ¹éšã®æé¢ç©ã®å€åã¯ãã³ã€ã«ã®èª
å·±ã€ã³ãã¯ã¿ã³ã¹ããã³ãã®æ¯ååšæãå€ããé©
åœãªæž¬å®ãè¡ãªãããšã«ããèºæŽ»é枬å®æ³ã«ãã
枬å®ãããæ¯å容ç©ãåæ ãããåŒåžç³»ãïŒã€ã®
èªç±åºŠããã€ãŠåããšä»®å®ãããšãè©²è£ çœ®ã¯ãè
骚ã®éªšçµãè ¹éšããã³ã¹ããã¡ãŒã¿å®¹ç©ãçšã
ãŠãè骚骚çµïŒã¹ããã¡ãŒã¿ïŒè ¹éšïŒã¹ããã¡ãŒ
ã¿ïŒïŒã®åŒã«ãã枬å®ããããæ£è ã¯ãäºã€ã®å§¿
å¢ã§ã¹ããã¡ãŒã¿ã«æ¯ãåããåšæçã«å€åãã
容ç©ã«å¯Ÿããè骚ã®éªšçµãšè ¹éšãšã®å¯äžã®å·®ãç
ããããæçã«åŒã解ããããåŒåžèªåŒãã¬ãã¹
ã¢ã°ã©ãã®æž¬å®ã®ç¢ºèªã¯ããŸã€ããç«ã€ãäœçœ®ã
ãã³ããåãã®äœçœ®ã§ãåæã«è¡ãªãèºæŽ»é枬å®
æ³ã«å¯ŸããŠè¡ãªãããæ£è ã®èºæŽ»é枬å®ããã®å¹³
åããŒã»ã³ãåå·®ïŒÂ±SDïŒã¯ãåã 4.1±2.4ïŒ ã
4.6±2.8ïŒ ã§ããã åŒåžèªåŒãã¬ãã¹ã¢ã°ã©ãããåŸãããä¿¡å·
ã¯ããã€ã¯ãããã»ããµãŒã·ã¹ãã ãåºæ¬ãšãã
â80AïŒRespicompRespitrace Corp.ã
ArdsleyãNYïŒã«èšé²ãããããã¯ã20ç¹ïŒç§
ã«ãŠä¿¡å·ãæ¡åãããæäžéèšéåžå ¥åšãäœåã
ãããšãã芳å¯è ã¯ãã³ã³ããŠãŒã¿ãŒã«ã¢ããã°
ã¹ãããé»å§ã«ãã€ãŠä¿¡å·ãéããã€ãã§ãèšé²
ãã«ãŒãœã«ããã°ã©ã ã«ããåæããã³ã³ããŠãŒ
ã¿ã¯ãã€ãã®ãã©ã¡ãŒã¿ãèšç®ããã (1) FRCããæäžéèšéåžå ¥åšã®æäœãžã®èºå®¹
ç©ã®å€åã (2) æäžéèšéåžå ¥åšã®æäœããåžå ¥ã®ããŒã¯ãž
ã®èºå®¹ç©ã®å€åã (3) (1)ããã³(2)ã®æç¶æéãããã³ã€ãã«æ¯ãå
ããŸã§ã®æ¯ãæ¢ããŠããæéã (4) FRCããæäœãŸã§ãããã³æäœããåžå ¥ã®
ããŒã¯ã«ãããå¹³ååžæ°æµé èºæ©èœæ¹åã®ããã®ïŒã€ã®åŠçœ®ã®éã®çµ±èšçãª
å·®ãããã¯ã¹ïŒHicksïŒãã®ãã¹ãããã»ãã¢ã¯
ããªã¢ã«ã»ãã¶ã€ã³ïŒãNested and Nested
Factorial ExperimentsããFundamental
Concepts in the Design of Experiments ïŒ
EditionïŒ1973ïŒHoltãRenehart and Winston
Inc.ãNew Yorkãpp188ã203ïŒã«ããåæã
ãããããè©Šéšæ¥éã®ããŒã¹ã©ã€ã³æž¬å®ã«ããã
è©äŸ¡ã®åå·®ãšããŠçšãããææå·®ãããã°ãããŒ
ã¿ãããã«ïŒ±çµ±èšè¡šã«ããåæãããã倧ããªå
å¿ãçããåŠçœ®ã決å®ããããŸããã¢ãïœâãã¹
ããè¡ãªãããæ°ç®¡æ¯æ¡åŒµå€ãçšããåŸã®åæé
ã«ãããïŒã€ã®åŠçœ®ã®å¹æãæ¯èŒãããæ°ç®¡æ¯æ¡
匵å€ã¯ãæäžéèšéåžå ¥åšã®åæ±ããããŸãæ£è
ã¯ããžããªæ£è ãšã»ãŒåãã§ããããšãã¢ã³ãã¢
ãïœâãã¹ãã«ãã瀺ãããçµæãå¹³å±æšæºèª€
å·®ïŒïŒžÂ±SEïŒãšããŠè¡šããã ïŒæ®µã«ã¹ã±ãŒãã€ã³ãã¯ã¿ãŒã«ãã枬å®ããã
ç²åŸååžã¯ãã»ãŒå¯Ÿæ°âæ£èŠæ°ã®é¢ä¿ã«ãããïŒ
âãïŒâããããã·âïŒâãïŒïŒâã¡ãã«ãšãã«ïŒ
ã¢ããããšãã«ããã³ãŒã³ãžãªãŒã«ã¯ã質éå¹³å
空æ°ååŠåŸ4.9ïŒSD±0.8ïŒÎŒïœã幟äœæšæºåå·®2.1
ãæããïŒâããããã·âïŒâã¡ããã·ã¡ãã«â
αâãïŒïœâããã«ã¢ããïŒã¡ãã«ããã³ãžã«ã¯ã
質éå¹³å空æ°ååŠåŸ2.4ïŒSD±0.28ïŒÎŒïœã幟äœæš
æºåå·®1.7ãæããã å£è åœé ã¢ãã«ã®è¡šé¢ã«ãããæäžéèšéåžå ¥
åšããã®è¡æãã¹ã¯ãïŒâãïŒâããããã·âïŒ
âãïŒïŒâã¡ãã«ãšãã«ïŒã¢ããããšãã«ããã³ãŒ
ã³ãžãªãŒã«ã«ã€ããŠã¯43ïŒ ãïŒâããããã·âïŒ
âããããã·ã¡ãã«âαâãïŒïœâããã«ã¢ããïŒ
ã¡ãã«ããã³ãžã«ã«ã€ããŠã¯31ïŒ ã§ãããïŒâ
ãïŒâããããã·âïŒâãïŒïŒâã¡ãã«ãšãã«ïŒã¢
ããããšãã«ããã³ãŒã³ãžãªãŒã«ã第ïŒå³ã«ç€ºã
ãšã¢ãŸãŒã«éåºã·ã¹ãã ã®ç©ºæ°è¢ã«äŸçµŠãããšã
æ°é®®ãªç©ºæ°ã§ïŒåæŽãããšã«ããããšã¢ãŸãŒã«ã®
50ïŒ ã¯ååããããšã¢ãŸãŒã«ã®41ïŒ ã¯ç¬¬ïŒå³ã®è£
眮äžã«å€±ãªããããã¬ã©ã¹ã¢ãã«ã«åä»ããå Ž
åã第ïŒå³ã®è£ 眮ã«ããäŸçµŠãããïŒâãïŒâã
ãããã·âïŒâãïŒïŒâã¡ãã«ãšãã«ïŒã¢ããããš
ãã«ããã³ãŒã³ãžãªãŒã«ã®ãšã¢ãŸãŒã«ïŒïŒ ã該ã¢
ãã«ã«ä»çããããããã€ãŠãïŒâãïŒâããã
ãã·âïŒâãïŒïŒâã¡ãã«ãšãã«ïŒã¢ããããšã
ã«ããã³ãŒã³ãžãªãŒã«ã«ã€ããŠã¯ããšã¢ãŸãŒã«ã®
47ïŒ ã倱ãªããããšãšãã«ã53ïŒ ãæœåšçã«ã¬ã©
ã¹ã¢ãã«ããé¢ããŠæ°éã«å ¥ãã ãšã¢ãŸãŒã«ã®æ°éãžã®ä»çãè¡ãªãããã®åŒåž
æ°ã®æ±ºå®ã¯ãïŒäººã®æ£åžžãªæ€äœããã³ïŒäººã®æ ¢æ§
æ°ç®¡æ¯çæ£è ã«ãã€ãŠåŸããããæ£åžžãªæ€äœã«ã
ããŠã¯ã第ïŒå³ã®è£ 眮äžã«åãã®ãšã¢ãŸã«ã®90ïŒ
ãèºã«ä¿æãããåŒåžåæ°ã¯ã4.8ïŒSD±0.8ïŒå
ã§ãããäžæ¹ãæ ¢æ§æ°ç®¡æ¯çãæããæ£è ã«ãã
ãŠã¯ã1.8ïŒSD±0.8ïŒåã§ããããããã€ãŠãæ£
è ã«ãããŠã¯ã第ïŒå³ã®è£ 眮ããã®ïŒåã®åŒåžãš
ããã«ç¶ãã該è¢ããã®å埩åŒåžã®ïŒåç®ã®åŒåž
ããã³ãããã®åŒåžã®éã®æ¯ãæ¢ããæéã«ã
ããèºèå ã®äºé žåççŽ ã®ç®ç«ã€ãå¢å ã䌎ãªã
ãã«ãšã¢ãŸã«ã®æé©ä»çãè¡ãªãããã æ°ç®¡æ¯æ¡åŒµå€ã«å¯Ÿããåå¿ã¯ãïŒçš®ã®æ²»çã«ã
ããèºæ©èœææšã®å¹³åå€åéã«ãã€ãŠåæãã
ããïŒçš®ã®æ²»çå šãŠã«ãããŠã Gawã¯70ïŒ ä»¥
äžå¢å ãããã第ïŒå³ã®è£ 眮ã«ããïŒâãïŒâã
ãããã·âïŒâãïŒïŒâã¡ãã«ãšãã«ïŒã¢ããããš
ãã«ããã³ãŒã³ãžãªãŒã«ã«å¯Ÿããåå¿ã¯ãå šãŠã®
å Žåã«ãããŠãæäžéèšéåžå ¥åšã«ããæäžãã
ãïŒâãïŒâããããã·âïŒâãïŒïŒâã¡ãã«ãšã
ã«ïŒã¢ããããšãã«ããã³ãŒã³ãžãªãŒã«ãŸãã¯ïŒ
âããããã·âïŒâããããã·ã¡ãã«âαâãïŒïœ
âããã«ã¢ããïŒã¡ãã«ããã³ãžã«ã®å Žåããã
ããªãé¡èã§ããïŒïœïŒ0.003ïŒãæäžéèšéåžå ¥
åšã«ããæäžãããïŒâããããã·âïŒâããã
ãã·ã¡ãã«âαâãïŒïœâããã«ã¢ããïŒã¡ãã«ã
ãã³ãžã«ããã³ïŒâãïŒâããããã·âïŒâãïŒïŒ
âã¡ãã«ãšãã«ïŒã¢ããããšãã«ããã³ãŒã³ãžãª
ãŒã«ã¯ãåã  Gawã®æ倧å¢å é86±26ïŒ ãã
ã³101±24ïŒ ã§ãã€ãŠé¡èãªå·®ã¯ãªããããã«å¯Ÿ
ããŠãæ¬çºæã«ããäžããããïŒâãïŒâããã
ãã·âïŒâãïŒïŒâã¡ãã«ãšãã«ïŒã¢ããããšã
ã«ããã³ãŒã³ãžãªãŒã«ã¯ãæ倧å¢å é195±52ïŒ
ã瀺ããæ°ç®¡æ¯æ¡åŒµå€ã®æäžïŒæéåŸãïŒâãã
ããã·âïŒâããããã·ã¡ãã«âαâãïŒïœâãã
ã«ã¢ããïŒã¡ãã«ããã³ãžã«ããã³ïŒâãïŒâã
ãããã·âïŒâãïŒïŒâã¡ãã«ãšãã«ïŒã¢ããããš
ãã«ããã³ãŒã³ãžãªãŒã«ã«ã€ããŠïŒ³ Gawã®æ倧
å€ããã®äœäžãèªãããããã第ïŒå³ã®è£ 眮ã«ã
ãïŒâãïŒâããããã·âïŒâãïŒïŒâã¡ãã«ãšã
ã«ïŒã¢ããããšãã«ããã³ãŒã³ãžãªãŒã«ã«å¯Ÿãã
åå¿ã¯ãè¯å¥œã«ä¿æãããã FEV1ã®å¢å ã¯ã第ïŒå³ã®è£ 眮ã«ããïŒâãïŒ
âããããã·âïŒâãïŒïŒâã¡ãã«ãšãã«ïŒã¢ã
ãããšãã«ããã³ãŒã³ãžãªãŒã«ã®å Žåã¯ãïŒâã
ãããã·âïŒâããããã·ã¡ãã«âαâãïŒïœâã
ãã«ã¢ããïŒã¡ãã«ããã³ãžã«ãŸãã¯ïŒâãïŒâ
ããããã·âïŒâãïŒïŒâã¡ãã«ãšãã«ïŒã¢ããã
ãšãã«ããã³ãŒã³ãžãªãŒã«ã«æ¯ããŠãã倧ããªã
ãšãå€ããå¹³åæ倧å¢å éã¯ãåã 47±13ïŒ ã24
±ïŒïŒ ããã³22±ïŒïŒ ã§ãããããããã®å·®ã¯ã
çµ±èšçææãªçŸ€ã«ã¯è³ããªãã€ããåæ§ã«ã
FVCã®å¢å ã¯ã第ïŒå³ã®è£ 眮ã«ããïŒâãïŒâã
ãããã·âïŒâãïŒïŒâã¡ãã«ãšãã«ïŒã¢ããããš
ãã«ããã³ãŒã³ãžãªãŒã«ã®å ŽåãïŒâããããã·
âïŒâããããã·ã¡ãã«âαâãïŒïœâããã«ã¢ã
ãïŒã¡ãã«ããã³ãžã«ãŸãã¯ïŒâãïŒâãããã
ã·âïŒâãïŒïŒâã¡ãã«ãšãã«ïŒã¢ããããšãã«ã
ãã³ãŒã³ãžãªãŒã«ã®å Žåããã倧ããããšãå€ã
èªããããåæ倧å¢å éã¯ã36±11ïŒ ã13±ïŒïŒ
ããã³ïŒÂ±ïŒïŒ ã§ãã€ããæ¬çºæã«ããå ŽåãåŸ
æ¥ã®æäžéèšéåžå ¥åšã«æ¯ããŠïŒâãïŒâããã
ãã·âïŒâãïŒïŒâã¡ãã«ãšãã«ïŒã¢ããããšã
ã«ããã³ãŒã³ãžãªãŒã«æäž30ååŸãé¡èãªå·®ç°ã
36±11ïŒ ããã³13±ïŒïŒ ãåã èªããããïŒïœïŒ
0.05ïŒãFRCã®æžå°ã¯ãå šãŠã®æ²»çã§èªãããã
æ¬çºæã®ãã®ãçšããïŒâãïŒâããããã·âïŒ
âãïŒïŒâã¡ãã«ãšãã«ïŒã¢ããããšãã«ããã³ãŒ
ã³ãžãªãŒã«ã®å Žåã¯ãä»ã®æ²»çã«æ¯ã¹ãŠãããã
ã§ãã倧ãããšèªããããïŒïœïŒ0.054ïŒã æäžéèšéåžå ¥åšã®åæ±ãæè¡ã¯ãã€ãã®æ¹æ³
ã«ãŠæ€èšãããå šãŠã®æ£è ã¯ãéåžžãæäžéèšé
åžå ¥åšãçšããŠããïŒå¹³å12.6幎䜿çšïŒãè©Šéšã®
ïŒãïŒç®åã«åèšç·Žãåãããã圌ãã®åããæ
瀺ã«åŸã€ãŠãåŸæ¥ã®æäžéèšéåžå ¥åšãæäœã§ã
ããã®ã¯ãããã§ãã€ããïŒäººã®æ£è ã¯ãåžå ¥æ
éäžãæäžéèšéåžå ¥åšã®æäœãè¡ãªããªãã€
ããã²ãšãã®æ£è ã¯ãã»ãŒïŒãåžå ¥ããïŒç§é
æ¯ãæ¢ããåŸãæäžéèšéåžå ¥åšãæäœããã€ã
ã§çŽã¡ã«æ¯ãåããã第ïŒã®æ£è ã¯ãæ·±åŒåžãã
åŸã®æ¯ãåãæéã«åžå ¥åšãæäœãã第ïŒã®æ£è
ã¯ãå¢æžããåŒåžã®åžæ°ã®ããŒã¯ã§ãã®æäœãè¡
ãªããæ¯ãåããã€ãã«æ·±åŒåžã延é·ããã第ïŒ
ã®æ£è ã¯ãæ¯ãåãéã«åžå ¥åšãæäœããã€ãã§
æ·±ãåžæ°ã«ç§»ã€ãããããã®æ£è ã¯å šãŠã第ïŒå³
ã®è£ 眮ãå°é£ãªã䜿çšã§ããã åžæ°äžã«åžå ¥åšãããŸãäœåãããïŒäººã®æ£è
ã®ãã¡ã倧éšåã¯ãã»ãŒ0.5ã®ç©ºæ°ãåžå ¥ãã
åŸã«ããããäœåããããäœåã«ã€ã¥ããå¹³ååž
å ¥å®¹éã¯ïŒã§ãããæ¯ããšããæéã¯14ç§ã§ã
ããåžå ¥é床ã§ã¯ããªãã®å·®ããããè¯å¥œãªæäž
éèšéåžå ¥åšæè¡ãæã€ïŒäººã®æ£è ã«ãããŠãã
ã®å¹³åæµéã¯ïŒâããããã·âïŒâããããã·ã¡
ãã«âαâãïŒïœâããã«ã¢ããïŒã¡ãã«ããã³ãž
ã«ããã³ïŒâãïŒâããããã·âïŒâãïŒïŒâã¡ã
ã«ãšãã«ïŒã¢ããããšãã«ããã³ãŒã³ãžãªãŒã«ã®
åžå ¥äžãåã ã1.02±0.29ïŒç§ããã³0.54±
0.16ïŒç§ã§ããã®ã«å¯ŸããŠã第ïŒå³ã®è£ 眮ãçš
ãã10人ã®æ£è å šãŠã«ãããŠã¯ã第ïŒçªç®ãšç¬¬ïŒ
çªç®ã®åžå ¥äžãåã ã0.19±0.02ïŒç§ããã³
0.24±0.03ïŒç§ã§ããã第ïŒå³ã®è£ 眮ã«ããæ
é«åžå ¥æµé床ã¯ãåŸæ¥ã®æäžéèšéåžå ¥åšã§ã®
1.90ïŒç§ã«å¯ŸããŠ0.50ïŒç§ã§ããã åŸæ¥ã®æäžéèšéåžå ¥åšæäžã«ããæ°ç®¡æ¯æ¡åŒµ
åå¿ã«ãããŠãæµéã«é¢ä¿ãªãåžæ°äžã«æäžéèš
éåžå ¥åšã®æäœãè¡ãªãè¯å¥œãªæè¡ãæã€æ£è
ãšãããã«å¯ŸããŠãæ¯ãæ¢ããéãŸãã¯æ¯ãåã
éã«æäžéèšéåžå ¥åšã®æäœãè¡ãªãäžååãªæ
è¡ãæã€æ£è ã®éã«æ確ãªå·®ç°ãèªãããããæ
äžéèšéåžå ¥åšã«ããïŒâãïŒâããããã·âïŒ
âãïŒïŒâã¡ãã«ãšãã«ïŒã¢ããããšãã«ããã³ãŒ
ã³ãžãªãŒã«ã®æäžåŸã®SGawã®æ倧å¢å ã¯ãè¯å¥œ
ãªæè¡ãæã€ïŒäººã®æ£è ã150±23ïŒ ã§ããã®ã«
察ããäžååãªæè¡ãæã€ïŒäººã®æ£è ã¯27±9.3
ïŒ ã§ããïŒïœïŒ0.005ïŒãåŸè ãæ¬çºæã䜿çšãã
å ŽåãïŒäººã¯163±90ïŒ ã®SGawã®æ倧平åå¢å é
ã瀺ããïŒäººã¯åŸæ¥ã®æäžéèšéåžå ¥åšã«ããå¢
å ãšåçã§ãããè¯å¥œãªæäžéèšéåžå ¥æè¡ãæ
ã€ïŒäººã®æ£è ã«ãããŠã¯ã第ïŒå³ã®è£ 眮ã«ãã
SGawã®æ倧åå¿ã¯ã236±78ïŒ ã§ãããïŒâãïŒ
âããããã·âïŒâãïŒïŒâã¡ãã«ãšãã«ïŒã¢ã
ãããšãã«ããã³ãŒã³ãžãªãŒã«ãéåºããæäžé
èšéåžå ¥åšã«ããæ倧åå¿150±23ïŒ ããããªã
倧ããã 第ïŒå³ã¯ãæ¬çºæã®ä»ã®æ æ§ã瀺ãããã®æ æ§
ã¯éŒ»ãä»ããåžå ¥ã«äœ¿çšã§ããæ§é ãæãã錻é
è·¯ã«ææã®è¬å€ãå¡åžããããšãã§ããã第ïŒå³
ã®æ æ§ã§ã¯ã第ïŒå³ã§ç€ºãããããªããŒã¹ïŒéš
åïŒïŒïŒããã³å å§åžå ¥ç¶ïŒïŒãåããåºæ¬çåŽ
é§è£ 眮ïŒïŒã䜿çšããããã¹ã¯ïŒïŒã¯ããœããã¬
ã¹ã±ããïŒïŒãšãšãã«æ£è ã«åä»ãããã該ãã¹
ã¯ã®å€æ°ããã®å¯éãæ¹åããããã¹ã¯ïŒïŒã¯ã
å³ç€ºããããã«ãæ£è ã®éŒ»ããã³å£ã«ãã¶ããŠäœ¿
çšããããã該ãã¹ã¯ã¯æ£è ã®éŒ»ã ãã«ãã¶ããŠ
ã䜿çšã§ããããã«ãããŠããããã¹ã¯ïŒïŒã¯ã
è¬å€ããã¹ã¯äžã«éãããããã®åºéšã«éå£ïŒïŒ
ãæãããããŠãŒãïŒïŒã¯ããã¹ã¯ïŒïŒã®éå£éš
ïŒïŒãåŽé§è£ 眮ïŒïŒã®ããŒã¹ïŒïŒã«é£çµãããã
ãŠãŒãïŒïŒã¯ãããŒã¹ïŒïŒã®åšå²ã«åºå®ãããã
ãæè»ãªãã©ã¹ãã€ã¯ã¹ãŸãã¯é©åœãªææã§è£œé
ãããŠãããåœæ¥è ã«åšç¥ã®ããŠãŒãïŒïŒãšããŠ
ã¹ããŒã¹ïŒïŒéã®ä»ã®ãããã®åœ¢åŒã®é£çµããã®
èšèŒããèããããããåŽé§è£ 眮ïŒïŒã¯ç©ºæ°è¢è£
眮ïŒïŒã®åä»éšïŒïŒã«åä»ããããã空æ°è¢è£ 眮
ïŒïŒã¯ãæå端éšãã€ããïŒïŒããã³ç«¯éšãã€ã
ãïŒïŒãããªããåŽå£ïŒïŒã«ããå ±ã«é£çµãããŠ
ãããæå端éšãã€ããïŒïŒã端éšïŒïŒããã³åŽ
å£ïŒïŒã¯ã空éïŒïŒã圢æãããæå端éšãã€ã
ãïŒïŒããã³ç«¯éšãã€ããïŒïŒã¯ãåžè²©ã®å ¥æå¯
èœãªãã©ã¹ããã¯ææãã補é ããŠãããå£ïŒïŒ
ã¯ãé©å®ã®æè»ã§è»œéãªãããã®ææã§ã§ããŠã
ãŠããããã2.25ãã«ããªãšãã¬ã³ãã補é ãã
ãã®ããããåŽå£ïŒïŒã¯ããã®å€åšïŒïŒã®åšå²ã«
ããŒãã·ãŒã«ãè¡ãªãããšã«ããæå端éšãã€ã
ãïŒïŒããã³ç«¯éšãã€ããïŒïŒã«é£çµãããã空
æ°è¢è£ 眮ïŒïŒã¯ãåŽé§è£ 眮ïŒïŒã«åä»ãããã¬ã¹
äžééæ§å¯éè¢ãæäŸãããããªé©åœãªææã§ã
ãã°ããããªãææã§èšèšãããŠããããæå端
éšãã€ããããã³ç«¯éšãã€ããã¯ã容æã«æã¡é
ã³ã§ããããã«è£œé ããããããã®äœ¿çšè ã®ãã±
ããã«ãé©åãããããšãããšãã«ã奜ãŸããã
æå端éšãã€ããïŒïŒããããã«ããåŽé§è£ 眮ïŒ
ïŒããåé¢ããããšãæå端éšãã€ããïŒïŒã¯ã
端éšãã€ããïŒïŒã«å¯ŸããŠå転ããããåŽå£ïŒïŒ
ããã®éã«èªåçã«æŒãã€ã¶ãããŠå¹³ããªè£ 眮ã
圢æãããããã«ãåŽé§åšïŒïŒã¯ããã¹ã¯ïŒïŒã
ãã³ããŠãŒãïŒïŒãããšãé¢ãããšãã§ãããã
ãã®éšåã¯ããŸããæ£è ã®ãã±ããã«ãã¡ããšçŽ
ãŸãã®ãããããããã®éšåã¯ãååããŠã容æ
ã«çµã¿ããŠããã容æã«äœ¿çšã§ããéåžžã«æå¹ãª
è£ çœ®ãæäŸããã æ¬çºæã®è¬å€éåºè£ 眮ã¯ãåŸæ¥ã®åžå ¥åšãäŸã
ã°ãå ¬ç¥ã®ïŒâãïŒâããããã·âïŒâãïŒïŒâã¡
ãã«ãšãã«ïŒã¢ããããšãã«ããã³ãŒã³ãžãªãŒã«
ããã³ïŒâããããã·âïŒâããããã·ã¡ãã«â
αâãïŒïœâããã«ã¢ããïŒã¡ãã«ããã³ãžã«ã¢ã«
ã³ãŒã«ïŒåã ãBoehringer Ingelheimããã³
SheringïŒãŸãã¯ãGlaxoïŒïŒã«çšããããå å§æ
äžåžå ¥åšããè¬å€ããåŽå°ãããããåŸæ¥ã®è¬å€
éåºã·ã¹ãã ã«å¯Ÿãæããã«å©ç¹ãæããããã
ãŸã§ã«ææ¡ãããŠããã¹ããŒãµãŒã·ã¹ãã ãšæ¯èŒ
ãããšãæ¬çºæã«ãããŠå ·äœåããã空æ°è¢ã·ã¹
ãã ã¯æ確ãªå©ç¹ãæããã空æ°è¢ã·ã¹ãã ã¯ã
è¬å€æäžäžã«å¿ èŠãªãæ£è ã«ãã調æŽãæå°ã§ã
ããšããç¹ãã奜ãŸãããæ¬çºæã®ä¿¡å·æ段ã¯ã
è¬å€æäžäžã空æ°ã®æµéããã³æµéãæ£è ã«ç¥ã
ããåŸæ¥ææ¡ãããŠããã¹ããŒãµãŒã·ã¹ãã ãã
ããã«ããããŠããããŸãã空æ°è¢ãžã®è¬å€ã®èš
éåŽå°ã«ããåçè¬å€æäžã¯ãå è¡æè¡ã«ãã
ãŠãïŒâãïŒâããããã·âïŒâãïŒïŒâã¡ãã«ãš
ãã«ïŒã¢ããããšãã«ããã³ãŒã³ãžãªãŒã«ããã³
ïŒâããããã·âïŒâããããã·ã¡ãã«âαâ
ãïŒïœâããã«ã¢ããïŒã¡ãã«ããã³ãžã«ã¢ã«ã³ãŒ
ã«ã®ããã«ææ¡ãããŠããå ¬ç¥ã®åžå ¥åšãããã
ãšãã«æå©ã§ãããåŸæ¥ææ¡ãããŠããïŒâãïŒ
âããããã·âïŒâãïŒïŒâã¡ãã«ãšãã«ïŒã¢ã
ãããšãã«ããã³ãŒã³ãžãªãŒã«ããã³ïŒâããã
ãã·âïŒâããããã·ã¡ãã«âαâãïŒïœâããã«
ã¢ããïŒã¡ãã«ããã³ãžã«ã¢ã«ã³ãŒã«çšã®ïŒã€ã®
åžå ¥åšããã³ã¹ããŒãµãŒãããããã«æå©ãªç¹
ã¯ãæ£è ã«ããåžå ¥åŠçœ®äžãããåäžãªè¬å€ååž
ãåŸãããããšã§ãããããå¹æçãªè¬å€ååžã«
ããæè¬ã®ç®¡çã¯ãæ¬çºæã®ç©ºæ°è¢ã·ã¹ãã ã®ã
ãã«æå©ãªç¹ã§ããã æ£è ã«ãšã€ãŠäœ¿çšã容æã§ããããšã¯ãæ¬çºæ
ã®ç©ºæ°è¢ã·ã¹ãã ã®éåžžã®äœ¿çšã®ããã«æ£è ã«ãš
ã€ãŠç¹ã«éèŠãªæå°ã®èŠæ±ã§ãã€ãŠããã®ç¹ã¯ã
å€ãã®æ£è ãåŸæ¥ã®ãïŒâãïŒâããããã·âïŒ
âãïŒïŒâã¡ãã«ãšãã«ïŒã¢ããããšãã«ããã³ãŒ
ã³ãžãªãŒã«ããã³ïŒâããããã·âïŒâãããã
ã·ã¡ãã«âαâãïŒïœâããã«ã¢ããïŒã¡ãã«ãã
ã³ãžã«ã¢ã«ã³ãŒã«åžå ¥åšã«å¯ŸããŠãããã®ã·ã¹ã
ã ãé©åã«äœ¿çšã§ããªãããšã瀺ããæ¬çºæã®è
æ¯ã®æ€èšã«ãããŠèšèŒã®ç 究ã«ãã匷調ãããŠã
ããä¿¡å·æ段ã奜ãŸããã¯ãæ¬çºæã®å¥œãŸããæ
æ§ã«ãŠå ·äœçã«ç€ºãããªãŒãç¬ã¯ãè¬å€æäžã®ã
ãã®é©æ£ãªåŒåžæè¡ãæ£è ã«å¯ŸããŠãèšç·Žããã
åœç¶ã空æ°æµéã®ææã®æ倧éãè¶ããå Žåã«ã¯
æ£è ã«åå³ãããããªä»å±ã®è£å©åšå ·ãšãªããã
ã®æ¹æ³ã«ãããæ£è ã¯ãèºè¬å€ã®æäžã«æå©ãªã
ã€ãããšããåžæ°æµéåããã³å€§ããªãæ·±åŒåžã
ãè¡ãªãæ¹æ³ãç¿åŸãããäžåºŠã«å€éã®è¬å€ãæ
äŸããïŒâãïŒâããããã·âïŒâãïŒïŒâã¡ãã«
ãšãã«ïŒã¢ããããšãã«ããã³ãŒã³ãžãªãŒã«ãŸã
ã¯ïŒâããããã·âïŒâããããã·ã¡ãã«âαâ
ãïŒïœâããã«ã¢ããïŒã¡ãã«ããã³ãžã«ã¢ã«ã³ãŒ
ã«çšåžå ¥åšã§ã®è¬å€ã®ãåŽå°ãã«å¯Ÿãã空æ°è¢ã
ãã®ç©ºæ°æµã«ãã調æŽãããè¬å€ã®éåºã«ããã
æ¬çºæ䜿çšã®ä»ã®å¹æã§ããå£è åœé ã«ããããš
ã¢ãŸã«ä»çã®æå°åãéæããããæ°ç®¡æ°ç®¡æ¯æš¹
ãžã®åçæäžã¯ãåæ§ã«ããŠæ倧ãšãªããæ°ç®¡æ°
管æ¯æš¹ã«åäžãªååžãäžããã«ã¯ãåžæ°åŠçœ®ã®
éãåäžãªæè¬ååžãšããã®ããããæ¬çºæè£ çœ®
ã®çµã¿ç«ãŠããã³æºåž¯ã®å®¹ææ§ã䞊ã³ã«åèšã®ä»
ã®å©ç¹ãšã¯ãŸãå¥ã«ãæ¬çºæã®è¬å€éåºè£ 眮ãçš
ãææã®æ°ç®¡æ°ç®¡æ¯æš¹ä»¥å€ããæ£è ã®åšå®äžã«å°
å ¥ãããè¬å€ãæå°åããããšã«ãã€ãŠãçŸåšã
åžè²©ã®ïŒâãïŒâããããã·âïŒâãïŒïŒâã¡ãã«
ãšãã«ïŒã¢ããããšãã«ããã³ãŒã³ãžãªãŒã«ãŸã
ã¯ïŒâããããã·âïŒâããããã·ã¡ãã«âαâ
ãïŒïœâããã«ã¢ããïŒã¡ãã«ããã³ãžã«ã¢ã«ã³ãŒ
ã«åžå ¥åšãçšãããããå¹æçãªæäžãè¡ãªãã
ãããšããšãã«èªããããã å£ãéããŠæ°ç®¡æ°ç®¡æ¯æš¹ã«è¬å€ãéåºãããã
ã®ç©ºæ°è¢ã®å®¹éã¯ã空æ°è¢ãååã«åºãã€ãç¶æ
ã§ã¯ã代衚çã«ã¯700c.c.ã§ããããçŽ500ãçŽ1500
c.c.ã®å¹ ããæ¬çºæã®å¥œãŸããæ æ§ã«ãããŠæ¡çšã
ãããã錻ç²èéè·¯ãžã®éåºã«ã¯æ¯èŒçå°å®¹éã
çšããããã¹ãã§ãã€ãŠã100c.c.ããã®äœ¿çšã«é©
ãã空æ°è¢ã®å¥œãŸããæ倧æ¡åŒµå®¹éã§ãããå°å®¹
éã§ããè¬å€ã錻ã®ç²èåå šäœãéãã®ã«ã¯åå
ãªç©ºæ°éã§ãããããã«æ£è ã«ç©ºæ°è¢ã®å 容ç©ã
浞éãããããã«æ£è ã«å®è³ªçã«ããå€ãã®ç©ºæ°
ãäžããããšã¯ãæ¬çºæã®ïŒã€ã®æ æ§ïŒéŒ»éè·¯ãž
ã ãã®æäžãæãå ŽåïŒã«ãããŠã¯é¿ããã¹ãã§
ãããè¬å€ã錻éè·¯ãè¶ããŠéåºãããå Žåã«
ã¯ãæ倧空æ°å®¹éã®ãã倧ããªç©ºæ°è¢ãçšããã
ãšãã§ãããããããå Žåã«ãããŠã¯ãäžè¬ã«å£
ãéããŠéåºãè¡ãªãããããšããããã ä¿¡å·æ段ãäœåãããã®ã«çšãããã空æ°é床
ã«é¢ããŠãåœæ¥è ã¯ãä¿¡å·ãçããé床ã¯ãææ
ã®é床ã«å¿ããŠå€åããããããšãåšç¥ããŠã
ããïŒâãïŒâããããã·âïŒâãïŒïŒâã¡ãã«ãš
ãã«ïŒã¢ããããã³ãŒã³ãžãªãŒã«ã®æäžãè¡ãªã
æ¬çºæã«ãããŠã¯ããã®ïŒã€ã®æ æ§ãšããŠã20
ïŒåãè¶ããåžåŒæµéã«ãŠä¿¡å·ãçããããšã
æãŸããããªãŒãç¬ã¯ã代衚çã«ã¯ã20ïŒå以
äžã®é床ã§ç©ºæ°ãåžã蟌ãŸããå Žåã«èããšãã
ãç¬ã®é³ãçºããããã«äºæ¹åæµè·¯ã«çœ®ãããã
ãã«ãã€ãŠç©ºæ°åžå ¥é床ãäœäžãããããã«æ£è
ã«åå³ããéå°ãªåžå ¥é床ããã³ããã«äŒŽãªãå
èšã®äžå©ãªç¹ãåé¿ããã æ¬çºæã«ããè¬å€éåºè£ 眮ãå°ãå®éšã«ãã
ãŠãå®éäžãè¡çªã«ããå šãŠã®ãšã¢ãŸã«ã®æ倱
ã¯ãã¬ã©ã¹è£œå£è åœé ã¢ãã«ã«ãããŠå šãçããª
ãã§ã空æ°è¢äžã§çããããšã芳å¯ãããæ°ç®¡æ°
管æ¯æš¹ä»¥å€ãéã€ãŠã®æ£è ã®åšå®ãžã®è¬å€äŸµå ¥ã
é¿ãããããšããç¹ã«ãããŠæ¬çºæãåªããŠãã
ããšã瀺ãããã該è¢ã§ã®ãšã¢ãŸã«æ倱ã®çšåºŠ
ã¯ãèšéãšã¢ãŸã«ã該ã¢ãã«ã«äœ¿çšãããå Žåã®
該ã¢ãã«äžã§ã®æ倱ãšåæ§ã§ããã質éå¹³åæµäœ
ååŠåŸ2.5ÎŒïœã®ãžâïŒâãšãã«ããã·ã«ã»ãã±ãŒ
ãã®ãšã¢ãŸã«ã0.5貯èµè¢ãã10åïŒåã§åžå ¥
ããæ£åžžãªè¢«éšè ããã³æ°ç®¡æ¯çæ£è ã«ããããš
ã¢ãŸã«ä»çã«ã€ããŠèª¿æ»ãããæ¬çºæã«çšããã
ã®ååŒã®æž¬å®æ³ã«ã€ããŠã®èå¯ã¯ããã©ãŠã³ã
ïŒBrown et alããMesurement of Aerosol
Retention Using ïœ Rebreathing Technique
in Normal and Chronic BronchiticsãAm.
Rev.Resp.Dis.ã«çºè¡šïŒå°å·äžïŒïŒã«ãã€ãŠãªãã
ãŠãããæ£åžžãªè¢«éšè ã«ãããŠã90ïŒ ä»çã¯ã
4.6ãSD0.7åŒåžãæ°ç®¡æ¯çæ£è ã«ãããŠã¯ã3.2ã
SD0.7åŒåžã§çããïŒïœïŒ0.01ïŒãæ°ç®¡æ¯çæ£è ã«
ãããåèšããŒã¿ã¯ã質éå¹³åæµäœååŠåŸ4ÎŒïœ
ã®ãšã¢ãŸã«ïŒèšéãšã¢ãŸã«ç²åã®å€§ããïŒã®90ïŒ
ä»çãïŒåŒåžä»¥å ã«çããã¯ãã§ããããšã瀺
ãã空æ°è¢ã§ã®è¬å€æ倱ã®ä»ã«ãæ¬çºæã®è¬å€é
åºè£ 眮ã¯ãåŸæ¥ããã®ïŒâãïŒâããããã·âïŒ
ãïŒïŒâã¡ãã«ãšãã«ïŒã¢ããããã³ãŒã³ãžãªãŒã«
ããã³ïŒâããããã·âïŒâããããã·ã¡ãã«â
αâãïŒïœâããã«ã¢ããïŒã¡ãã«ããã³ãžã«ã¢ã«
ã³ãŒã«çšåžå ¥åšã®ãããªå ¬ç¥ã®è£ 眮ãšæ¯èŒããŠå£
ããã³éŒ»çµè·¯ã«ããæäžãããè¬å€ã®éåºã«åªã
ãŠããããããåŸæ¥ã®åžå ¥åšãšåæ§ã«çµã¿ç«ãŠã®
容ææ§ãšè£œé ã®çµæžæ§ãæããæ£è ã®éåžžã®äœ¿çš
ã容æã«ãã該æ£è ã¯ã€ã¶ãã空æ°è¢ãå°ããªã
ã±ããã«å ¥ããŠéã³ã空æ°è¢ããã³éšåãç°¡åã«
çµç«ãŠãããšãã§ããæžå€ã«ãããŠãå¿ èŠãªãšã
ã«äœ¿çšã§ããã æ¬çºæã®ä»ã®æ æ§ã«ããã°ãååç©6αâãã«
ãªãâ11βïŒ16αïŒ17ïŒ21âããã©ããããã·ã
ã¬ã°ãâïŒïŒïŒâãžãšã³âïŒïŒ20âãžãªã³ç°åŒ
16ïŒ17âã¢ã»ã¿ãŒã«ã¯ã第ïŒå³ã«ç€ºãããããªã
ãŠã¹ããŒã¹ã«ããæ°ç®¡æ°ç®¡æ¯æš¹ãéããŠæäžãã
å Žåãæ°ç®¡æ¯åæ¯ã®æ²»ççšè¬å€ãšããŠäœ¿çšã§ã
ãã該è¬å€ã¯ç¬¬ïŒå³ãšåæ§ãªæ¹æ³ã§æ£è ã«æäžã
ããæ°ç®¡æ¯åæ¯ã®è»œæžãè¡ãªãã該è¬å€6αâã
ã«ãªãâ11βïŒ16αïŒ17ïŒ21âããã©ããããã·
ãã¬ã°ãâïŒïŒïŒâãžãšã³âïŒïŒ20âãžãªã³ç°åŒ
16ïŒ17âã¢ã»ã¿ãŒã«ã¯ãçŸåšãåæšããµã©ã€ã
ïŒNasalidïŒïŒSyntex LaboratoriesãInc.ãPolo
AltoãCaliforniaïŒã«ãŠã錻ããã®æäžã«ããä»
ã®çšéãç¥ãããŠãããæ¬çºæã«ãã6αâãã«
ãªãâ11βïŒ16αïŒ17ïŒ21âããã©ããããã¬ã°
ãâïŒïŒïŒâãžãšã³âïŒïŒ20âãžãªã³ç°åŒ16ïŒ17
âã¢ã»ã¿ãŒã«ãæ°ç®¡æ¯åæ¯è»œæžã®ããã«å£ãä»ã
ãŠæ°ç®¡æ°ç®¡æ¯æš¹ã«æäžããå Žåãããµã©ã€ãã®åŽ
é§ã第ïŒå³ã®ç©ºæ°è¢äžãžè¡ãªã€ãŠããããæ°ç®¡æ¯
åæ¯ãæ²»çããå Žåãæ¬çºæã®ïŒã€ã®æ æ§ãšããŠ
ããµã©ã€ãïŒåã®åŽå°30mcgãïŒæ¥åœããïŒåæ
äžããçšéãæšå¥šãããã æ¬çºæã®ããã«å¥ã®æ æ§ã«ããã°ãååç©6α
âãã«ãªãâ11βïŒ16αïŒ17ïŒ21âããã©ããã
ãã·ãã¬ã°ãâïŒïŒïŒâãžãšã³âïŒïŒ20âãžãªã³
ç°åŒ16ïŒ17âã¢ã»ã¿ãŒã«ã¯ã第ïŒå³ã®æ æ§ã«åŸã€
ãŠéŒ»ã«æäžããå Žåãã¢ã¬ã«ã®ãŒæ§éŒ»çã«äœ¿çšã§
ãããšèãããããã¢ã¬ã«ã®ãŒæ§éŒ»çã®æ²»ççšã®
6αâãã«ãªãâ11βïŒ16αïŒ17ïŒ21âããã©ãã
ããã·ãã¬ã°ãâïŒïŒïŒâãžãšã³âïŒïŒ20âãžãª
ã³ç°åŒ16ïŒ17âã¢ã»ã¿ãŒã«ã®äœ¿çšã¯ã錻ã«æäžã
ãåžè²©ã®ããµã©ã€ãã®äœ¿çšã«ããå ¬ç¥ã§ããã第
ïŒå³ã®å ·äœäŸã瀺ããããšã錻ããã®æäžã¯ãè¬
å€ã®éŒ»ç²èéè·¯ãžã®ããåäžãªååžãæäŸãããš
ãšãã«ãä»ã®æ段ã«ããçããè¬å€ã®æ£è ã®åšå®
ãžã®äŸµå ¥ãæå°ã«ãããã®ã§ã6αâãã«ãªãâ
11βïŒ16αïŒ17ïŒ21âããã©ããããã¬ã°ãâïŒïŒ
ïŒâãžãšã³âïŒïŒ20âãžãªã³ç°åŒ16ïŒ17âã¢ã»ã¿
ãŒã«ã®æäžã«ãããŠåŸãããå©ç¹ã¯éåžžã«å€ãã
ããµã©ã€ãã®åŽå¯ã«ãã€ãŠã¯ãïŒæ¥ã«ã€ãïŒåæ
äžã§ïŒåã®åŽå°30mcïœãæ¬çºæã®ãã®æ æ§ã®äž
å ·äœäŸã«åŸãè¡ãªãã¹ãã§ãããšèããããã æ¬çºæã®ç©ºæ°è¢ã¯ãè¬å€ã®ééã«å¯ŸããŠãäžé
éãã§ãããšèšèŒãããŠããããšã«æ³šç®ãã¹ãã§
ãããæ¬çºæã®ç©ºæ°è¢ã®ææãšããŠèããããã
ãªãšãã¬ã³ã®ãããªææã¯ãäŸãã°ãçµç®è¬å€æ
äžæ¹æ³ã®æº¶è§£æ§èã«ãŠçšããããæ¯èŒçäœéã®è¬
å€ååã®ééã蚱容ãããšç解ãã¹ãã§ãããã
ããã€ãŠããäžééããªãèªãããè¬å€ãçæé
ã ã空æ°è¢ãšæ¥è§Šããæ¬çºæã§ã®äœ¿çšã«ã¯ãè¬å€
ååã®ééã«å¯ŸããŠå®è³ªçã«äžééã§ããææã
æ¡çšãããããªãšãã¬ã³ããã³æ¬çºæã®ç©ºæ°è¢ã®
æ§é ã«é©ããæ¬çºæã®ç¯å²å ã«ããä»ã®ææãæ¡
çšããããšç解ãã¹ãã§ããããŸããæ¬çºæã®äž
ã€ã®æ æ§ã«ãããŠã¯ãè¬å€ã«å¯ŸããŠã¯å®è³ªçã«äž
ééã§ããããããããã®ç©ºæ°ã®ééã¯èš±å®¹ãã
ã空æ°è¢ææãæ¬çºæã«ãããŠæå©ã«äœ¿çšã§ãã
ããšãèªãããããããããçŸåšãæ¬çºæã®ãã®
ç¹å¥ã®æ æ§ãæºè¶³ããææã¯å®éã«ã¯ååšããª
ãã ãŸããããæ£è ã«å¯ŸããŠããšãã«å°å ããã³è
人ã®æ£è ã®å Žåã«ã¯ããªãŒãç¬ã®ãããªä¿¡å·æ段
ã¯æºè¶³ãªçµæã瀺ããªãããšãããããããšã«æ³š
æãã¹ãã§ãããåäŸã¯ãç解ã®æ¬ åŠããŸãã¯å€§
人ã®å Žåã«æ±ããããå»è ã®æ瀺ã«åŸãèšç·Žãäž
è¬çã«æ¬ åŠããŠãããç¬ã®ãåœä»€ãã«åŸãããšã
å°ãªãããã§ãããè人ã®æ£è ã«ãã€ãŠã¯ããã°
ãã°ãèŽåã®åé¡ã«ééããããããã€ãŠã第ïŒ
å³ã®ç©ºæ°è¢ã¯ãåèšäºæ¹åæµè·¯å ã«ç©ºæ°æµææ段
ãæããããã«å€åœ¢ããŠããããããã«ãããæ£
è åŽã倧ããªåªåãã¯ãã€ããšããŠãã該äºæ¹å
æµè·¯ãéãäžå®ã®æ倧空æ°æµéééãè¶ããããš
ã¯å®¹æã§ãªããªããããªãã¡ãä»ã®å Žåã«ã¯ä¿¡å·
æ段ã«ãã€ãŠå¶åŸ¡ãããäžå®ã®æ倧空æ°æµéã¯ã
äºæ¹åæµè·¯ã«æµææ段ãå å«ããããšã«ãã€ãŠã
該äºæ¹åæµè·¯ã«åºæã®æ倧空æ°æµéãšããããšã
ã§ããã第ïŒå³ã«ç€ºããæµææ段ïŒç¬¬ïŒå³ã®æ æ§
ã®ããŠã¹ããŒã¹ã®äžéšã ãã瀺ãïŒã®ããšããã¯
ãã·ã€ãŒåœ¢ãã€ã¹ã¯ïŒïŒãåãããã該äºæ¹åæµ
è·¯ãéã€ãŠééã§ãã空æ°éã¯ããªãªãã€ã¹ïŒïŒ
ãæããã¯ãã·ã€ãŒåœ¢ãã€ã¹ã¯ïŒïŒã«ãã€ãŠå¶é
ãããŠãããã¯ãã·ã€ãŒåœ¢ãã€ã¹ã¯ïŒïŒã¯ã第ïŒ
å³ã«ã瀺ããã¯ãã·ã€ãŒåœ¢ãã€ã¹ã¯ïŒïŒã«å ã
ãŠãä»ã®æµææ段ãšããŠã¯ã第ïŒå³ã«ç€ºããã¬ãŒ
ã ïŒïŒã«åŒµãããã¹ã¯ãªãŒã³ïŒïŒãåãããã¬ãŒ
ã ïŒïŒãæããã¹ã¯ãªãŒã³éšæïŒïŒãæãããã
ããã¯ã第ïŒå³ã«ãããä»ã®åœ¢æ ã®ã¯ãã·ã€ãŒåœ¢
ãã€ã¹ã¯ïŒïŒã眮ãæãããã®ã§ããã第ïŒå³ã
ãã³ç¬¬ïŒå³ã«ç€ºããæµææ段ã®ä»£ããšããŠãäºæ¹
åæµè·¯ãéãåäœæéåœããã®ç©ºæ°éãæžå°ãã
ã該äºæ¹åæµè·¯å ã®ä»ã®é害ç©ã䜿çšããããŸ
ããè¬å€ã空æ°è¢ã«å ¥ãå°ç¹ããå£ãšã€ãªããå°
ç¹ãŸã§ã®éã®äºæ¹åæµè·¯ã®äžéšãŸãã¯å šéšããåŽ
é§ãããè¬å€ã®äŸµå ¥å°ç¹ãšç©ºæ°è¢ã®éã®äºæ¹åæµ
è·¯ã®æé¢ç©ãããçãæé¢ç©ãæããŠãããã éåžžã«åŸ®å°ãªç²åãæ°ç®¡æ°ç®¡æ¯æš¹ã«æäžããã
ãšãå¿ èŠãªæ¬çºæã®ä»ã®æ æ§ã«ãããŠã¯ã第ïŒå³
ã«ç€ºãããããªéåžžã«å°ããªç²åã ãã蚱容ãã
ã¹ã¯ãªãŒã³ãçšããŠããããäŸãã°ãã°ã©ã é°æ§
èºçã®å Žåã«ã¯ã掻æ§è¬å€ãäŸãã°ãã²ã³ããã·
ã³ãµã«ããšãŒãïŒgentimicin sulfateïŒã§èºã®æ
ãæ·±ãåºåãæ²»çããããšãæãŸãããè¬å€ã®é§
ã倧ããªç²åãæããå Žåã倧ããªç²åã¯ãèºã®
æ·±ãåºåã«å°éããåã«æ°ç®¡æ°ç®¡æ¯æš¹ããææã
ãããäŸãã°ãç²åŸçŽ0.1ãã¯ãã³ä»¥äžã®å°ããªç²
åã ããééããããã¹ã¯ãªãŒã³ãåããããšã«
ãããæ£è ã¯ãã®è¬å€ã®å®è³ªéšåãèºã®ææã®æ
ãæ·±ãåºåã«éããããã«è¬å€ã®åŽé§ãåããã
ã²ã³ããã·ã³ãµã«ããšãŒããã°ã©ã é°æ§èºçã®æ²»
çã«çšããæ¬çºæã®æ æ§ã®äžå ·äœäŸã«ãããŠã第
ïŒå³ã«åŸã€ãŠæ¹è¯ãã0.1ãã¯ãã³ä»¥äžã®çŽåŸã
æããç²åã ããééãããã¹ã¯ãªãŒã³ã«ãŠå€åœ¢
ãã第ïŒå³ã®è£ 眮ã«ããäžåã®åŽé§è¬å€éã¯ä»£è¡š
çã«ã¯60mgã§ããã
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1983/000736 WO1983003976A1 (en) | 1982-05-12 | 1983-05-12 | Device and method for delivery of a drug |
US377469 | 1989-07-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS59500900A JPS59500900A (ja) | 1984-05-24 |
JPS6349511B2 true JPS6349511B2 (ja) | 1988-10-04 |
Family
ID=22175137
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP50197683A Granted JPS59500900A (ja) | 1982-05-12 | 1983-05-12 | è¬å€ã®éåºè£ 眮 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS59500900A (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2768379C (en) * | 2009-07-17 | 2017-10-10 | David Mark Blakey | Negatively biased sealed nebulizers systems and methods |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4119097A (en) * | 1977-02-03 | 1978-10-10 | Applied Research Commodities Industries, Inc. | Emergency oxygen supply |
-
1983
- 1983-05-12 JP JP50197683A patent/JPS59500900A/ja active Granted
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4119097A (en) * | 1977-02-03 | 1978-10-10 | Applied Research Commodities Industries, Inc. | Emergency oxygen supply |
Also Published As
Publication number | Publication date |
---|---|
JPS59500900A (ja) | 1984-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0108145B1 (en) | Device for delivery of a drug | |
Rau | The inhalation of drugs: advantages and problems | |
US4926852A (en) | Medication delivery system phase one | |
Newman et al. | Therapeutic aerosols 1--physical and practical considerations. | |
US5320094A (en) | Method of administering insulin | |
Tobin et al. | Response to bronchodilator drug administration by a new reservoir aerosol delivery system and a review of other auxiliary delivery systems | |
Fink | Aerosol delivery to ventilated infant and pediatric patients | |
DOLOVICH | New propellant-free technologies under investigation | |
Newman et al. | Effect of InspirEase on the deposition of metered-dose aerosols in the human respiratory tract | |
SchÃŒepp et al. | In vitro determination of the optimal particle size for nebulized aerosol delivery to infants | |
Ariyananda et al. | Aerosol delivery systems for bronchial asthma | |
JP2010088864A (ja) | ããªãªãã¯ã¹ãçšãããšã¢ããŸã«åããè¬ç©ã®åžå ¥ã®ããã®å»çããã€ã¹ | |
US20130118485A1 (en) | Means and method for administering medicaments to infants | |
O'Callaghan et al. | Evaluation of techniques for delivery of steroids to lungs of neonates using a rabbit model. | |
Newhouse et al. | Clickhaler (a novel dry powder inhaler) provides similar bronchodilation to pressurized metered-dose inhaler, even at low flow rates | |
Robertson et al. | Treatment of acute asthma: salbutamol via jet nebuliser vs spacer and metered dose inhaler | |
Barry et al. | Nebuliser therapy in childhood | |
Fok et al. | Aerosol delivery to nonâventilated infants by metered dose inhaler: Should a valved spacer be used? | |
Tobin | Use of bronchodilator aerosols | |
Zainudin et al. | Influence of breathing pattern on lung deposition and bronchodilator response to nebulised salbutamol in patients with stable asthma. | |
Reiser et al. | Inhalation treatment for asthma. | |
Pedersen et al. | Comparative efficacy of different methods of nebulising terbutaline | |
König et al. | A trial of metaproterenol by meteredâdose inhaler and two spacers in preschool asthmatics | |
JPS6349511B2 (ja) | ||
Rivlin et al. | Effect of administration technique on bronchodilator response to fenoterol in a metered-dose inhaler |